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ANP: Atrial Natriuretic peptide (also Nppa)
AVC: Atrioventricular canal
Bcl2: B cell leukemia/lymphoma 2
Bmp: Bone morphogenetic protein
Bst: Belly spot and tail
Cdk4: Cyclin-dependent kinase 4
Cnc: Cardiac neural crest
Dpp: Decapentaplegic
??????????????????????????????????????
ECM: Extracellular matrix
EGF:  Epidermal growth factor
EMT: epithelial to mesenchymal transition
EPDCs: Epicardial derived cells
????????????????????????????????????????
?????????????????????
Fwe: Flower
iMOS: Inducible mosaics
ISH: In situ hybridization
IVS: Interventricular septum
LV: Left Ventricle
MEF2C: Myocyte enhancer factor 2C
mESC: Mouse embryonic stem cell
MI: Myocardial infarction
Myc: Myelocytomatosis oncogene
Mycn: v-myc myelocytomatosis viral related oncogene, neuroblastoma derived
Myh6: myosin, heavy polypeptide 6, cardiac muscle, alpha
Nppa: See ANP
?????????????????
PE: Proepicardium
PHH3: Phosfohistone 3
Pi3K: Phosphatidylinositol 3-kinase
Tbx18: T-box18
TGFb: Transforming Growth Factor beta
VFW: Ventricular free wall
WT: Wild-type
Wt1: Wilms tumor 1 homolog
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Heterogeneous anabolic capacity in cell populations can trigger a phenomenon known as cell competition, through which less active cells are eliminated. Cell 
competition has been induced experimentally in stem/precursor cell populations 
in insects and mammals and takes place endogenously in early mouse embryo-
?????????????????????????????????????????????????????????????????????????????????
cardiomyocytes by mosaic overexpression of Myc both during gestation and adult 
life. The expansion of the Myc-overexpressing cardiomyocyte population is driven 
by the elimination of wild type cardiomyocytes, which happens through apoptosis 
in the embryonic heart and autophagic cell death in the adult cardiomyocytes. 
Importantly, this cardiomyocyte replacement is phenotypically silent and does not 
affect heart anatomy or function. Myc overexpression in the adult heart induces a 
cardioprotective response through the reactivation of fetal programs.
 Moreover, cell competition induction in the epicardium  during development shows 
an increased contribution of this lineage to cardiac myocytes. These results show 
that capacity for cell competition in mammals is not restricted to stem cell popula-
tions and suggest that stimulated cell competition has potential as a cardiomyo-
cyte replacement strategy.
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L?????????????????????????????????????????????????????????????????????????-cadena un fenómeno que se conoce como Competición Celular, mediante 
el cual las células metabólicamente menos activas son eliminadas. La competi-
ción celular se ha inducido experimentalmente en poblaciones de células madre/
progenitoras en insectos y mamíferos y se ha demostrado que ocurre de forma 
endógena en células madre embrionarias de ratón. En esta tesis demostramos 
que la competición celular puede inducirse en cardiomiocitos de ratón mediante 
sobreexpresión en mosaico de Myc, tanto en desarrollo como en el corazón adul-
to. La expansión de los cardiomiocitos que sobreexpresan Myc tiene lugar debido 
a la eliminación de los cardiomiocitos salvajes. 
Cabe resaltar que este reemplazo de cardiomiocitos ocurre de manera fenotipica-
mente silenciosa y no afecta a la anatomía o función cardiacas. 
Aún más, la inducción de competición celular en el epicardio (que ha demostrado 
ser una población celular con características de células progenitoras) durante el 
desarrollo da lugar a un aumento en la contribución de dicho linaje a cardiomio-
citos.
Estos resultados demuestran que la capacidad de competir en células de mamí-
fero no se restringen a poblaciones de células madre y se propone que el estímu-
lo de esta capacidad celular podría tener potencial en estrategias de reemplazo 
de cardiomiocitos.
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Cell competition
During evolution, multicellular organisms 
have evolved different ways to ensure the 
proper development of their organs and tis-
sues. Such mechanisms rely on complex in-
teractions between cells and depend on the 
integration of different signals that  will lead 
to cell survival or cell death. If cells fail to  re-
ceive appropriate signals from their neigh-
bours they undergo programmed cell death 
(Raff 1992).
????? ? ??????????? ? ??? ? ???????? ? ?????????
signals provides a way to eliminate mispla-
ced cells, to regulate cell numbers and, per-
?????? ?????????? ???? ???????????????????????????
the mainteinance of the homeostasis of the 
whole organism. 
One such mechanism that has been pro-
posed to ensure homeostasis is cell compe-
??????????????????????????????????????????????
given context colonize the tissue at the ex-
????????? ??????????? ????? ??? ?????????????????
eliminated by induction of apoptosis. There-
fore, cell competition is acting as a quality 
control system to eliminate suboptimal cells.
????? ???????????? ???? ????? ??????? ??????
Cell competition has only recently been described to be a mechanism that en-
?????????????????????????????????????????-
pment (Claveria et al., 2013). 
However, whether it is a universal featu-
re to all cells and tissues in the embryo or 
restricted to pluripotent cells in the epiblast, 
remains to be determined. In this thesis we 
address how cell competition can be induced 
in the developing heart as well as in adult 
cardiomyocytes in homeostatic conditions. 
Moreover, we explore the possibility of in-
ducing cell competition among heart lineages 
????????????????????????????? ????????????????
the putative use of cell competition in heart 
regeneration approaches.
various contexts and comprises different ty-
???? ??? ???????????? ?????????????? ???? ???????
feature that underlies cell competition is the 
elimination of cells that are viable on their 
own but actively eliminated when confronted 
with more competitive cells. 
????????????????????????????????????????????
in three types regarding the characteristics of 
??????????????????????????????????????????????
3). 
- Canonical cell competition (Morata and Ri-
poll, 1975): In this type of cell competition wild-
type (WT) cells outcompete neighbouring cells 
that are somehow defective in their competi-
??????????????????????????????????????????????
Cell competition
Supercompetition
Supercompetitor:
Myc overexpression
Wild type cell
M/+ cell
????????????????????????????????????????-­‐
????????????????????? ????????
????????????????????????????????????????????
?????????????????????? ?????????????????? ??????
?????????????????? ??????Minute/+????????????
??????????? ????? ??? ????? ?????? ???? ????????
???????????? ???????? ???????????????????????
????????????????????????????Minute/+?????????????
???????????????????? ?????
????????????????????????????? ????????????
??????????????????????????????????????????????
?? ?????????? ??????????? ???? ?????? ????? ??????
?????????????????????????????????? ??????????????
???????????? ?????????????????????? ????????????
??????????????????????? ??????????????????????
??????? ????? ?????????? ????? ??????? ????????
????
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in an homotypic enviroment.
-  Supercompetition: (Moreno and Bas-
ler 2004) Supercompetitor cells have been 
???????????? ????????? ???? ????? ????????????
confers them a competitive advantage over 
????????????????????????????????????????????
growing in a mosaic fashion. 
-  Endogenous cell competition: (Claveria, 
et al. 2013)
Endogenous cell competition has only very 
recently been described, in contrast with the 
previously mentioned types. It has been pro-
????????????????????????????????????????????-
?????? ????????? ???????? ?????? ?????? ????????
induced.
The studies leading to the description of 
these three types of cell competition as well 
as factors implicated in one or more compe 
??????? ????????????? ????????????? ??????????????
but all three types share the non-cell-autono-
mous elimination of “loser cells”, that are only 
?????????????????????????????
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??????? ??? ????? ??? ????? ?? ????? ????????
???? ?????? ?????? ???? ????????? ????????
????? ????? ????????? ????? ???????????????
???????????????????????????????????? ??????
??????????????????????????????????????????
???????????????????????????????????????
?????? ??????? ???? ??? ????????? ???????
????? ???????? ??????? ??? ??????? ??????
??????????????? ????????????????????????
???? ??????? ??? ??????? ?????? ????? ????
??????????????????????
????????? ????? ????????? ???? ???????
??????
A little bit of history: lessons from the 
??
First observation of the phenomenon now 
termed cell competition was reported almost 
40 years ago by Ginés Morata and Pedro 
Ripoll (Morata and Ripoll, 1975)(reviewed in 
Diaz and Moreno, 2005) using Drosophila’s 
wing disc, where two different cell popula-
tions that differed in metabolic rates were 
?????????????????????????????????????????????
would have otherwise been viable were eli-
minated when growing in the presence of 
cells that were metabolically more active. 
This experiment was performed using Minu-
te???????????????????????????????????????????
proteins, lacking full ribosome machinery. 
Homozygous Minute? ????? ???? ???????? ????
when the mutation is carried in heterozigosi-
ty, they are viable and develop forming nor-
???????????? ???????????????????????????????????
rate. 
However, when Minute/+ (M/+) cells were 
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growing in a mosaic wing in direct confron-
tation with wild type cells, they were comple-
tely eliminated (Morata and Ripoll 1975). The 
conclusion from this was that Minute cells, 
although viable on their own, were elimina-
ted when they had to grow among wild-type 
cells, metabolically more active. 
This model was supported by several stu-
dies that followed. Simpson (Simpson, 1979) 
used a starvation model, that allowed to redu-
ce growth rates in the wing disc. It was des-
cribed that, in starvation conditions, M/+ cell 
elimination happened at a slower rate, and 
??????????????????????????????????????????????
This way it was demonstrated that diffe-
rences in growth rates driven by metabolic 
activity (abolished upon starvation) underlaid 
Minute/+????????? ??????????? ???????????????-
viewed in de Beco et al., 2012).
It wasn’t until many years later that some 
light was shed on the phenomenon of cell 
competition. In 2002 a study was published 
reporting that cells in the imaginal disc could 
be competing for survival or growth factor 
signals and that differences in ligand capture 
mediated the elimination of M/+ cells. 
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Heterogeneous Myc levels Re!ned Myc levelsCell competition
Myc levels  
E6.5 E9.5 
?????????? ????????????????
???????????????????????-­‐
??????? ?????????
? ??? ??????????????????????
????? ??????? ?????????????
???? ??????? ???? ??????????????
?????????????? ???? ?????
??????? ????? ??????????
??????? ???? ????????? ?????
??????????????????????????
???????? ??? ?????? ????? ????
???????? ???? ???????? ??????
????? ?????????? ??????????
????????????????????????????
??? ???? ????????? ????? ??????
???????????????????????????
??????????
In the model proposed, cells compete for 
a secreted protein involved in cell survival, 
???????????????????????????????????????b 
????????????????????????????????????????????-
llant, 2005, Milan, 2002). They reproduced 
classic experiments using Minute mutants 
???? ??????? ?????M/+ cells were eliminated 
by apoptosis when confronted with a WT 
?????????????????????????????????????????
how blocking apoptosis using the baculoviral 
inhibitor p35 reduced cell competition. It was 
described that in Minute cells, uptake of Dpp 
signal is defective, leading to apoptotic cell 
death. In this model, suboptimal cells would 
have a reduced Dpp uptake, which would 
lead to their elimination.
 Despite the relevance of this study and 
the description of the ligand capture model, 
many mechanistic questions remained unan-
swered. The relevance of the ligand-captu-
re model and other trophic theories for cell 
???????????? ??? ?????? ?????????? ??????? ????????
the condition of a limiting amount of survi-
???? ???????? ?? ??????? ????? ???????? ???? ???-
???????? ??? ????? ??????? ??? ???????? ????????
Yamada and O’Connor, 2002, Gibson and 
30
Perrimon, 2005, Shen and Dahmann, 2005).
Supercompetition  
In 2004 two papers linking cell competition 
to the proto-oncogen dMyc generated a new 
wave of interest in this process. dMyc is a 
??????????????????????????????????????Myc 
transcription factors (which includes Myc, 
Mycn and L-Myc), and it is able to regulate 
the expression of many genes involved in cell 
proliferation, growth, and the cell’s anabolic 
machinery, including ribosome biogenesis 
????????????????????????????????????????????
Bellosta and Gallant, 2010).  
These two papers studied the role of dMyc 
in cell competition and its implications by 
inducing clonal dMyc overexpression in the 
wing disc (de la Cova et al., 2004, Moreno 
and Basler, 2004). Clones expressing high 
levels of dMyc were able to expand at the 
????????????????????????????????????????????????
compartment. This expansion required the 
elimination of wild-type cells by apoptosis. In 
this context wild-type cells behaved as “lo-
sers” and thus dMyc overexpressing cells 
were termed “supercompetitors”.
 It was also shown that these supercompe-
titor cells (expressing two additional copies 
of dMyc) behaved as “winners” when con-
fronted with wild type cells but were “losers” 
if confronted with cells expressing four extra 
dMyc copies (Moreno and Basler, 2004).
This supported the idea that it’s not abso-
lute dMyc levels that drive cell competition 
but rather the relative dMyc in a given cell 
population. 
Moreover, cell competition was not a sim-
ple outcome of cell overproliferation, since 
overexpression of different known factors in-
ducing cell growth (Pi3K, Dp110) or cell cycle 
regulators (CyclinD and Cdk4) was unable to 
eliminate wild-type cells however much the 
??????????????? ??????????????????????????
de la Cova et al., 2004).
In this context, dMyc???????????????????????
comparable to Minute/+ cells, suggesting 
that the force driving cell competition is dMyc 
control over the cell’s anabolic machinery. As 
in Minute classic experiments, dMyc-overex-
pressing clones only expanded within their 
??????????????????????????????????????????
There are, however, some differences 
between classic cell competition and super-
competition, since it has been described that 
Minute-driven cell competition required cell-
cell contact (Martin et al., 2009) and dMyc- 
driven cell competition could be triggered 
about 10 cell diameters away (de la Cova et 
al., 2004).
This is consistent with an in vitro study per-
formed using Drosophila’s cells in which con-
ditioned media from cell competition could 
induce a competitive response (Senoo-Mat-
suda and Johnston, 2007).
All of these data further support the idea 
???????????????????????????????????????????????????
between neighbouring cells what drives cell 
competition and that some sensing mecha-
nism has to allow cells to communicate their 
?????????????????????????????????
 Other players involved in cell competi-
tion in Drosophila 
Recently other pathways have been linked 
to cell competition, either more players in the 
already described cell competition or novel 
pathways that affect cell competition in di-
????????????????????????????????????????????????
adding more factors that trigger cell compe-
tition, more mediators or cell-cell signals im-
plicated. 
We will only mention some of them since 
in-depth analysis of these pathways falls out 
of the scope of this thesis.
Regarding which factors are able to induce 
????????????????????????????????????????????-
terized in two groups:
1.- Those that involve differences in ana-
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bolic ability, resulting in different growth ra-
?????????????????????????????????????????????-
llcompetition (Morata and Ripoll, 1975, More-
no et al., 2002, Simpson and Morata, 1981).
2.- Those in which epithelial integrity is al-
tered. Cells lacking basolateral proteins such 
as Scribble, undergo apoptosis in the presen-
ce of wild-type cells. (Norman et al., 2012). 
Even if we will not describe this in detail, 
loss of epithelial integrity has been described 
both in Drosophila (Igaki et al., 2006, Froldi 
et al., 2010) and in mammalian models (Nor-
man et al., 2012) (Tamori et al., 2010) to be a 
trigger of cell competition.
Engulfment as a requirement for cell 
competition?
Studies of cell competition performed using 
Minute mutants showed that competitive cell 
death of M/+ cells by WT clones that expan-
ded at their expense, usually happened whe-
re both cell populations were adjacent.
 This suggested the existence of winner/lo-
ser contact-dependent induction of cell dea-
th, and hinted for a requirement of loser cell 
engulfment by winner cells for cell competi-
????? ????????? ????????????????????? ?????????
in Li and Baker, 2007). It also addressed the 
question of the fate of the outcompeted bo-
dies and how they are eliminated from the 
tissue, since initial observations claimed that 
apoptotic cells were extruded from the tissue 
and accumulated basally (Moreno and Bas-
ler, 2004). 
It was described that M/+ cells adjacent 
to WT population were 5-10x more likely to 
undergo apoptosis than cells that weren’t 
in contact. Moreover, corpses of M/+ cells 
were typically found within the cytoplasm of 
WT cells. This led to the thought that engulf-
ment played a major role in loser cell corpse 
clearance. To test this, genes involved in en-
gulfment were mutated, which resulted in an 
abrogation of cell competition (Li and Baker, 
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 However, these results have not been re-
??????????????????????????????????????????????
et al., 2013), and it has also been proposed 
that engulfment was only required for the 
elimination of already delaminated cells and 
mostly performed by haemocytes since win-
ner cells didn’t need to express engulfment 
genes forcell competition to occur. 
This reopened the question of the mecha-
nism responsible for the elimination of loser 
cell corpses and also of the meaning of loser 
cell increased apoptosis at clonal bounda-
ries. 
The Flower code
A possible mechanism that could explain 
apoptosis of loser cells in clonal boundaries 
would be a cell-cell communication of the 
???????????????????????????????????????????????-
?????????????????????????????????????????????
??????????????????????????????????????????-
ker that would allow cells to compare each 
other’s anabolic status. 
Using gene expression arrays, several ge-
nes that were expressed during cell competi-
????????????????????????????????????????????
a membrane calcium channel involved in 
endocytosis and exocytosis. Further assays 
lead to propose it as a mechanism that would 
?????? ????????????? ?????? ??? ??????? ?????? ??-
ness: Flower (fwe) (Rhiner et al., 2010). Fwe 
protein contains 3 to 4 transmembrane do-
mains and it is found in three isoforms, which 
express different C-terminal regions exposed 
to the extracellular space. One of Flower’s 
isoforms is predominant and it is expressed 
in WT cells: fweUbi. By induction of supercom-
petition driven by dMyc overexpression, WT 
loser clones were found to express two other 
isoforms: fweLose-A and fweLose-B. 
These isoforms were also expressed in lo-
ser cells in Minute induced cell competition 
(Rhiner et al., 2010). 
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If FweLose isoforms were forcedly expressed 
in wild-type cells homogenously, no effect 
was observed. However, when they were 
expressed in clones, they strongly induced 
apoptosis. 
Moreover, upon reduction of the FweUbi le-
vels in clones, this effect was also observed, 
suggesting that the ability of Fwe to induce 
cell death is strongly context dependent, 
relying on the cell-cell differences in Fwe iso-
form expression. 
Loss of Fwe expression doesn’t affect non-
???????????????????????? ???? ???????? ??????????
Fwe is proposed to be a downstream effector 
of cell competition, labelling loser cells and 
leading to their elimination. 
The regulation mechanism by which fwe 
mRNA is alternatively spliced into Ubi or Lose 
forms is still to be determined, as well as how 
this extracellular code is interpreted in order 
to lead to cell death or cell survival. 
Cell competition relevance for cancer
All of these studies leave an open ques-
tion on whether cell competition is a univer-
sal feature in metazoans, since it could have 
potential implications in homeostasis, can-
cer and regeneration. Several studies have 
linked cell competition to genes implicated in 
cancer, such as Myc but also the tumor su-
????????????????????????????????????????????
Chen et al., 2012), Jak/Stat signalling pa-
thway (Rodrigues et al., 2012) and tumor su-
ppressor p53 (de la Cova et al., 2014).
It is thought that cell competition could be 
implicated in the growth of tumour cells, lin-
king supercompetition with the precancerous 
?????? ?????????????????????????????????????-
lonize the tissue by eliminating surrounding 
cells (Rhiner and Moreno, 2009, de Beco et 
???????????????????????????????????????????
However, the role of cell competition in 
cancer is still unclear, since it has also been 
proposed to be a mechanism involved in tu-
 
mor supression, by driving the elimination of 
?????????????????????????????????????????????
the accumulation of cells carrying mutations 
????????????????????????????????????????????????
It was then necessary to elucidate the role 
of cell competition in mammalian models to 
further understand its possible implications 
and relevance for cancer.
Cell competition in mammals
A couple of early studies had suggested 
that cell competition could be an extended 
mechanism among metazoans:
The ‘Belly spot and tail’ (Bst) mutation is 
?? ?????? ??????????? ??? ???? ??? Minute mu-
tants, since these mice are defective in the 
ribosomic protein L24. As in Drosophila Mi-
nutes, homozygous Bst mice are not viable, 
whereas heterozygous show decreased pig-
mentation and a kinked tail, along with some 
??????????????????????????????????????????????-
nerating chimaeras it was shown that Bst/+ 
?????????????????????????????????????????????-
sadvantage in the presence of wild-type cells 
(Oliver et al., 2004), however this study did 
not address whether the observed differen-
ces resulted from cell-autonomous features 
or from cell competition. 
A further study was published, suggesting a 
role for cell competition in liver regeneration 
(Oertel et al., 2006). Upon partial resection 
??????????????????????????????????????????????????
and it was shown that fetal hepatocytes gra-
fted and proliferated in the host for long pe-
riods being able to replace up to 23% of the 
liver mass. Moreover it was also shown that 
this repopulation was associated with increa-
sed apoptosis of host hepatocytes immedia-
tely adjacent to the transplanted fetal ones 
(Oertel et al., 2006). 
 Two studies published later assessed the 
role of the tumour suppressor gene p53. A 
form of cell competition based on stress and 
mediated by p53 was described, being res-
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tricted to the hematopoietic compartment. In 
this case, cell competition induced a senes-
cence-like phenotype in outcompeted cells 
rather than their apoptotic elimination (Bon-
dar and Medzhitov, 2010, Marusyk et al., 
2010). When mixed with irradiated wild-type 
cells, cells with mutant p53 have an advanta-
ge and become winners, repopulating hosts 
??????????????????????????????????????????????-
tion selects for less damaged cells by com-
paring p53 levels (Bondar and Medzhitov, 
2010).
Loss of epithelial polarity has also been re-
lated with cell competition in vitro in several 
studies (Tamori et al., 2010) which describe 
???? ???? ????? ?? ?? ????????????????????? ????????
cell competition in mammals.  More recently, 
it has been reported in a mammalian model 
in vitro how loss of Scribble in clones induced 
them to be eliminated (Norman et al., 2012). 
All of the mentioned assays performed in 
mammalian systems suggested that cell 
competition could be a universal characteris-
tic of metazoans. 
The reports of cell competition commented, 
however, involved the experimental introduc-
tion of stress or mutations and did not address 
the potential roles of natural cell competition 
in normal developmental or tissue homeos-
tasis processes. Clavería and colleagues 
approached the study of cell competition in 
mammals by developing a system of indu-
cible mosaics based on Cre recombination 
(Clavería et al., 2013). Recombination gene-
?????? ?????????????? ???????????????????????????
one of which overexpresses Myc under the 
control of the Rosa26 promoter. Using this 
system, it was demonstrated that supercom-
petition could be induced in the mouse epi-
blast and that it provoked the phenotypically 
silent replacement of wild type cells. 
 This replacement relied on apopto-
sis of WT loser cells that was shown to 
be contact dependent, as WT cells in di-
rect contact with Myc overexpressing ones 
showed higher apoptotic rates. Moreover, 
it was demonstrated that cell competition 
occurred endogenously in the epiblast. Epi-
blast pluripotent cells were shown to have 
high number of naturally occurring apopto-
tic events and express Myc in an heteroge-
neous fashion, which was not observed with 
other pluripotency markers. 
It was shown that those epiblast cells un-
dergoing apoptosis were the ones that ex-
pressed lower relative Myc levels, and thus, 
??? ?????????????????????????????????????????
of the developing embryo. Rescuing cells by 
p35 expression showed that their Myc levels 
were relatively lower than those of the rest of 
the population (they were “loser” cells), indi-
cating that cells that were eliminated in nor-
mal conditions were those which expressed 
less Myc. 
This study also explored cell competi-
tion in vitro in mouse embryonic stem cells 
(mESC). 
??? ???? ????????? ???? ???? ????? ?? ?? ???? ?????
that cell competition could be induced in 
mESC cultures but also that these cultures 
were also subject to endogenous cell com-
petition, dependent on their differences in 
endogenous Myc levels. The mechanism for 
the elimination of loser cells both in the epi-
blast and in mESC cultures was also explo-
red, and it was shown that those cells with 
relative lower Myc levels were engulfed by 
their winner neighbours, shedding some light 
on the mechanism by which loser cell corp-
ses are eliminated and why cell contact could 
be a key mechanism in this elimination.
??????????????? ????????? ??? ????????????????
endogenous cell competition happening na-
turally in the developing embryo and propo-
sed a model in which epiblast cells compare 
their anabolic ability and eliminate those with 
????????????????????????????????????????????????
??????????????????????????????????????????????
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?????? ????????? ???????? ????? ????? ??????????
Flower-mediated endogenous cell competi-
tion in Drosophila  for the elimination of su-
pernumerary neurons (Merino et al., 2013). 
A second study in mESCs demonstrated 
cell competition dependent of BMP receptor 
and Myc levels (Sancho et al., 2013).  It is not 
clear, however, that the phenomena reported 
are equivalent, since in the Claveria study, 
Myc-induced cell competition took place in 
undifferentiated mESCs and required close 
????????? ???????????? ????????????????????????-
ced differentiation was required for competi-
tion and cell competition could be induced by 
transferring the supernatant of the cultures. 
A more recent example of endogenous 
cell competition has been reported for T-cell 
progenitors in the thymus (Martins et al., 
2014). It was shown that resident progenitor 
cells were outcompeted by bone-marrow-
derived colonizing cells upon competition 
for the survival factor Interleukin7 (IL7) and 
that cell competition is required to replace 
thymus-resident progenitors with fresh cells 
???????????????????????????????????????????
cell competition in this context led to a can-
????????????????????????? ????????????????????
suggesting cell competition could play a role 
in eliminating faulty cells and thus preventing 
oncogenic responses. 
These studies open the door to unders-
tanding the role of cell competition in normal 
organism development and physiology.
Despite the universality of cell competition 
mechanism (shown to be conserved across 
metazoans) the studies performed in insects 
and specially those in mammals seem to link 
cell competition to cellular stemness or pro-
genitor states, but this hypothesis remains to 
be tested experimentally. 
In this thesis we explore this issue by asking 
whether cell competition could be induced in 
?????????????????????????????????????????????????
mammalian embryo, the cardiac lineage. 
Heart development
?????????? ??? ??????????????? ??? ????? ??? ????
???????? ???? ???? ???????????? ??? ?? ????????
process that involves the integration of many 
different cell populations that must be incor-
porated into an already functional organ.
 Heart progenitor cells arise from the splan-
chnic mesoderm that migrate anteriorly du-
ring gastrulation to give rise to two regions or 
????????? ??????????????????? ??????? ???????????
both sides of the midline (reviewed in Rana et 
??????????????????????????????????????????
Around day E7.5, these two bilateral regions 
then fuse at the midline to give rise to what is 
????????? ??????? ??????????????????????? ??-
gure 4). These cardiac crescent cells migrate 
to fuse into a heart tube that detaches from 
the splanchnic mesoderm, and remains only 
connected to the dorsal pericardial walls by 
its ends, the arterial and the venous poles. 
This primary heart tube mostly contains left 
ventricle (LV) and atrial precursors, and is re-
?????????????????????????????????????????????
by a myocardial layer lined by an internal en-
docardial layer. However, the majority of the 
precursors that will form the heart remain in 
an undifferentiated state medially and poste-
riorly to the primary cardiac tube. 
This second source of cardiac progenitors 
???????????????????????????????????????????
due to its later contribution to the developing 
heart, although the nature of the dynamics 
and molecular mechanisms underlying  the 
???????????????????????????????????????????-
genitors is still debated. 
???? ????? ?????? ????? ?????? ????? ???????????-
tion lower their proliferation rate and growth 
of the heart tube at this stage relies mostly 
on incorporation of SHF progenitors at both 
poles of the tube (de Boer et al., 2012). The-
se progenitors remain highly proliferative and 
undifferentiated, and are progressively added 
IN
TR
O
D
U
CT
IO
N
35
to the heart tube allowing its expansion. At 
the arterial pole, SHF cells give rise to the 
??????? ?????? ??????? ???? ?????? ?????????? ????
the ventricular septum (Zaffran et al., 2004), 
whereas at the venous pole, SHF progeni-
tors contribute to atria (although the majority 
of cells in the atria come form FHF) and atrial 
septum (Snarr et al., 2008). 
While this addition is taking place, 
the heart undergoes a rightward loo-
ping that positions the forming chambers 
????? ???? ?????? ?????????? ???? ?????? ????-
me displaced cranial to the ventricles.
At this point, chamber regions (LV, RV, atria) 
?????????????????????????????????????????-
??????????????????????????????????????????????????
as opposed to valve forming regions, namely 
atrio-ventricular canal (AVC) which will give 
???????? ??????????????????????????????????????
tract (OFT), where pulmonary and aortic val-
ves are formed. 
During this phase, the chambers reach 
?????? ????? ????????????? ???? ???? ???????????
layer thickens forming a layer of projections 
that invade the heart lumen (the trabecules), 
which allow the myocardium to meet the car-
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?????
diac pumping needs and still allow for proper 
nutrition and gas exchange before the forma-
tion of the coronary vessels. 
This trabecules emerge at around day E9.5 
and last until approximately day E14.5, when 
the myocardium undergoes compaction, the 
trabeculae stop growing and thicken, merging 
with the compact layer of the myocardium. 
As these process takes place, the space 
between trabeculae forms capillaries (re-
viewed in Samsa et al., 2013). 
Afterwards, septation of both atria and ven-
tricles occurs. Cells from neural crest (cardiac 
neural crest or CNC) also become added to 
the developing heart and give rise to the se-
paration of the OFT into aorta and pulmonary 
vein (Kirby and Hutson, 2010). 
Epicardium and its contribution to the 
developing heart
The epicardium is the outermost layer of 
the heart. It derives from an extracardiac 
structure, the proepicardium (PE), a mass of 
cells from the coelomic epithelium that forms 
at the posterior dorsal pericardial wall, near 
the venous pole of the heart, protruding to 
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the pericardial cavity, at around E9.5 (re-
viewed in Perez-Pomares and de la Pompa, 
2011). 
The proepicardial cells then migrate onto 
the looping heart and attach to the myocar-
????? ????????? ?????? ????? ??????? ???? ??????
their characteristic “cobble-stone” morpholo-
gy. The epicardium then undergoes a process 
of EMT (epithelial to mesenchymal transition) 
and gives rise to EPDCs (epicardial derived 
cells) that invade the myocardial layer and 
differentiate into several cell types within the 
developing heart. EPDCs contribute mostly 
to form the coronary vessels and interstitial 
????????????????????????????
EPDCs have been reported to give rise to 
endothelial cells (Perez-Pomares et al., 2002) 
and vascular smooth muscle cells (Mikawa 
and Gourdie, 1996) in the coronary vessels 
???? ??? ???????? ??????????? ?????????????????
Groot et al., 1998). Contribution of the epi-
cardium to the cardiomyocyte population has 
also been reported (Zhou et al., 2008, Cai et 
????????????????????????????????????????????????????
(Christoffels et al., 2009) and remains to be 
elucidated.
Epicardial derived cells (EPDCs)
undergoing EMT
Cardiomyocytes
Fibroblasts
Endothelial cell
Smooth muscle
Epicardium
Myocardium
EPDC
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??????????????? ??????????-­‐
???????????
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??? ??????????? ????????????
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??????????????????????????????
????????? ??????? ???? ????
????????????????????????????
??????? ???? ???????????????
???????? ???? ? ?????? ??????
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Despite the controversy, EPDCs have been 
shown to be a multipotent progenitor within 
the heart (Wessels and Perez-Pomares, 
2004).
 Moreover, studies in adult mice in a myo-
cardial infarction context upon priming have 
shown that epicardial cells are able to reca-
pitulate an embryonic program and give rise 
to new vasculature (Smart et al., 2007) and 
cardiomyocytes (Smart et al., 2011), which 
supports the notion that EPDCs in the adult 
heart can be a source of progenitor cells 
(Chong et al., 2011) with multiple potentials, 
and evidences the need for further studies 
regarding epicardium both in embryonic and 
in adult context.
Maintaining the numbers: cell proli-
feration/renewal in the developing and 
adult heart 
As mentioned previously, during develop- 
ment, the linear heart tube is a slow proli-
ferating structure and during this phase the 
heart grows by addition of cells from the 
????? ?????? ????? ?????????????? ?????? ??????
upon differentiation (Kelly et al., 2001). 
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An increase in cell proliferation takes pla-
ce in the chamber forming regions during the 
ballooning phase (de Boer et al., 2012). 
After that, the fetal heart grows through 
continuous proliferation. In postnatal stages, 
proliferation declines and cardiomyocytes 
undergo binucleation. Thus, there are two 
distinct cycling phases: the fetal one, resul-
ting in cell division and the postnatal one, 
which takes place after birth and results in 
cardiomyocytes entering a quiescent state 
and undergoing binucleation through lack of 
???????????????????????????????????????????????
1996). 
This switch from hyperplastic to hypertro-
phic growth is tightly linked to binucleation 
and “terminal differentiation” of cardiomyo-
cytes. Caryokinesis without cytokinesis is 
therefore associated with the loss of the pro-
liferative capacity. 
Moreover, lower vertebrate species in which 
cardiomyocytes do not undergo binucleation, 
have been long shown to be able to regene-
??????????????????????????????????????????????
the ventricle is undivided, and the animal can 
survive removal of the apex. 
It was shown  in 1974 that newt heart could 
undergo a resection of its ventricle and grow 
??? ?????? ?????? ???? ?????????? ???? ?????????
close to the wound (Oberpriller and Oberpri-
???????????????????????????? ?????????????????
been stablished as a cardiac regeneration 
model (Poss et al., 2002, Raya et al., 2003). 
The fact that mammalian heart underwent 
a phase of hypertrophic growth and binuclea-
tion associated with the loss of proliferative 
capacity, led to the long-standing belief that 
the heart was a fully “post-mitotic organ” and 
unable to regenerate.  While this view holds 
true for the most part of the postnatal life, it 
has been shown that postnatal heart retains 
regenerative ability until P7 (postnatal day 7) 
(Porrello, Mahmoud et al. 2011), coinciding 
with the cessation of developmental proli-
feration of cardiomyocytes (Soonpaa et al., 
1996). 
The question on adult cardiomyocyte tur-
nover rate remains controversial, although 
it is widely accepted now that some degree 
of cardiomyocyte renewal takes place in the 
mammalian adult heart. 
Several studies report a low rate of car-
diomyocyte renewal in homeostatic condi-
tions both in humans (Bergmann et al., 2009, 
Kajstura et al., 2010) and rodents (Soonpaa 
and Field, 1997, Senyo et al., 2013, Ali et al., 
??????????????????????? ?????????????????????????
cardiomyocytes and cardiomyocyte renewal 
is increased near the border of the infracted 
zone (Senyo et al., 2013). 
Despite intensive research regarding this 
topic, the results are intensely debated and 
proliferation rates of existing cardiomyo-
cytes in the adult heart differ, ranging from 
1% (Soonpaa and Field, 1994, Bergmann et 
al., 2009) to 40% per year (Kajstura et al., 
2010). 
Interestingly, it has also been shown that 
inducing cardiomyocyte-restricted Cyclin D2 
expression resulted in regenerative growth in 
injured hearts (Pasumarthi et al., 2005). The 
proliferative activation of cardiomyocytes led 
to a clear reduction in scarring and an increa-
sed number of cardiomyocytes, concomitant 
with improved heart function and anatomy 
following myocardial infarction (MI).
Therefore, new insight on the heart capaci-
ty to replenish cardiomyocytes in homeosta-
???????????????????????????????????????????????
implications of further studies addressing this 
issue would be very relevant for the future of 
cardiovascular medicine. 
Dealing with stress: how the heart res-
ponds to physiological and pathological 
challenges
In the adult heart, growth of the organ 
usually corresponds to its functional load. In 
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responses to changes in demand, the heart 
triggers a hypertrophic response to counter-
balance the increase in wall stress (reviewed 
in (McMullen and Jennings, 2007). 
Hypertrophic responses in the adult heart 
???? ???????? ?????????? ??? ?????????????? ????
pathological, and although they both share 
common features they are caused by diffe-
rent stimuli and associated with different mo-
lecular and cellular responses (Iemitsu et al., 
2001).  
Pathological cardiac hypertrophy is as-
sociated with hypertension, valve disease, 
??????????? ??????????? ???? ???????? ????????
whereas physiological hypertrophy occurs 
during development or early postnatal stages 
and in response to exercise (Fagard, 1997).
Both of them concur with an  increase in 
myocyte volume and the pathological res-
ponse involves also a depressed cardiac 
function. Pathological hypertrophy is usually 
???????????? ??? ???????? ???? ??????????????
matrix (ECM) accumulation (Brower et al., 
2006), although both types involve remode-
lling of the ECM. 
In pathological hypertrophy there is usually 
a reactivation of fetal genes, which show an 
increased expression, such as atrial natriure-
tic peptide (ANP) (Saito et al., 1987).
 The fetal gene program also triggers signi-
????????????????????????????????????????-
cardial energy metabolism during cardiac hy-
pertrophy presents a shift in fuel consumption 
similar to that seen in fetal heart tissue: the 
heart muscle decreases fatty-acid oxidation 
and increases glucose utilization. 
This metabolic change appears to be ad-
vantageous by delaying the transition to heart 
failure (Lopaschuk et al., 2010). 
The understanding of the molecular pa-
thways activated under pathological stress 
conditions will help developing new cardio-
??????????? ??????????? ???? ??????????? ????????
insight in cardiomyocyte turnover promotion, 
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will provide tools for myocyte replenishment.
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A??????????????????????????????????????????????????????????????????????????????????????????plutipotent epiblast cells and the potential relevance of cell competition to cancer, we 
??????????????????????????????????????????????????????????????????????????????????????????????
both during embryonic development and in adult homeostatic conditions. Moreover we 
addressed the potential role of cell competition in a pool of cardiac cells with potential re-
generative ability, the epicardium.
In this study we have induced cell competition in embryonic cardiomyocytes by genera-
ting heterogeneity in Myc levels.
?????????? ??
Determine whether induced heterogeneous Myc levels induce cell competition in deve-
loping cardiomyocytes and study the mechanisms involved
Determine whether induced heterogeneous Myc levels induce cell competition during 
cardiac tissue homeostasis in adult cardiomyocytes  and study of the implications for 
cardiac function.
Determine how cell cardiomyocyte competition affects cardiac adaptation to physiologi-
cal stress.
????????????????????????????????????????????????????????????????????????????????-
diomyocytes.
Determine how the epicardium and epicardial-derived lineages respond to Myc-induced 
cell competition. 
42
O
BJ
EC
TI
V
ES
43
MATERIALS AND 
METHODS
????????????????????????????????????????
??????????????
M
	
    &
	
    M
44
M
	
    &
	
    M
45
MATERIALS	
    AND	
    METHODS
Animal models
iMOS lines. The mosaic lines used in this 
thesis have been previously described: (Cla-
veria et al., 2013) and are shown in ????????
iMOSWT in which both labelled cell populations 
are WT.
iMOST1-Myc in which EYFP population overex-
presses Myc and ECFP population is WT.
iMOST1-Myc/T2-p35  in which EYFP population ove-
rexpresses Myc and ECFP population expres-
ses apoptosis inhibitor p35.
iMOST2-p35 in which EYFP population is WT 
and ECFP population expresses the apoptosis 
inhibitor p35.
 
Rosa26 PGK-Neo tPA
T0 T1 T2
Buffer IRES EYFP tPA Buffer IRES ECFP tPA 
Rosa26
T2
Buffer IRES ECFP tPA 
Rosa26
T1 T2
Buffer IRES EYFP tPA Buffer IRES ECFP tPA 
expression
ECFP 
EYFP 
ORCre T1Rec 
T2
Rec 
R26 Buffer IRES EYFP tPA Buffer IRES ECFP tPA 
c-myc IRES EYFP tPA Buffer IRES ECFP tPA 
c-myc IRES EYFP tPA p35 IRES ECFP tPA 
R26
R26
iMOS 
iMOS 
iMOS 
WT
T1-c-myc
T1-c-myc/T2-p35
Buffer IRES EYFP tPA p35 IRES ECFP tPA R26iMOS T2-p35
A
B
????????????????????????????????????
???????iMOS????????????????????
????????????????????????????? ???????????
???????????????????????????????????????
?????????????????????????????????????
????????? ????? ????? ?????? ??? ????????
??????????????????????????????????????
?????????????????????????????????????????
??????????????????????????????????????
???????????????????????????????????????
?????????????????????????????????????????
?????????????????????????????????????
?????????????????????????????????????????
???????????????????????????????????????
??????????????????????????????????????
??? ??????? ???? ???????? ????? ???????
????????????????????????????????????????
Rosa26?????????????? ???????????????????
??????????????????????????????????????
????????????????????????????????????????
????????????????????????????????????????
??????? ??????????? ? ???????? ??????? ???
???????????????????????????????????
Cre lines:
Nkx2.5-Cre  (Stanley et al., 2002)
Islet1-Cre (Cai et al., 2003)
Mef2C-AHF-Cre (Verzi et al., 2005)
My6-merCremer (Sohal et al., 2001)
Wt1-Cre (Wessels et al., 2012)
Wt1 CreERT2 (Zhou et al., 2008) 
Tie2-Cre (Kisanuki et al., 2001)
?????????????????????????????????
Embryo harvest
Mice embryos were extracted at different 
developmental stages. Females from different 
genotypes (usually iMOS positive females) 
were mated with males (usually carrying the 
Cre recombinase). 
To estimate the developmental stage, vaginal 
plugs were checked every morning. Midday of 
the day when the vaginal plug was detected 
was considered gestational day 0.5 (E0.5). Fe-
??????????? ???????????????2 inhalation and 
abdominal cavity was opened to expose the 
????????????????????????????????????????	
    iMOS? ???????????????????????????????
???iMOS	
    WT???????????????????????????????????????????iMOS	
    T1-­‐c-­‐Myc?????????????????? ?????????????????????????
????????????? ???????????????	
    iMOS	
    T1-­‐C-­‐Myc/T2-­‐p35???????????????????????????????Myc????????????????????
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uterus, which was removed by dissection.
 In cold PBS under the scope in a Petri dish, 
muscular uterine wall and decidual layer were 
carefully ripped to expose the embryo, cove-
red which the yolk sac. Yolk sac and Reichter 
membrane were teared apart and the embryos 
harvested.
Yolk sac was recovered to use for genotyping 
purposes in small embryos (in bigger ones, 
pieces of the embryo such as limbs or tails 
were preferentially used). This procedure was 
????????????????????????????????????????????
?????????????????????????????????????????????
embryo’s genotype.
???????? ????? ????? ??? ???? ???????? ??? ???
PBS overnight at 4ºC. 
 Adult heart dissection
?????? ??????????? ????????????????? ??????-
tion, thoracic cavity was opened and ribs cut 
apart to expose the heart. Heart was dissected 
and collected in a Petri Dish on cold PBS. 
After dissection, cannulation through the 
aorta was performed and new cold PBS was 
infused through coronary vessels to remove 
the blood. If hearts were collected for cryosec-
tioning they were infused through the cannula 
?????????????????????????????????????????????
overnight at 4º C. 
If fresh confocal imaging was performed, 
hearts were cut into slices using a blade and 
imaged directly in PBS on a MatTek Glass 
Bottom Microwell Dish. 
BrDU and tamoxifen administration
BrDU (5mg/ml) was administered to preg-
nant females by intraperitoneal injection 2 
hours prior to embryo collection. When using 
and inducible Cre, recombination was induced 
by tamoxifen  administration by oral gavage 
(from 2 to 6 mg/female).
BrDU 0.5 mg/ml was administered to adult 
mice through the drinking water for one month
Tamoxifen (40g/kg Teklad TD.07262) pellets 
were fed to adult mice at whining for one month 
to induce recombination in My6-merCremer. 
 Whole mount embryo staining
  
 Whole mount embryo staining: TUNEL
When E8.5, E9.5 and 10.5 embryos were 
harvested, most often staining was performed 
on the whole embryo to further analyse perfor-
ming confocal sections. In some cases, heart 
???????????????????????????????????????????????
other, whole embryos were stained. Following 
?????????? ???????? ???????? ????? ??????? ???
PBS several times and permeabilized using 
0.5% Triton X-100 (Calbiochem) for 30 minu-
tes. 
TUNEL staining was performed by pretrea-
ting embryos after permeabilization in TUNEL 
solution (PBS, TdT buffer and CoCl2 –TdT kit 
from Roche) for one hour and then terminal 
transferase and Biotin-16-dUTPs were added 
(accordingly to manufacturers’ directions) and 
incubated for 1h at 37ºC. Afterwards, reaction 
was stopped in Citrate buffer 10mM pH6 for 20 
minutes at room temperature. After PBS was-
hes, blocking step in 10% goat serum (Gibco-
BRL Life-Technologies) for one hour was per-
formed and developing took place by overnight 
??????????????????????????????????????????? ????
streptavidins (1:500) and DAPI (1:200). On the 
following day, after several washes embryos 
were stored in Vectashield solution at 4ºC until 
visualization took place.
Cy-3 and Cy-5 conjugated streptavidins 
(Jackson ImmunoResearch) were used.
Whole mount embryo staining: Immu-
??????????????
???? ? ???????????????? ??????????? ?????
procedure was followed as mentioned in the 
previous paragraph but after permeabilization 
(performed in 0.25% to 0.5% depending on 
the antibody), blocking was performed in 10% 
goat serum for one hour and then incubation 
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with the primary antibody was performed over-
night at 4ºC. Following day and after several 
washes, embryos were incubated with a se-
???????? ????????? ???????? ????? ?? ???????????
protein overnight at 4ºC. On the third day, 
after several washes embryos were ready to 
be imaged and store, which was performed in 
Vectashield mounting medium (Vector Labora-
tories, USA).
????????????? ???? ????? ?????????? ?? ??????????
with DNAse I 1:20 (Roche) for 1h at 37ºC was 
performed after permeabilization.
Primary antibodies used were:
Rabbit anti-phosphohistone 3 polyclonal (Mi-
llipore) 1:300
Rabbit anti-GFP polyclonal (Living Colors) 
1:150
Rabbit anti-LC3 polyclonal (Abgent) 1:100
Rabbit anti-Beclin polyclonal (Cell signalling) 
1:50
Mouse anti-Troponin T monoclonal (Thermo 
????????????????
Mouse anti-BrDU monoclonal (Invitrogen) 
1:50
Rabbit anti-Myc polyclonal (Millipore) 1:300 
Rabbit anti-Wt1 polyclonal (SantaCruz) 
1:100
Chick anti-GFP polyclonal (Abcam) 1:200
Rabbit anti Beclin-1 polyclonal (cell signa-
lling) 1:100
Rabbit anti Nppa polyclonal (Millipore) 1:200
Mouse anti Mycn monoclonal (Abcam)
Secondary antibodies used were:
Cy3-goat anti rabbit 1:500 (Jackson)
Cy5-goat anti rabbit 1:500 (Jackson)
Cy3-goat anti mouse 1:500 (Jackson)
594-goat anti mouse 1:500 (Invitrogen)
488-goat anti chicken 1:500 (Invitrogen)
Whole mount staining: In situ hybridiza-
tion
Whole mount in situ hybridization was per-
formed on E9.5 embryos to detect Myc mRNA 
(probe used in Claveria et al., 2013). Embryos 
????? ???????????? ??? ?? ?? ??? ???? ????????
with H2O2 and then treated with protei-nase K 
at 20ug/ml for 8 minutes. After that, they were 
?????????????????????????????????????????? ?-
ter incubation in prehybridization solution (50% 
formamide, 4xSSC pH4.5, 50ug/ml heparine, 
20ug/ml tRNA, 7% blocking reagent solution, 
1% SDS), probe hybridization was done in that 
solution overnight at 65ºC. 
After hybridization, several washes were 
performed in posthybridization solution I (50% 
formamide, 5x SSC, 1% SDS) and posthybri-
dization solution II (50% formamide, 2xCCS, 
0.1%SDS). Afterwards, embryos were was-
hed in TBST (50mM Tris-HCl pH 7.5, 150 mM 
NaCl, 10 mM KCl, 0.1% Tween20). Next step 
was blocking in goat serum and incubating in 
anti Digoxigenin antibody overnight at 4ºC. Af-
ter that, the embryos were washed in NTMT 
solution (NaCl 100mM, Tris HCl 0.1M, 50mM 
MgCl2, 0.1% Tween20) and  developing of the 
signal was performed adding BM Purple subs-
trate.
 Tissue processing for cryosectio-
ning
?????? ?????????? ????????? ??????? ????????? ???
adult hearts) was wash in PBS several times 
and then left in 15% sucrose in PBS overnight 
at 4ºC. Following that, samples were included 
in a sucrose 15% and gelatin 7.5% (Sigma 
Aldrich) at 37ºC. After that, gelatin blocks are 
made and cooled at 4ºC. Gelatin blocks are 
frozen at -70ºC in isopentane for 1 minute and 
stored at -80ºC. 
Cryosections (8 or 10um) were made using a 
Leica CM1950 Automated Cryostat.
Immunostaining on gelatin sections
Gelatin must be removed from the sections 
by incubating them at 37ºC in PBS for 15 mi-
nutes. After that, sections were washed and
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permeabilized using 0.2% Triton X-100 in PBS 
for 10 minutes. Blocking was performed in 
PBS with 10% goat serum for one hour. 
Primary antibody was incubated overnight at 
4ºC. On the following day, sections were was-
hed and DAPI and secondary antibody incu-
bation was done for 45 minutes to 1 hour at 
room temperature. Afterwards, sections were 
washed again and mounted in Vectashield to 
?????????????????????
All antibodies used have been mentioned 
previously. Other stainings performed were 
membrane staining through incubation with 
wheat germ agglutinin (WGA) coupled with 
Cy3 or 633 (Invitrogen) to analyze cell diame-
ter. 
Embryonic heart digestion: plating 
and citometry
After embryos were harvested, embryonic 
hearts from stages E11.5 and E14.5 were dis-
sected carefully, removing lungs and vessels in 
cold PBS under the scope. Hearts were disag-
gregated in small pieces using microscissors. 
Small pieces were incubated in 5-10ml of a di-
gestion buffer containing Colagenase II (Wor-
thington) at 4mg/ml and 2.5% trypsin in PBS. 
Incubation was performed at 37ºC from 15 to 
45 minutes depending on size of the heart. 
When the pieces appeared digested by vi-
sual inspection, solution was pipetted carefully 
to terminally disaggregate the pieces without 
inducing bubble formation. Solution was then 
transferred to a 50ml falcon tube through a 
40um cell strainer (BD Biosciences). Then, 
10ml of Complete DMEM (DMEM (cc) + FBS 
10%  + Penicillium/Streptoptomycin 1% (Cam-
brex Bioscience) was added to stop enzymatic 
reaction. 
Afterwards, digestion mix was centrifuged 
for 5 minutes at 1200 rpm to pellet the cells. 
Supernatant was removed by aspiration and 
cells resuspended in a volume of complete 
DMEM medium depending on the purpose of 
the isolation.
??? ?????? ????? ?????? ??? ??? ????????? ??? ????
cytometer, samples were resuspended in 
500ul-1ml of complete DMEM. Cells were also 
plated in MatTek glassbottom dishes or in glass 
coverslips (either way coated with 0.1% gelatin 
in PBS). In this case, cells were resuspended 
in 1-2 ml of DMEM complete medium.
Flow cytometer  
Isolated cardiac cells from embryonic hearts 
????? ????????? ??? ???? ?????????? ??? ?????????
EYFP population since ECFP wasn’t detected 
?????????????????? ???????????????? ?????????
to the cells to asses viability (1:5000). An LSR 
Fortessa 4L Flow Cytometer was used for the 
analysis (Laser wavelengths 488, 640, 405, 
561). For the analysis, FACSDiva and FlowJo 
softwares were used.
Adult cardiomyocyte isolation
Mice were injected with 200ul heparine 30 
??????????????????????????????????????????????
no clots were formed in the coronary vessels 
during the procedure.
????????????????????? ???????? ?2 inhalation, 
thoracic cavity was opened and ribs cut apart 
to expose the heart. Hearts were dissected 
and collected in a Petri Dish on cold Perfus-
sion Buffer. (For buffers used in this protocol 
refer to Table1A.) After dissection, hearts were 
cannulated through the aorta and cannula se-
cured with surgical thread.
To digest the matrix and isolate de cardiom-
yocytes different buffers were subject to Lan-
gerdorff perfusion through the aorta (Obame 
2008, Sambrano 2002, Zhou 2000). A sys-
tem that enabled the buffer to enter the heart 
?????????????????????????????????????????????
gravity  and maintained a constant tempera-
ture of 37ºC throughout the whole digestion 
procedure.
After 15 minutes of introducing Perfusion Bu-
ffer through the aorta, the solution was chan-
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ged to Digestion Buffer (See table 1A) and this 
solution perfuses the heart for about 10-15 mi-
nutes.
After being perfused with digestion Buffer the 
heart matrix was digested and cardiomyocytes 
???????????????????????????????????????????????-
nishing disaggregation with a Pasteur pipette.
 From this point onwards, steps were carried 
out at room temperature. These isolated car-
diomyocytes were transferred to a 50ml Falcon 
Tube through a 100um strain net, to remove all 
the remaining matrix. 
After that, Stopping Buffer I was added to the
????????????????????????????????????????????????????????????????????????????????????????????????????????????
A?????????????????????????????????????????????????
cells and incubated for 15-20 minutes (or until 
all the cardiomyocytes reached the bottom). 
Supernatant was discarded and cells newly 
resuspended in Stopping Buffer II in a 15ml 
Falcon tube. Cells were incubated in Stop-
ping Buffer II about 15-20 minutes or until 
cardiomyocytes reached the bottom. Super-
natant was discarded and then several steps 
of calcium reintroduction were performed 
(T1-T5) at 15ºC. Cardiomyocytes were then 
ready to be plated. This was done on laminin-
coated MatTek glass bottom dishes or in la-
minin (BD Biosciences) coated glass round
A
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REAGENT Company
Sodium chloride Sigma - Aldrich
Potassium choride Sigma - Aldrich
Potassium phosphate monobasic Sigma - Aldrich
Sodium phosohate dibasic Sigma - Aldrich
Magnesium sulphate heptahydrate Sigma - Aldrich
Sodium bicarbonate Sigma - Aldrich
Potassium bicarbonate Sigma - Aldrich
Phenol Red Sigma - Aldrich
HEPES salt Sigma - Aldrich
Taurine Sigma - Aldrich
Butanodione monoxime (BDM) Sigma - Aldrich
Glucose Sigma - Aldrich
H2O
Perfussion buffer -
Liberase TM 100mg Roche Appl. Biosc
Trypsin 2,5% Gibco
Calcium Chloride 100mM Sigma - Aldrich
Perfussion buffer -
Fetal Bovine Serum Gibco
Calcium Choride 10mM Sigma - Aldrich
Perfussion buffer -
Fetal Bovine Serum Gibco
Calcium Choride 10mM Sigma - Aldrich
1X
0,2mg/ml
0,14mg/ml
30mM
10mM
5,5mM
1,2mM
12mM
10mM
0,032mM
10mM
Final concentration
113mM
4,7mM
0,6mM
0,6mM
S
T
O
P
P
IN
G
 
B
U
FF
E
R
 I
I
1X
10%
12,5uM
B
U
FF
E
R
H2O
S
T
O
P
P
IN
G
 
B
U
FF
E
R
 I
5%
12,5uM
1X
D
IG
E
S
T
IO
N
 
12,5uM
P
E
R
FU
S
S
IO
N
 B
U
FF
E
R
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coverslips. Firstly, cardiomyocytes were pla-
ted using plating medium and then, after one 
hour that medium was removed and culture 
medium was added (again, refer to the table 
for full composition of buffers and culture me-
diums). These cardiomyocytes were usually 
imaged straight after plating but also were 
??????????????? ??? ???? ?????????? ???????????
immunostaining. 
Adult physiological cardiac stress in-
duced by exercise
 
To induce physiological stress in adult mouse 
hearts, we submitted mice to exercise through 
swimming for a two month period. Animals 
???????????????????????????????????
??????????????????????????????????
????????????????????????????????-­‐
???????
?B? ???????? ?????????????? ?????????
???????? ??? ??????????? ????? ???????
???????
????????????????????????????????????????????????????????????????????????????????????????????????????-­‐
???????
C????????? ????????????????????????????????
B
C
were swimming for increasing lengths of time 
everyday in a thermostatized water tank, kept 
at 37ºC. Table 2 summarizes the swimming ti-
mes that were followed throughout the experi-
???????????????? illustrates the protocol.
Echocardiography
?????????????????????????????????????????-
lation (1.25%) and examined with a 30-MHz 
transthoracic echocardiography probe. Ima-
ges were obtained with Vevo 770 (VisualSo-
nics, Toronto, Canada). Short-axis, long-axis, 
B-mode and two-dimensional M-mode views 
were obtained as previously described (Cruz-
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REAGENT Company
Medium 199 Invitrogen
PEN-STREPT Lonza
L-Glutamine Lonza
BSA Sigma-Aldrich
NaHCO3 Sigma-Aldrich
FBS GIBCO
ITS-A Liquid Media 100x
BDM
Blebistatin
Medium 199 Invitrogen
PEN-STREPT Lonza
L-Glutamine Lonza
BSA Sigma-Aldrich
NaHCO3 Sigma-Aldrich
FBS GIBCO
ITS-A Liquid Media 100x
BDM
Blebistatin
22mM
0,05
Final concentration
100U/ml
1%
0,20%
M
E
D
IU
M
25uM
C
U
LT
U
R
E
M
E
D
IU
M
100U/ml
1%
0,20%
22mM
0,20%
0,00%
10mM
0,00%
10mM
25uM
P
LA
T
IN
G
 
Tube SBII
T1 1X
T2 1X
T3 1X
T4 1X
T5 1X 1mM
C
A
LC
IU
M
R
E
IN
T
R
.
CaCl2 
62uM
112uM
212uM
500uM
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?????????????????????????????????????? ??????????????????????????????????????????????????????????????????
??????????????????????????
??? ???? ??????????????????????????????????? ??????????????????????????????????????????????? ???????
?????????????????????????????
????????????????????????????????????????????? ???
??????????
Adalia et al., 2010). Left ventricle function was 
estimated from the ejection fraction, obtained 
from M-mode echocardiographic images by a 
blinded echocardiography expert. For these 
measurements, a long- or short-axis view of 
the heart was selected to obtain an M-mode 
registration in a line perpendicular to the left 
ventricular septum and posterior wall at the le-
vel of the mitral chordae tendinea.
Ex vivo assays. Explants
  
Epicardium 
Following method described in (Chen et al., 
2002).
To derive primary epicardial cells, embryos 
from different developmental stages were har-
vested. 
To isolate epicardial cells from E10.5 and 
E11.5 embryos, hearts were dissected, both 
?????????? ????????????????? ????????????????-
ved and the ventricles were each cut into two 
pieces. 
Each piece was placed with the epicardial 
epicardial outermost part facing down onto 
a gelatin covered MatTek Glass bottom Dish 
(0.1%Gelatin in PBS). These myocardial pie-
ces were cultured in DMEM containing 10% 
FBS and 1% Penicillium Streptomycin. After 
24 to 48 hours, epicardial cells had migrated 
from the explant and form a monolayer. 
At this point, the myocardial explant was re-
moved using forceps and epicardial cells were 
left to grow for 3-5 days, at which point they 
were visualized by confocal microscopy and/or 
????????? ? ????????????? ???????????????????
at 4ºC.
In order to derive epicardial cells from embr-
yonic hearts from E15.5 to P0, a different tech-
nique was used, involving the manual peeling 
of the outermost epicardial layer from the heart 
surface and posterior placing of these cells on 
a gelatin coated MatTek glass bottom dish. 
Isolated epicardial layers were cultured for 5-7 
days in DMEM+FBS 10% + Pen Strept 1%.  
Migrating epicardial cells were either analy-
??????????????????????????????????????????????
overnight at 4ºC for immunostaining.
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WEEK Monday Tuesday Wednesday Thursday Friday S S
1 5 10 15 20 25 Rest Rest
2 25 30 35 40 45 Rest Rest
3 45 45 45 45 45 Rest Rest
4 60 60 60 60 60 Rest Rest
5 75 75 75 75 75 Rest Rest
6 90 90 90 90 90 Rest Rest
7 90 90 90 90 90 Rest Rest
8 90 90 90 90 90 Rest Rest
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Proepicardium 
This method is extensively described in (Ga-
rriock et al., 2014).
Embryos for proepicardium explants were 
harvested at E9.0, since after E9.5 much of 
the proepicardium had already transferred 
onto the heart. 
After the embryos were removed from deci-
dual layer and yolk sac, the pericardium was 
???????? ?????? ???? ????????? ???? ?????????-
????????? ?????????? ??????????? ???????????????
“grape-like” clustering of cells. Heart tube was 
removed and discarded to have better access 
and proepicardial cells were removed using 
forceps. 
Proepicardial explants were cultured in 
DMEM 10% FBS 1% Pens-Strept for 48h on 
gelatin coated MatTek Glass bottom dishes.
Embryonic myocardium
In some cases, coexplant assays were per-
formed by culturing epicardium (E10.5) with 
myocardium (E9.0-9.5). Epicardial explant 
was performed as described previously but in 
this case, close to the myocardium from the 
E10.5 heart, the whole heart from a E9.0 em-
bryo was placed, trying to orient the atrioven-
tricular canal region facing the E10.5 explant. 
?????????????? ??????????????????????????? ???
2% PFA overnight at 4ºC for immunostaining.
RNA isolation from adult hearts
In order to perform RNA differential expres-
sion analysis, RNA from whole hearts was iso-
lated. Hearts were dissected and washed tho-
???????? ?????? ???????????? ?????????????????
run through the aorta by cannulation to ensure 
coronary vessels were also as free as possible 
from blood residue.
Hearts were then cut into pieces and homo-
genised in cold trizol reagent (Life Technolo-
gies) using the Tissue Lyser. Settings for the 
tissue lyser were 500 oscilations/second in 
1minute cycles. About 4 cycles were needed 
until complete homogenization of the tissue. 
Then 0.2 ml of chloroform were added to ho-
mogeneized sample. After shaking and centri-
fuging for 12.000 x g for 15 minutes two pha-
???????????????????????????????????????????
transferred to a new tube.
 RNA was afterwards cleaned by using QIA-
GEN RNeasy colums following manufacturers’ 
directions. RNA purity was assessed by Nano-
drop plots and agarose ????????????
Isolated RNA was then handed to Genomic 
Unit in CNIC to proceed with sequentiation. 
 
RNASeq. Data analysis
RNASeq library production
In order to assess the gene expression chan-
ges in iMOST1-Myc hearts upon mosaic Myc 
overexpression, total RNA was extracted from 
hearts induced to recombine with tamoxifen at 
?????????????????????????????????????????
Two hearts from iMOST1-Myc??My6-merCremer 
were used while  two hearts from  iMOST1-Myc 
littermates without Cre expression were used 
as control. RNA was isolated using standard 
procedures and analyzed using RNA-Seq. To-
???????????????????????????????????????????
nm in a NanoDrop spectrophotometer and its 
integrity was determined using an Agilent Bio-
analyzer (Santa Clara, CA). 
??????????????????????????????????????????
RNA Sample Preparation v2 Kit (Illumina, San 
Diego, CA) to construct index-tagged cDNA 
libraries. The quality, quantity and the size dis-
tribution of the Illumina libraries were determi-
ned using the DNA-1000 Kit (Agilent Bioanaly-
zer). 
Prepared cDNA libraries were applied to an 
?????????????????? ???? ??????????????????? ??????
Seq SR Cluster Kit V2 cBot) and sequence-by-
synthesis single reads of 75 base length using 
the TruSeq SBS Kit v5 (Illumina) were genera-
ted on the Genome Analyzer IIx following the 
standard RNA sequencing protocol.
M
	
    &
	
    M
53
RNASeq data analysis
Sequencing adaptor contaminations were 
removed from reads using cutadapt software 
(http://code.google.com/p/cutadapt/) and the 
?????????? ?????? ???????????? ???? ??????????
on the transcriptome (Ensembl gene-build 70) 
using RSEM v1.2.3 (Li and Dewey, 2011). 
Only genes with at least 2 counts per million 
in at least 1 sample were considered for statis-
tical analysis. Data were then normalized and 
deferential expression tested using the bio-
conductor package EdgeR (Robinson et al., 
2010). We considered as differentially expres-
sed those genes with a Benjamini-Hochberg 
????????????????????????
Analysis of the data was performed using 
Gene set enrichment analysis and Ingenuity 
pathways analysis software (Biobase Interna-
tional).
Image acquisition
Images were acquired using a Nikon A1R 
confocal microscope using 405,458,488,568 
and 633 nm wavelengths and 20x/0.75 dry 
and 40x/1.30 oil objectives. Tile scan, Z-stacks 
and large image acquisitions were performed 
using NIS software (version). 
Acquisitions were commonly 1024x1024 px, 
A.U. set to 1 (except for adult cardiomyocyte 
imaging and Z-stacks steps as recommended 
?????????????????????????????
Image analysis
Myc levels
To quantify Myc protein expression ImageJ 
(http://rsb.info.nih.gov/ij) was used. Nucleai 
were detected by DAPI staining and segmen-
ted using threshold tool to create a mask. 
When nucleai were too close, manual co-
rrection was applied to ensure segmentation 
detected only individual cells. Segmentation 
generated a mask that was used to measure 
??????????????????????????????????????????
Mask was applied to Cy3 red channel stai-
ning (detecting Myc protein) and measure tool 
gave the mean intensity for every single ob-
ject. 
?????? ?????????????????????? ???????????????
into intervals and represented as interpolated 
curves derived from the original frequencies. 
EYFP/ECFP proportion 
????????????????????????????????????????
using ImageJ software. In cases when both 
EYFP and ECFP were clearly detected, both 
????????????????? ???????????????????????? ??-
suring the occupied area (using thresholding 
tool) for each cell type or counting cells (using 
cell counter plugin).
In those cases where ECFP was not detec-
table (in adults or neonate hearts), EYFP was 
???????????????????????????????????????????-
timate ECFP proportion, antiGFP staining was 
used to determine whole recombination.
EYFP levels
?????????????????????????????????????????????
cardiomyocytes by determining cell area using 
threshold tool in ImageJ on a background 
channel. These areas were used to generate a 
mask that enabled to measure average inten-
sity in EYFP channel. This was represented in 
??????????????????????????????????????? ????? ??-
tervals and assigned to EYFP-negative, -me-
dium or –high expression categories, which 
?????????????????????????????????????? ?????
Cell area
??????????????????????????? ???????? ?????-
ted adult cardiomyocytes’ area was measu-
red using background green channel to detect 
objects and then ‘analyze particles’ tool from 
Image J to detect every cell as an object. Mea-
sure tool would give area for any given cell.
To measure area of cells stained with WGA 
(wheat germ agglutinin) on sections, Image J 
manual free hand selection was used.
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3D Recontructions
Z-stacks from embryonic hearts were re-
constructed using Imaris x64 software. Ima-
ris allowed to generate different isosurfaces 
(EYFP positive and negative cells) and detect 
those nucleai within isosurfaces. 
A parameter ‘distance to EYFP’ was 
set to each TUNEL event and tho-
se within a cell diameter from a 
????????????????????????????????????????????
contact”. 
Statistical analysis
 
To compare percentages of ECFP cells/
area between more than two groups, Kurskall-
Wallis test was used (assuming non-normal 
distributions). 
For comparisons of two groups, Man-Whit-
ney test was used. To test the correlation bet-
ween cell size and EYFP expression levels, a 
linear regression model was used. 
??????????????????? ??????????????????? ?-
nonucleated cardiomyocyte frequency compa-
risons from adult hearts was analyzed using a 
proportions test as implemented in R. 
All comparisons (and graphs) were made 
using Prism 5.0 statistical analysis software.
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Cell competition in the developing heart
Myc family expression in the developing 
heart.
To explore cell competition in the develo-
????? ??????? ??? ??????? ?????????? ???? ????? ???
Myc in the embryonic myocardium, as it has 
been shown to be a regulator of cell anabo-
lism. Myc mRNA was not detected at E9.5 
in the developing heart by in situ hybridiza-
????? ?????? ???????? ?????????? ??? ??? ???? ?????
previously reported. (Moens, Stanton et al. 
1993). 
We then decided to delete both Myc alleles 
in the developing heart to discard a role of 
????????????????????????????????????????
so we took advantage of Nkx2.5-Cre line to 
recombine Myc????????????????????????????-
pressed in cardiac progenitors as early as 
E7.5 and Cre recombination takes place in 
myocardium derived from primary heart tube 
???? ????? ??????? ?????? ????? ????????????? ???
well as the endocardium and valve mesen-
chyme (Stanley et al. 2002). 
Deletion of Myc gene using this driver did 
not produce any apparent cardiac embryonic 
?????????? ??????? ???? ??????? ???? ???? ???-
???????????????????????????????????????????
???? ??? ???? ???? ?????????? ??? ????????? ??-
gure 8 D). This result is in agreement with 
the expression pattern of Myc. We therefo-
re focused on Mycn, a member of the Myc 
family expressed in the developing heart 
??????????????????????????? ??? ???????????? ??-
yer of the myocardium (Davis et al. 1993, 
?????????????? ???????????-­‐
?????????????????????????
A.?? ????? ????????????????
??????????????????? ?????
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???????????????????B.? ?????
??????? ?????????????????
??? ???????? C.	
     ??????
??????? ?????????????????
????????????????????????
D.? ?????? ???????? ???? ???
??????? ???? ????????? ????
??????? ??? ?????? ??? ????
??????????????? ???????????
????????? ???????????????
??????????????????????
?????????????????????????
????? E.? ????????? ???????
??? ?? ????? ??????? ?????????
?????? ???????? ????? ? ?
??????????????E’.	
    ??????
?????????? ??????????? ?????
??????????????E??F.??????????
??????? ??? ?? ?????? ??????
?????? ?????????? ????????
????????????? ?????????????
?????????????????????????
?????????????????????????????
???? ??? ?????? ????? ???????
????????????????????
58
Moens, Stanton et al. 1993). It has been re-
ported that nMyc deletion in the heart, using 
TnT-Cre? ??????????? ???????????? ??? ????????
myocytes) produces a defect in myocardium 
proliferation and does not yield live embryos 
past E12.5, with most of them being recove-
red alive only up to E11.5 (Harmelink et al. 
2013). Interestingly, Myc and Mycn proteins 
are very similar and are able to functionally 
replace each other in mice in which  Mycn 
has been knocked-in replacing endogenous 
Myc (Malynn et al. 2000). Myc overexpres-
sion through the iMOS system should there-
fore be functionally equivalent to Mycn ex-
pression, recapitulating and contributing to 
its function in the developing myocardium.
Moreover, using anti-Myc antibodies in 
wild-type, heterozygous and knock-out em-
bryos, nuclear signal was still detected in 
the myocardium, indicating that the antibody 
also recognizes Mycn expression in the myo-
?????????????????????
Generation of random genetic mosaics 
in the developing heart through the iMOS 
system. Overexpression of Myc under the 
Rosa26 promoter
To study cell competition in the developing 
heart we used Nkx2.5-Cre to induce iMOS 
recombination in early cardiac progenitors. 
This approach is expected to generate ran-
dom mosaics in cardiac lineages during de-
velopment. 
??? ????? ?????????? ???????? ????????????
the iMOSWT transgene, which gives rise to 
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?????????? ?????? ????????????????????????????Nkx2.5-­‐Cre?????????????????????????
A-­‐C.	
    ????????????????????????????????????????????????????????????? ?????????????????? ????????????????
??????????????????????????????????????????????????????????????iMOSWT??????????????????????????????????G??A’-­‐
C’?????? ??????????????????????????????????????A-­‐C.	
    D-­‐F’	
    ?? ???????????????????????????????????????iMOST1-­‐Myc?
??????????????????????????? ??? ???????????????B’?????E’??????????????????????????????????????????????????????????
????????????????????????? ???? ?????????????????????????????????????????????????????????????????
G.	
    ??????????????????????????????????????????????????????????????????????A-­‐F’?	
    ?????????????????????????????
????????????????????????????????????????????????????????????????H.???????????????????????????????????????????????
???????????????????????????????????????????????	
    iMOSWT??????????????????????????	
    I,	
    J.	
    ??????????????? ???
???????????????????????????????????????????????????????iMOSWT?????????iMOST1-­‐Myc????? ?????? ??????????????????????
??????????????????? ??????????????????????? ????????????????? ??????? ???????????????????????????????????????
??????????????????????????????????????????????????? ?????????????????????????
random mosaics of ECFP- and EYFP-WT 
cell populations. 
Quantitative confocal analysis of recombi-
nation at E10.5 in iMOSWT;Nkx2.5-Cre hearts 
????????? ?????????????????????????????????
the two reporter proteins in embryonic car-
diomyocytes at a reproducible cell population 
ratio, as previously described (EYFP:ECFP 
??????????????????????????????????????????????
H). 
As had been shown for the Nkx2.5-Cre line 
???????????????????????????????????????????????
distribution pattern showed iMOS activation 
??????????? ???? ?????????? ?????? ??????? ??
A-C’). 
We then generated Nkx2.5-Cre-induced 
iMOST1-Myc mosaics, in which the EYFP 
cell population moderately overexpres-
ses Myc   under the Rosa26 promoter 
????? ???????? ?????? ??? ???????? ?? ???????
To address functional Myc overex-
pression we analyzed Myc protein le-
vels through immunodetection on con-
focal sections in both mosaics. This 
analysis showed that Myc levels in iMOSWT 
mosaics were comparable between the 
???? ??????? ????????????? ????? ??? ?????????
to what had been observed in the epiblast 
in the context of endogenous cell competi-
tion (Claveria et al. 2013), levels were cell-
to-cell homogeneous. In the EYFP cell po-
pulation of iMOST1-Myc mosaic hearts an 
expected increase in Myc expression levels 
???????????????????????????????????????????-
gure 9 I, J). 
This increase is attributable presumably to 
the simultaneous detection by the antibody 
of exogenous Myc and endogenous Mycn.
 Mosaic Myc overexpression induces 
cardiomyocyte population expansion in 
the developing heart
To test the effect of Myc overexpression in 
a mosaic fashion during heart development, 
we analyzed neonatal hearts from iMOSWT 
and iMOST1-Myc mosaics. Confocal analysis 
showed a strong reduction of the ECFP-WT 
cell population in iMOST1Myc mosaics, where 
these cells are confronted with Myc overex-
pressing ones.  
At birth, the contribution of WT cardiomyo-
cytes in iMOST1-Myc mosaics had dropped to 
25% of its original contribution to the heart 
?????????????????????????????
To understand the temporal dynamics of the 
shift in the contribution of the EYFP-Myc and 
??????????????????????????????????????????
confocal analysis the contribution of the mo-
saic cell populations at different stages of the 
developing heart, using again Nkx2.5-Cre to 
induce the iMOS system. 
In iMOST1-Myc mosaics we found a pro-
gressive reduction in the contribution of the 
ECFP-WT cell population (and a correla-
tively increased contribution of the EYFP- 
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Myc population) that was not observed in the 
iMOSWT?????????????????????????
The reduction in the proportion of ECFP- 
WT cardiomyocytes in iMOST1-Myc  mosaic 
hearts compared with iMOSWT hearts was 
detected already at E9.5, although this de-
???????????????????????????????????????
However, from this developmental stage 
on, the contribution of ECFP-WT population 
in iMOST1-Myc hearts was progressively redu-
ced during development, with  elimination of 
75% of the normal ECFP-WT population con-
tribution at birth. The reduction was 40% of 
the iMOSWT value at E10.5, 60% at E11.5 and 
????????????????????????
This indicates that the shift in cell popula-
tions probably takes place constantly during
??????????? ????????????????????????????????????????????????????
A-­‐C.????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????iMOSWT???????A???iMOST1-­‐Myc????????B??????iMOST1-­‐Myc/T2-­‐p35	
    ?????
????? ?????C???????????????D-­‐F.?????? ?????????????????????????????A-­‐C??G.????????????????????????????????????
????????? ???????????????????iMOST1-­‐Myc????????????iMOSWT??????? ???????????????????????????????????????	
    iMOSWT	
    
????? ???????? ????? ???????????????????????????????G????? ??????????????????????????????????????????
the period observed but it does so more in-
tensely in a two-day window between E9.5 
and E11.5.
Mosaic Myc overexpression in the em-
bryonic heart provokes no pathological 
hyperplasia of cardiomyocytes 
Previous studies showed that Myc overex-
pression in cardiomyocytes during fetal life 
can lead to pathological cardiac hyperplasia 
(Jackson et al., 1990). 
However, in these studies Myc overexpres-
sion was 20-fold above normal. Myc-overex-
pression levels through the Rosa26 promoter 
had been shown to be mild in the quantitative 
analysis performed  initially to test iMOS sys-
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??????????? ?????????????????????????????????????????????????????????????????????????
	
    A-­‐F.	
    ???????????????????????????????????????????????????????????????????? ??? ???? ???????????????????????
??????????????????????????????????????????????iMOSWT	
    ???????A-­‐C??????iMOST1-­‐Myc????????D-­‐F????????????????
??????	
    G.	
    ?????????????????????????????????????????????????????? ??????????????????	
    iMOST1-­‐Myc??????? ???????
????????????????????????????????iMOSWT???????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????G????? ?????
?????????????????????????????????????
tem recombination (Claveria et al. 2013) and 
in agreement with the observations in early 
????????? ??? ???? ????? ???? ???????????????
levels approximate to the addition of one WT 
Mycn????????????????????????????????
To determine whether this overexpression 
levels could lead to cardiac hyperplasia we 
characterized postnatal heart anatomy and 
cardiomyocyte size. P0 hearts from Nkx2.5-
Cre-recombined iMOST1-Myc and iMOSWT 
mice were of normal size and anatomy (not 
shown), and cardiomyocytes from the iMOST1-
Myc hearts were of a similar size to those from 
iMOSWT hearts in area, as measured in histo-
????????????????????????????
The shift in the cell population proportion 
observed in iMOST1-Myc mosaics thus results
from expansion of the EYFP Myc-overex-
pressing cardiomyocyte population at the ex-
pense of the ECFP-WT population, without 
?????????? ? ????????????? ??? ??????????????
number or  size or heart anatomy. 
These results also indicate that the levels 
of Myc overexpression from the iMOST1-Myc 
allele through Rosa26 promoter are within 
the limits that allow normal cardiac develop-
ment and cardiomyocyte function and do not 
lead to hyperplasia. 
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??????????? ???????????????????????????????? ????????????????????????????????? ?????????????????????????
????????
A	
    ????B.	
    ????????????????????????? ??????????????????????????????????????????????????????????????????????
?????? iMOSWT? ??????A?????? iMOST1-­‐Myc	
    ???????B???????????????????????C.???????????????????????????????????????
iMOSWT?????????	
    iMOST1-­‐Myc	
    ?????? ???????????????????????????????????????????
Islet1 progenitors are highly sensitive to 
Myc-induced cell competition
We then explored whether this expansion 
????????????????????????????????????????????
?????????????????????????? ???????????? ?????
advantage of Islet1-Cre, to induce recombi-
???????????????????????????????????????????????
??????????????????????????????????????????????
(Yang et al. 2006). 
We wanted to test whether Islet1+ second 
??????????????????????????????????????????????
Myc-induced cell competition, and the impact 
of inducing mosaicism in this particular cell 
population. 
To test this, we generated iMOSWT mo-
?????? ??? ????????????????? ????? ????????????
Islet1 to drive Cre expression. This driver 
provides partial interspersed recombination 
in the SHF population resulting in a 7% con-
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??????????? ????????????????????????????????????????????????????????????????????????????????????????-­‐
??????????????????????
A-­‐G’.	
    ??????????????????????????	
    (A-­‐C)??????????? ??????????????????????????????????????????????(E-­‐G)	
    
??????????????????????????????????	
    (E’-­‐G’)	
    ???????????????????????????????????????????????????iMOSWT	
    ????	
    (A,	
    
E,	
    E’),	
    iMOST1-­‐Myc???????(B,	
    F,	
    F’)????	
    iMOST1-­‐Myc/T2-­‐p35??????????????????? ????????E’-­‐G’?????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????	
    A????C???????????????E’.?????????????????????????????????????????????????????????
???????????????D.???????????????????????????????????????????????? ????????????????????????????????????????
iMOSWT??????? iMOST1-­‐Myc? ?????????? iMOST1-­‐Myc/T2-­‐p35	
     ??????????????????????? ???????H.?????????????????????
???????????????? ??????????????????????????????????????????????????????????????????????????iMOST1-­‐Myc???????
????iMOST1-­‐Myc/T2-­‐p35???????????????????????????????????????????????????iMOSWT????????????????????????????
??????????????????????????????D??H????? ?????????????????????????????????????????
tribution of EYFP cardiomyocytes to the right 
?????????? ????? ??? ???? ????????? ??????? ???????
13 A, E, E’). 
Interestingly, Myc mosaic overexpression 
in this SHF population dramatically increa-
sed the contribution of EYFP-Myc cells to 
the RV, which was  40% of the RV at P0, 
which represents a 6-7-fold expansion of the 
original EYFP cardiomyocyte population du-
??????????????????????????????????????????-
reover, the ECFP-WT cardiomyocyte popula-
tion was almost completely eliminated from 
the RV in iMOST1-Myc mosaic hearts, indica-
ting a very active elimination of the ECFP-WT 
population and a continued expansion of the 
Myc-overexpressing cardiomyocyte popula- 
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tion during fetal life, in a context in which it is 
continuously confronted with WT cardiomyo-
????????????????????
To further understand how this expansion 
takes place, we characterized the temporal 
progression of the ECFP-WT cardiomyo-
cytes in iMOST1-Myc ????????????? ?????? ?????
as early as E9.5 this population is already 
decreased to 40% of its normal contribution 
in the iMOSWT? ?????????????????????????????-
sive reduction until the near-complete elimi-
?????????????????????????????????????
This enhanced early elimination of ECFP- 
WT cells indicates that the undifferentiated 
Islet1 progenitors are especially sensitive to 
Myc mosaic overexpression.
Cell proliferation does not account for 
the expansion of the Myc-overexpressing 
cardiomyocyte population
We then studied which mechanisms could 
underlie Myc-overexpressing cardiomyocy-
??????????? ?????????????????????????????????????????????????????????????????????????????????????????????
A-­‐C.???????????????????????????????A?????????????B?? ?????????????????????C?????????????????????????????iMOST1-­‐
Myc??????????????????????????????????????????????????????????????????????A?????B????????????????C?????????????
?????????????? ??????????????????????????????????????????????????????????????????????????????????????iMOST1-­‐Myc?
?????? ???????????????????????????????????????iMOSWT?????? ??????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????? ???????D????? ?????
????????????????????????????????????
??? ??????????? ???? ??????? ??? ?????????? ????
role of cell proliferation in this process.
To do so, we performed Phosfohistone3 
(PHH3) staining in E10.5 hearts, when the 
shift in the cell population is taking place.  We 
determined the percentage of proliferating 
cells in both iMOSWT; and iMOST1-Myc??Nkx2.5-
Cre????????????????????????????????????
??? ?????? ??? ??????????? ???????????? ???
tween the overall rates of PHH3+ cells in 
?????????????????????????????????????????
???????? ??????????????????????????????????????
the proportion of PHH3+ cells between the 
two cell populations in the iMOST1-Myc mosaic 
?????????????????
??? ??????? ?????? ?????????????? ??? ?????
performed BrDU staining and results were 
similar, with no differences in BrDU+ cell fre-
quency between iMOSWT and iMOST1-Myc ???-
gure 15 F-H) or between the EYFP-Myc and 
ECFP-WT populations of the  iMOST1-Myc mo-
????????????????????????????
?????? ???????? ??? ????? ????????? ???????
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?????????????????????????????????????????????? ??? ?????????????????????????????????????????????
A,	
    B????????????????????????????????????????????????????????????????????????????????iMOSWT??????????iMOST1-­‐Myc?
????????????????????????????????????????????????????????????????????????????C.?????????????????????????????
????????????????????????????????????????????????????????????????iMOSWT??????????iMOST1-­‐Myc??????? ????????????
???????????????????????????????????D.?????????????????????? ??? ??????????????????????????????????????????????
??????????????????????????????????????????????????????E.??????????????????????????????????????????????????
??????????iMOST1-­‐Myc? ??????????????????????????????????????????????????????????? ??????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????F,G.	
    
??????????????????????????????????????????????iMOSWT??????????iMOST1-­‐Myc??????? ?????????????????????????????
??????H.	
    ??????????????????????????????????????????????????	
    iMOSWT??????????iMOST1-­‐Myc????????????????????
??????????????????????????????????I.???????????????????????iMOST1-­‐Myc??????????????????????????????????????????
???? ???????????? ??? ?????? ???? ?????? ??????? I’.? ????????? ? ???? ??? ???? ?????? ????? ??? I?? J.? ???????????????????
?????????? ??? ????????????? ?????????????????? ??????????????????? ???? iMOST1-­‐Myc???????? ??????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????
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showing that the Myc dosage induced by a 
single Rosa26 allele does not increase proli-
feration rates in most tissues (Clavería et al., 
?????????????????????????????????????????????
differences in cell proliferation do not account 
for the shift in cardiomyocyte populations.
Myc-overexpressing cardiomyocyte po-
pulation expands by apoptosis-driven cell 
competition
Then we decided to evaluate the role of 
apoptotic cell death in the depletion of WT
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??????????? ?????????????????????????????????????????????????????????????????????????????? ???????????-­‐
?????
A,	
    B?? ??? ????????????????????????????????????? ????????????????? ????????????? ?????????????????????iMOSWT?
??????A??????iMOST1-­‐Myc????????B??????????????????????????????????????????????????????C?????????????????????
?????????????????????????????????? ????????????????A??B???????? ???????? ??? ?????????D??E???????????????????
?????????????????????????????????????iMOSWT???????D??????iMOST1-­‐Myc????????E?? ?????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????F.?????????????????????????????????????????????????????
?????????????????????????iMOSWT??????????iMOST1-­‐Myc??????????????????????????????????????? ???????? ???
??????????????????????????????????????????????????????????????????????????????? ???????????????????????????????
????????????????????????G.? ??? ??????????????????????????????????????????????????????iMOST1-­‐Myc?????????????
??????????????????????????????????????????????????????????????????H.????????????????????????????????????????
?????????G??H’.? ??????????????????????????????????H????????????????? ????????????????????????????????????
??????????????????????????????? ?????????????????????????????????????????????????????????? ??????????????????
??????????????????????????????????????????????????????? ????????????????????????????????????????????????????
????????C??F??I????? ?????????????????????????????????????????
cardiomyocytes. 
??????????????????????????????? ????????????
iMOST1-Myc/T2p35, which generates random mo-
saics upon recombination. In these mosaics, 
an ECFP-p35 cell population is confronted 
with an EYFP-Myc population. 
P35 is a baculoviral caspase inhibitor that 
prevents apoptosis both in insects and ma-
mmals (Claveria et al., 2013, Hay et al., 
1994).
 Quantitative confocal analysis of neona-
tal hearts induced with Nkx2.5-Cre showed 
that these mosaics retained at birth 70% of 
?????????????????????????????????????????????
10 C, F, G). This contrasts with the 25% of 
WT cells observed in iMOSWT mosaics, indi-
??????? ????? ?????????? ??????????? ??????????????
although not totally, preserved WT cells from 
elimination when confronted with Myc-ove-
????????????????????????????????
 We also tested generating iMOST1-Myc/T2p35 
mosaics using Islet1-Cre to analyze the be-
???????????????????????????????????????????-
gure 13 C, G, G’). We found, accordingly with 
the observations with Nkx2.5-Cre recombi-
nation, that the ECFP population is partially 
?????????????????? ?????????????????????
We found, however, that the expansion 
of the EYFP-Myc population was similar to 
that observed in iMOST1-Myc????????? ???????
11D), indicating that the expansion of Myc-
overexpressing cardiomyocytes takes place 
also by eliminating non-recombined WT car-
diomyocytes, being not affected by the pre-
sence of a low proportion of ECFP-p35 car-
diomyocytes.
These results indicate that cell death is a 
predominant mechanism in the population 
shift observed in iMOST1-Myc mosaics. 
To further assess this, we performed TU-
NEL assays to score apoptotic rates in E10.5 
mosaic hearts recombined using  Nkx2.5-
Cre. We decided to focus mainly on the 
??????? ?????? ??????? ?????? ?????? ??? ???? ????
one showing higher apoptotic rates in the 
iMOSWT??????????????????????????
While the proportion of TUNEL-positive 
cardiomyocytes was in general extremely 
low in iMOSWT mosaics, we observed a 
5-fold increase in the overall apoptotic rate in 
iMOST1-Myc?????????????????????????????????
in iMOST1-Myc mosaics, the apoptotic rate in 
the ECFP-WT population was remarkably 
higher than that seen in the EYFP Myc popu-
??????????????????????
Interestingly, the apoptosis rate varied 
between heart regions: whereas the ECFP/
EYFP TUNEL ratio was 4 to 5-fold above 
baseline in the ventricles, in the OFT it was 
over 10-fold higher, indicating that ECFP-WT 
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cardiomyocytes in this region are especially 
?????????? ????????????????????????????? ??-
gure 16 F). 
Competition induced apoptosis relies 
on short range interactions 
Since ECFP-WT cells are normal viable 
cells, our results suggested that a cell-non 
autonomous mechanism was involved in 
their increased death rates. 
We therefore studied the spatial range of 
these interactions of these interactions. To 
do so, we took advantage of the low-rate, 
interspersed recombination generated in the 
OFT region by the Islet1-Cre driver. This way, 
we generated a mosaic in which a few EYFP 
cells would lie within an excess of WT cells, 
allowing us to score apoptosis separately in 
WT cells in direct contact with EYFP-Myc 
?????? ???? ??? ?????? ???? ??? ???????? ??????? ???
G-H’). 
Apoptotic rate was found to be highly in-
creased only in those WT cardiomyocytes 
that were in direct contact with Myc-overex-
???????????????????????????????????????????
we found a 17-fold increase in apoptosis in 
WT contacting cardiomyocytes compared to 
??? ??????????????? ??????????????? ???????
16 I). 
Therefore, these results indicate that the 
expansion of Myc-overexpressing cardiom-
yocytes is dependent on the elimination of 
neighbouring WT cardiomyocytes through 
apoptosis triggered by direct cell-cell contact 
or short-range signalling. 
 Our characterization thus establishes that 
the replacement of the WT cardiomyocyte 
population by the Myc-overexpressing popu-
lation is due to apoptosis-driven cell compe-
tition.
   Flower is not involved in Myc induced 
cell competition in the developing heart
Flower protein has been previously pro-
posed to be implicated in cell competition in 
Drosophila through the expression of diffe-
rent protein isoforms that allow cells to com-
???????????????????????????????
To determine whether Flower plays a role 
in induced cell competition in the developing 
heart, we generated iMOST1-Myc mosaics 
using Nkx2.5-Cre recombination in a Flower 
knockout background (Flower knock-outs 
have been described to be fertile, viable and 
to display a reduced indicence of papilloma 
formation) (Petrova et al., 2012). 
Analysis of confocal sections showed that 
ECFP-WT cell elimination in iMOST1-Myc mo-
saics was similar in WT, heterozygous and 
homozygous Flower knockout backgrounds 
????????????????
This indicates that, in this cell competition 
model, Flower activity is dispensable for the 
elimination of WT cells. Moreover we were 
unable to detect Flower expression in the 
???????????????????????????
Endogenous cell competition does not 
play a role in the developing heart 
Our results indicate that cardiac cells, in-
cluding cardiomyocytes, are sensitive to in-
duced cell competition.  
These results however do not address whe-
ther endogenous cell competition could play 
a substantial physiological role in cardiac 
development. To test this, we generated a 
mouse mosaic strain in which EYFP labelled 
cells were WT (EYFP-WT) and ECFP labe-
lled cells expressed p35 (ECFP-p35) cells.
 This line, iMOSt2-p35, was recombined using 
Mef2C-AHF-Cre, which recombines the an-
?????????????????????????????????????????????
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Figure	
    17.	
    Flower??????????????????????????????????????????????????????????????????
A,	
    B,	
    C.?????????????????????????????????????????????????	
    iMOST1-­‐Myc????????????????????????????????????? ??
???????????Fwe?????????????Fwe???????????????????????????????D.??????????????????????????????????????????????
????iMOST1-­‐Myc??????? ???????????????????????????????????????????????????????????????????????????? ??????????
????????? ????? ?????????????????????????????????????E.???????? ???????????????????????????????????? ???
??? ???????????????????????D????? ???????????????????????????????????????????????????
this is the population that we have found to 
be more sensitive to cell competition. 
In case endogenous cell death would be 
eliminating a substantial number of cardiac 
???????????? ??? ?????? ??????? ?? ???????????
enrichment in the proportion of ECFP-p35 
cells. 
In addition, in the case that these cells 
would have been eliminated by Myc-regu-
lated cell competition, we would expect the 
ECFP-p35 cell population to express lower 
Myc levels than the EYFP-WT population. 
We then measured Myc protein levels in the 
ECFP-p35 population, in which apoptosis 
?????????????????????????????????
Analysis of Myc levels by immunodetection 
showed no differences between the EYFP-
WT population and the ECFP-p35 population 
(protected from elimination), indicating that 
a mechanism for endogenous cell competi-
tion dependent on Myc levels is not present 
??? ??????????????????????????????????????????
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????????????????????????????????????????????????????????????? ?????????
A.? ????????? ? ???? ???????? ??????????????? ??????? ??????? ????? iMOST2-­‐p35;	
    AHF-­‐Mef2C	
     ??????????????? ????????
??????????????????????? ???? ??????????????B.???????? ??????? ??????????????????????????????A??C.	
    ??????? ????
????????????????????????????????????????????D.	
    ??????? ????????????????????????????????????????????????D.? ????????
??????? ?????????????????????????????????????????????????????????????????iMOST2-­‐p35.
??????????????????????????????????????????? ????????????????? ??????? ??????????????????????????????????
??????????????????????????? ?????????????????????????
?????????????????????????????????????????????
18 D).
Mycn and Myc levels interplay in cell 
competition in the developing heart 
We then explored whether modifying the 
relative differences in Myc dose between
neighbouring cells affected the competition 
process. 
To study this question, we manipulated 
Mycn levels in the myocardium by conditio-
nal elimination and combined this elimination 
with recombined iMOST1-Myc? ???????? ????-
re 19 A-C). We found that when EYFP-Myc 
cells were generated in a Mycn heterozygous 
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Figure	
    19.	
    Mycn??????????????????? ?????????????????????????????????????????????????
A-­‐C?????????????????????????????????????????????????????????iMOST1-­‐Myc? ?????????????????????????????????? ??
?A???Mycn	
    ???????B?????	
    Mycn?????C?????????????????????????????????????????????????D????????????????????????????
??????????????????????	
    iMOST1-­‐Myc	
    ?????? ?????????????????????????????Mycn???????????????????????????????????
??????????	
    iMOSWT?????? ???????? ????? ???????????????????????????????D????? ???????????????????????????????
???????????? ?????????????? ????iMOSWT	
    ?????????????????????????????????? ?????????????? ???	
    iMOST1-­‐Myc?
?????????????
background, ECFP-Mycn +/- cells were de-
pleted to a similar extent than that found in a 
???????????????????????????????
Hence, confronting cells with the equivalent 
to two doses of Myc function with cells with 
one dose also eliminates those with lower re-
lative Myc levels. 
Moreover, ECFP-Mycn null cells were 
drastically reduced to 15% of the initial 
ECPF proportion when confronted with 
EYFP cells expressing a single Myc dose
at stage E10.5 (Figure 19 C, D). 
These results show that it is not the abso-
lute level of Myc expression but the relative 
differences between cell populations, what 
triggers the elimination of those with relative 
low Myc levels. 
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Myc induced competition during adult heart homeostasis
 Myc-overexpression in the adult heart 
causes no pathological alteration neither 
in homeostatic conditions nor in intense 
exercise conditions
Once we had determined that cell competi-
tion could be induced in embryonic cardiom-
yocytes during heart development, we then 
explored if an organ such as the adult heart 
could also be sensitive to Myc-induced cell 
competition. 
To test this, we generated mosaic mouse li-
nes in the adult heart taking advantage of the 
tamoxifen-inducible My6-merCremer strain 
??????????????????????????????? ??? ???????????
???????????????? ???????????????? ????????????
??? ????????? ???????????????????????????????
the diet, feeding the animals a tamoxifen diet 
for 1 month, starting right after weaning. 
This protocol yields an initial EYFP recom-
??????????????????????????????????????????????
Since previous studies have reported that 
high Myc overexpression in cardiomyocytes 
of adult mice induces cardiomyocyte hyper-
trophy (Xiao et al., 2001), we performed a se-
ries of assays to address if this could be the 
case when we overexpress Myc moderately 
through the iMOS system in a long-term fa-
??????????? ?????? ??????????????????????????????????????????????????????????????????
A.	
    ?????????????????????????iMOST1-­‐Myc? ????????????????????????????????????????????????????????????????
???? ????????B??B.	
    ??????????????????????????????????? ???????????	
    iMOST1-­‐Myc?????????????? ????????????
???????????????C??????????????????????????????????????????????????? ??????????????????????????????????????????
??????????? ?????????????E?????????iMOST1-­‐Myc? ???????????????????? ???????????????????????????????D.??????????
??????? ??????????????????????????????????????????????????????????????????????? ???????????????????F??G????????
?????????????????????????????????????????????????????????????????????????????? ?????????iMOSWT???????F??????
iMOST1-­‐Myc????????G?? ??????????????????????????H?	
    I?????????????????????????????????????????????????????????????
iMOSWT	
    ??????H?????	
     iMOST1-­‐Myc? ???????I???????????????????????????????????J.	
    ?????????????????????????????????
?????????H?	
    I?????????????????????????????????????????????????????????????????????????????????????? ????????????
K??L.??????????????????????????????????????????????????????????????????????????????????????iMOSWT(?????K??????
iMOST1-­‐Myc	
    ???????L?? ?????????????????K?????L??????????????????????????????????????????????????????????????????
?????????????
shion. 
Hearts from animals generated using the 
????????? ??????????? ?????????? ??????? ??????
were tested for hypertrophic response. Firstly, 
we analyzed heart function and anatomy 
in iMOSWT and iMOST1-Myc mosaics through 
echocardiographic study in basal conditions.
 This study did not detect any differences 
???????????? ???????????????????????????????
D) in any parameter analyzed, neither anato-
?????????? ???????????? ??????????????????? ????-
tion and left ventricular mass.
 We then studied whether challenging 
heart function following a protocol of intense 
exercise could trigger differences between 
iMOSWT and iMOST1-Myc animals. We set up a 
swimming protocol that lasted for two months 
and that got the animals to swim for up to 90 
minutes everyday (see methods: table 2). 
Echocardiographic assays performed right 
???????????????????????????????????????????-
hing showed again no differences in any of 
the parameters analyzed, regarding heart 
???????????????????????????????????????????-
nels). 
Even though hearts were not altered ma-
?????????????? ??????? ??? ???? ??? ?????????
cardiomyocyte size to determine the conse-
quences of long-term Myc overexpression. 
Measurement of average cardiomyocyte 
2D-size, both in histological sections and 
?????????????????????????????????????????????
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gure 20 F-I), showed that cardiomyocytes in 
iMOST1-Myc hearts were not only not bigger 
than those in iMOSWT hearts, but were in fact 
???????????????????????????????
Moreover, we also measured the correla-
tion between Myc levels and cell size: since 
recombination occurs after binucleation, adult 
cardiomyocytes could contain more than one 
recombined EYFP-Myc copy and therefore 
are predicted to express variable levels of 
extra Myc in correlation with EYFP levels. 
In iMOST1-Myc mosaics EYFP levels corre-
late with the Myc dose. Analysis of per-cell 
cardiomyocyte size and EYFP level showed 
no correlation between these two parame-
ters in either iMOSWT or iMOST1-Myc mosaic 
??????? ??????? ??? ??? ???? ??????????? ?????????
expression in our system has no direct effect 
over cell size.  
These results show that sustained Myc 
overexpression from the iMOST1-Myc allele 
during adult life does not pro-
voke cardiomyocyte hypertrophy. 
Heart size and heart/body weight ratios 
were moreover similar in both mosaics, indi-
cating that overall cardiac cellular and organ 
????????????????????????????????????
RE
SU
LT
S
75
Myc overexpression induces cardio-
myocyte population expansion in the 
adult heart 
Once we had established the lack of pa-
thological response due to Myc mild overex-
pression, we proceeded to determine the 
proportions of cardiomyocyte populations at 
different times after mosaic induction. 
While in iMOSWT hearts the proportion of 
EYFP cardiomyocytes did not increase du-
ring aging and was 53% at 1 year of age 
??????? ????? ???? ??? ???? iMOST1-Myc mosaics 
the proportion increased progressively from 
a frequency similar to that found in iMOSWT 
????????????????????????????????????????????
D).
 Interestingly, half of this enrichment took 
????????????? ???? ?????????????? ?????????????
Since there were no major changes in heart 
????????????????????????????????????????????
these observations suggest that Myc-ove-
rexpressing cardiomyocytes expand at the 
expense of WT cardiomyocytes during adult 
life. 
To directly test this, we determined the re-
lative frequency of ECFP cardiomyocytes 
???????????????????????????????????????????
cardiomyocytes in 1-year-old iMOST1-Myc and 
iMOSWT?????????????????????????
The ECFP cell frequency was ~60% lower 
in the iMOST1-Myc? ???????????????????????????
expansion of the Myc- overexpressing car-
diomyocyte population is concomitant with a 
reduction in the WT population. 
Since we had detected differences in Myc 
levels due to ploidy and nucleation of car-
diomyocytes (most adult cardiomyocytes in 
the mouse are tetraploid and contain two nu-
???????????????????????????????????????????????
partial recombination achieved by tamoxifen 
treatment, we had generated heterogeneous 
levels of EYFP-Myc content in cardiomyo-
cytes, with a predicted predominance of car-
diomyocytes with one or two active EYFP-
Myc copies. 
????????????????????????????????????????-
ne whether cardiomyocyte population expan-
sion correlated with EYFP-Myc levels. 
Fluorescence was measured in isolated 
cardiomyocytes and the frequency of cells 
?????????? ??????????????? ????????????????-
????????????????????????????????????????????
that the enrichment in EYFP+ cardiomyo-
cytes in iMOST1-Myc mosaics mostly affects 
the populations with higher EYFP levels at 
the expense of EYFP-negative cardiomyo-
??????????? ???????????????????????????????????????????????????????????????
A-­‐C??????????? ? ?????????????????????????????? ???????????? ??? ?????????????????????????????????????????????
??????????????????????????????????????? ??????????? iMOSWT? ??????A??? iMOST1-­‐Myc? ???????B?????? iMOST1-­‐Myc/
T2-­‐p35????????????C?????????????????????????????????????????????????????????????????????????D.????????????
?????????????????????????????????????????????????? ???????????????????????	
    iMOSWT???????????????????????
????????????iMOST1-­‐Myc????????????????????????????????????????????????????? ????????????E-­‐G.??????????? ????????
?????????????????????????????????????A-­‐C??????????????????? ??????????????????????????????????????????
??????????????????????????????????H.	
    ???????????????????????????????????A-­‐G????????H.??????????????????????
?????????????????????????????????????????????????????????????????????????iMOSWT	
    ??????iMOST1-­‐Myc	
    ?????????	
    
iMOST1-­‐Myc/T2-­‐p35??????????? ?????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????iMOSWT???????????????????????????????????????
?????? I.???????????????????????????????????????????????????????????????????? ?????????? ?????????????????????
??????????????????????????iMOSWT?????????	
    iMOST1-­‐Myc??????? ???????? ???????????????????????????????????
?????????????A-­‐C????????????????????????? ??????????? ??????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????? ????????????????
??????????????????????? ????????????????????????????????????????
RESU
LTS
76
????????????? ???????????????????????????
19 I). These observations indicate a correla-
tion between Myc dose levels and cardiom-
yocyte population prevalence in the adult 
myocardium.
?????????????????????????????????????????????????????????????? ??? ?????????????????????????????????????????
??????????????????????????
A?????????????????????????????????????????????????????????????iMOST1-­‐Myc??????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????	
    B.?????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????A??????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????
Analysis of the pathways involved in 
adult cardiomyocyte competition
To identify the pathways altered in the 
iMOST1-Myc adult mosaic heart, we performed 
a transcriptomic analysis by RNA-seq, com-
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????????????????????????????????????????????????????????????? ?????????????????????????????????????????????
???????????????????????????????????
A-­‐C	
    ????????????????? ????????????????? ???????????????? ??? ???? ?????????????????????? ???????????????????A???
?????????????B???????????????????????????C??
paring 8-week old iMOST1-Myc and control 
???????????????????
????????????????????????????????????????
downregulated in iMOST1-Myc hearts there is 
a strong representation of genes involved 
in the response to cardiac overload, in cell 
growth/division, in energy metabolism and in 
????????????????????????
Gene set enrichment analysis on all genes 
present in the RNAseq experiment again 
detected the protective response to cardiac 
overload in iMOST1-Myc hearts, including the 
activation of the atrial natriuretic peptide and 
fetal cardiomyocyte programs (Kishimoto et 
al., 2001) (Kuhn et al., 2002) and the HGF/
Rho/Tissue remodeling pathways (Madonna 
et al., 2012). 
In contrast, the EGF pathway, involved in 
the development of pathological hypertrophy 
(Shah and Catt, 2003) was found repressed 
in iMOST1-Myc hearts. 
Regarding metabolic processes, activation 
of the ribosome biosynthesis, a typical res-
ponse to Myc overexpression, was also de-
tected. In parallel, activation of the lysosomal 
pathway was as well present, indicating that 
metabolic activity was globally increased in-
cluding both anabolic and catabolic proces-
ses. 
With regard to the metabolic processes, 
iMOST1-Myc hearts showed a reduction in lipid 
catabolism and in assembly of the peroxiso-
me, the main organelle for lipid catabolism, 
????????????????????????? ??? ???? ????? ??????
by Myc-overexpressing cardiomyocytes. 
A remarkable alteration was found in va-
??????????????????????????????????????????Dbp 
and Per1, 2 and 3 were upregulated and Ar-
ntl (Bmal1) was downregulated. Circadian 
rhythm transcription factors are essential re-
gulators of cardiac metabolism, regulate the 
balance between lipid and glucose usage in 
the heart and display a feedback regulation 
with the oxidative phosphorylation pathway 
(Durgan and Parker, 2010). 
A major regulator of cardiac metabolism, 
AMPK, has also been described to under-
go circadian regulation (Tsai et al., 2010) its 
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regulatory subunit is overexpressed in the 
iMOST1-Myc hearts, and it can be activated by 
Myc overexpression (Nieminen et al., 2013). 
The results observed are therefore compa-
????????????????????????????????????????? ????
iMOST1-Myc with either a direct or indirect im-
pact of Myc overexpression on the circadian 
metabolic regulation. 
In agreement with this view, the Ingenuity 
Pathway analysis on the selected up- and 
????????????????????????????????????????????
????????????????????????????????????????????
reduction of the Oxidative Phosphorylation 
activity in iMOST1-Myc hearts. 
????????????????????????????????????????????
for the upregulated, the downregulated and 
the joint gene sets are again the networks 
????????????????????????????????????????????-
gure 22 B, 23A-C). In agreement with these 
results we found that the expression of the 
atrial natriuretic peptide was clearly activa-
ted in a patchy pattern in the ventricles of the 
iMOST1-Myc??????????????????????????????
Given the known functions of Myc in car-
diomyocytes, the pathways detected likely 
?????????????????????????????????? iMOS	
    
T1-­‐Myc? ?????
	
     A.	
    ??????????? ????????? ??? ????? ????????
????????	
    iMOSWT??????B.	
    iMOST1-­‐Myc	
    ??????
?????????A?????B?????????????????????
?????????? ????????? ????????????????
????????? ??? ????? ???? ?????? ?????? ????
??????????????????????A’?????B’?????????
?????????????????????????????????????????????
??????????????????????
result from cell-autonomous Myc functions 
and may relate to the ability of Myc-overex-
pressing cardiomyocytes to replace the WT 
cardiomyocyte population. 
In addition, the Gene Set Enrichment study 
??????????????????????????????????????????????-
???????????????????????????????????iMOST1-
Myc hearts, which could be related to the dea-
th and removal of WT cardiomyocytes. We 
therefore used the iMOST1-Myc/T2p35 mosaics to 
undertake a functional study of the involve-
ment of cell death. 
This analysis showed that p35 expression 
???????????????????????????????????????????-
gure 21 C, G, H). 
These results indicate that adult cardio-
myocytes undergo Myc-induced cell compe-
tition, which progresses by elimination of WT 
cardiomyocytes and their replacement by 
cardiomyocytes with high Myc levels. 
We then analyzed whether increased pro-
liferation of the Myc-overexpressing popula-
tion is contributing to this phenomenon. We 
found that BrdU incorporation was 4-fold 
more frequent in the EYFP-Myc cardio-
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myocytes than in the WT cardiomyocytes of 
iMOST1-Myc ??????????????????????????????
 This increase did not alter the proportion of 
?????????????? ??????????????? ??????? ???
C), suggesting that the balance between mo-
nonucleated cardiomyocyte division and bi-
nucleation is preserved. 
To directly assess the involvement of apop-
tosis in the cardiomyocyte population shi-
ft, we analyzed the TUNEL pattern in adult 
iMOST1-Myc mosaics, however, we found no 
??????????? ???????????? ??? ?????? ??????????
between the EYFP-Myc and ECFP-WT cell 
populations.
 These results suggested that, unlike the si-
tuation during development, apoptosis might 
not be involved in the elimination of WT car-
diomyocytes in adults, despite the activation 
of apoptotic pathways detected by RNAseq. 
????????????????????????????????????????????????????????????
A.??????????? ???????????????????????????????????????? ???????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????? ???????
????????? ???????????????????????????? ???????????????????????????????????????? ?????????????????????
??????????????????????????????? ??????????????????????????????????????? ???????????????? ?????????
??????????????????? ?????????????????????????????????????????????????????????? ??????????????? ?????? ?????
??????????????????????????????????????????????????????????????????????????????????????????????????????????
We then explored whether alternative cell 
death pathways could be operating in post-
natal cardiomyocytes. 
Given that p35, in addition to inhibiting 
apoptotic cell death, can also inhibit autopha-
gic cell death (Martin and Baehrecke, 2004) 
and that many apoptosis regulators are also 
involved in autophagic cell death, we tested 
whether this pathway could be involved in 
postnatal cardiomyocyte cell competition.
????????????? ?????????????????????????????
marker Beclin (Liang et al., 1999) showed 
rare positive cells in iMOSWT ?????????????????
A, A’, A’’), however the frequency of Beclin-
positive cells increased by 5-fold in iMOST1-
Myc ????????????????????????????????????????
Moreover, the frequency of Beclin-positive 
cells within the iMOST1-Myc mosaics was 9-fold 
higher in ECFP-WT cells than in EYFP-Myc
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????????????????????????????????????????????????????
A-­‐C.	
    ????????? ???????? ???????? ????????? ??????? ????? iMOSWT? ????? ?A?? ???? iMOST1-­‐Myc? ?????????????? ?B??
????????????????????????????????????????????????iMOS??????????????????????????????????????A’,	
    B’.????????
??????????????????????????????D	
    ????E?????????????????????????????????????A’’,	
    B’’?????????????????????????????
A’,	
    B’? ?????????????????????????C.	
    ???????????????????????????????? iMOSWT?????????? iMOST1-­‐Myc???????????????
???????????????????	
    D.?????????????? ?????????????????????????????????????????????????????????????????
????????????	
    iMOST1-­‐Myc? ??????????????????C??F??G?????? ?????????????????????????????????????????
????????????????????
These results indicate that autophagic cell 
death instead of apoptotic cell death is a ma-
jor contributor to postnatal cardiomyocyte 
cell competition.
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Cell competition in the develo-ping epicardium
Myc overexpression increases the con-
tribution of Wt1 lineage to the heart du-
ring development
 Having induced cell competition in the 
cardiomyocyte lineage during heart develop-
ment, we decided to test the potential of cell 
competition in the developing epicardium.
 The epicardium gives rise to different cell 
types during heart development (Wessels 
and Perez-Pomares, 2004) and has risen a 
lot of attention as a possible source of proge-
nitors to replenish smooth muscle cells and 
myocardium, both during development and 
in the adult heart upon injury (Smart et al., 
2011, Smart et al., 2007, Zhou et al., 2008). 
To explore the roles of Cell Competition in 
epicardium, we recombined either iMOSWT or 
iMOST1-Myc transgenes using Wt1-Cre. 
Analysis of histological sections at E14.5 
in the iMOSWT heart showed the described 
contribution of the Wt1 lineage to the myo-
cardium. We found contribution to the epi-
cardial layer and to epicardial derived cells 
(EPDCs) as well as to a few cardiomyocytes 
that appear scattered in the inter-ventricular 
??????? ????????? ??? ????? ???????????? ??????
A’). 
In contrast, histological sections from E14.5 
iMOST1-Myc hearts showed a remarkable con-
tribution to both ventricles and the inter-ven-
tricular septum (IVS) of the Wt1-Cre lineage 
?????????????????
?????????????? ??? ???? ??????????? ?????
??????? ?? ????? ??? ????? ????? ????????? ??? ????
contribution of Wt1 lineage to the ventricles 
?????????????????????????????????????
This contribution progressed until birth 
when the proportion of the Wt1-Cre lineage 
to the ventricles raised to 50% of the total 
???????????????????????????????????????????-
reas the increase in the area of contribution 
??????????????????????????????????
Myc overexpression in the Wt1-Cre line-
age promotes preferential colonization of 
epicardium, EPDCs and Ventricular Car-
diomyocyte populations. 
To determine the contribution of EYFP-Myc 
cells from the Wt1-Cre lineage at E14.5, we 
??????????????????????????????????????????
E14.5 iMOSWT and iMOST1-Myc hearts. 
?????????????? ??? ?????? ??????? ??????? ??
doubling in the EYFP population proportion 
in iMOST1-Myc hearts compared with that ob-
served in iMOSWT ??????????????????????
We detected that the increase in the area of 
contribution of Wt1-Cre lineage was mostly 
due to a contribution to the cardiomyocyte 
????????????????????????????
To further determine the effect of Myc ove-
rexpression on the Wt1-Cre lineage in the 
?????????? ????? ????????????? ??? ?????????? ????
relative proportion of EYFP cells with respect 
to the total recombination (EYFP+ECFP) in 
histological sections in non-cardiomyocyte 
(mostly EPDCs and epicardial cells) and in 
cardiomyocyte cell populations from the free 
walls of both ventricles (VFW) and the IVS.
  In both left and right VFWs and in the IVS, 
we detected a homogeneous enrichment 
(as an increase in the EYFP/ECFP ratio) in 
EYFP-Myc cells in the non-cardiomyocy-
te fraction of around 10-15% in iMOST1-Myc 
versus iMOSWT? ??????? ??????? ???????????-
reover, in histological sections we detected 
that the coronary perivascular cell population 
was composed 100% of EYFP-Myc cells in 
iMOST1-Myc ??????? ??????? ????????? ???????????
a competitive advantage of  Myc-overex-
pressing EPDCs in colonizing the perivas-
cular niche and differentiating to smooth
RESU
LTS
82
??????????? ??????????????????????????? ??????????????????????????????????????????????
A-­‐B’.??????????? ??????????????????????????????????iMOSWT???????A?????	
    iMOST1-­‐Myc????????B???????????????????????
???? ???? ????????A’?????B’?????? ???????????????????????????????????????A?????B??C-­‐D’???????????? ??????????
???????????????????????????iMOSWT???????C??????iMOST1-­‐Myc?????????D?????????????????? ????????C??????D???????
????????????????????????????????????????C?????D??E-­‐F.??????????????????????????????????????????????????
????????????iMOSWT?????????	
    iMOST1-­‐Myc??????????????????????????????????E????????F??????????G??????????????E,	
    F,	
    G?
????? ????????????????????????????????????????????????????????A,B,C,D???????????A’,B’,	
    C’,	
    D??????????????
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??????? ???? ?????????? ????????-­‐
??????????????????????????? ???
????????????????
A.?????????? ?????????? ?????
???????? ??????? ??? ?????? ???????
????? ?????? ?????? ?????????? ???
iMOSWT? ???????????????????????
???? ???????? B.? ?????????? ??????
??????????????????????????????????
??????????????????????????????????
??	
     iMOST1-­‐Myc? ?????? ?????? ??????
????????? ???????? C.? ?????????
???? ??? ?????? ?????????? ?????
???? ??? ???? ?????? ??????? ??? ?????
?????? ????????? ??? ???? ??????????
???? iMOSWT? ????? ???? iMOST1-­‐Myc	
    
????????????????????????????????
?????? ?? ???????????? ??????????
???????????????????????
muscle cells. 
As mentioned before, we detected no 
EYFP or ECFP cells in the iMOSWT in either 
?????????????????????????????? ????????????????
C-E). 
In agreement, all contribution of the Wt1-
Cre lineage to the VFW cardiomyocyte po-
pulation in iMOST1-Myc hearts was 100% from 
??????????????????????????????????????????
C, E). An important enrichment in the EYFP/
ECFP ratio was also detected in the IVS car-
diomyocite fraction in iMOST1-Myc? ??????? ???
D). 
These results indicate that Myc overexpres-
sion promotes preferential expansion cells 
derived from the epicardium and EPDCs, 
both known derivatives of the Wt1-Cre line-
age.  In addition, we found thatMyc overex-
pression drives a strong contribution of the 
WT1-Cre lineage to the cardiomyocyte popu-
lation, especially that of the VFWs.
 Myc overexpression promotes the inva-
sive behaviour of epicardial cells 
To further understand the effect of Myc 
overexpression in epicardial cells, we set up 
a new ex-vivo system of epicardium-myo-
cardium co-explants. This system allows us 
to understand epicardial behaviour when in 
presence of myocardium and myocardial sig-
nals, and represents an ex-vivo way of un-
derstanding epicardium-myocardium cross-
talk.
We performed co-explant assays of E10.5 
left ventricles (covered by epicardium) from 
iMOSWT and iMOST1-Myc mosaics confronting 
them with E9.5 WT left ventricles (not yet co-
vered by epicardium), and cultured them for 
24 hours. 
We detected that epicardial cells form both 
iMOSWT and iMOST1-Myc E10.5 LVs were able 
to expand, migrate and reach the surface of 
the E9.5 WT myocardium.  While  iMOSWT 
epicardial cells remained on the myocardial 
?????????????????????? ????????????? iMOST1-Myc 
epicardial cells invaded the WT myocardium
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??????????? ?????????????????????????????????????????????????????????????????????????????????? ?????????-­‐
????????????????????????????????? ????????????????????????????? ?????????
A-­‐B’.	
    ????????? ? ????? ?????????????????? ??????????? iMOSWT? ????? ?A?????? iMOST1-­‐Myc??????? ?B??????????????????
????????????? ????????A’?????B’???????????????????????????????????????????A?????B??C-­‐E?????????????????????
??????????????????????????? ???????????????????iMOST1-­‐Myc????????????iMOSWT??????? ????????????????????????????
?????????????????????????????????????????????????????????C????????D??????????E???????????? ?????????????????????
??????????????????????????????????????????????????????????????????????
?????????????????????????????????????????
?????????? ?????????????????????????
A-­‐C.? ????????? ? ???? ????? ?????????????
?????????????? iMOST1-­‐Myc?????????????????
??????A?????????????????????B???????? ???
????? ???????????????????????????C????????
?????????????????????????????????????????
??????? ?????? ???????????? ??? ????????????
??????????????????????????????????????
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????????????????????????????????????????????-
yocytes and showing a mesenchymal mor-
?????????????????????????
Contribution of Wt1-Cre lineage to car-
diomyocytes in the VFW can not be ex-
plained by expansion of interventricular 
septum cardiomyocytes or transdifferen-
tiation from blood or endocardial cells. 
We then addressed the source of the newly 
found contribution of Wt1-Cre lineage to the 
cardiomyocyte fraction. Since Wt1-Cre is 
also reported to give rise to cardiomyocytes 
scattered in the IVS (Wessels et al., 2012), 
we addressed whether these cardiomyocytes 
could be expanding by cell competition. 
Since there is no Cre line available that 
??????? ???? ?? ???????? ?????????????? ??? ????
IVS, we took advantage of Mef2C-AHF-Cre 
(Verzi et al., 2005), that recombines the an-
????????????????????????????????????????????????
cardiomyocytes in the right ventricle and in 
the vast majority of the interventricular sep-
tum, excluding the left outermost region. 
??????? ???????? ???????????
????? ???? ??????? ???????-­‐
?????? ??? ???????????????
????? ???? ??????? ??? ????-­‐
???????????????????????????
A,	
     B.	
     ????????? ? ?????
????? ????????????? ????????
??? iMOSWT? ????? ?A?? ????
iMOST1-­‐Myc????????B?? ??????
???????????????????????????
???????????????????? C,	
     C’?
????????? ? ????? ????? ????
?????????????????????iMOST1-­‐
Myc????????????????????????
???????????????????C’???????
?? ???????????? ????? ????
?????? ????? ??? ??? ? ????? ????
?????????????????????????	
    
We found that in iMOST1-Myc mosaics, even 
though the majority of the IVS cardiomyo-
cytes overexpress Myc, there is no coloniza-
??????????????????????????? ??????????????????
is unable to induce cardiomyocytes coloniza-
????????????????????????????????????????
Wt1-Cre has also been shown to recom-
bine cells from the endocardial/endothelial 
lineage, as well as haematopoietic progeni-
tors (Alberta et al., 2003). 
To study whether either of these cell ty-
pes could be transdifferentiating upon Myc 
overexpression and giving rise to cardiom-
yocytes, we took advantage of the Tie2-Cre 
mouse line that recombines both endocar-
dial/endothelial lineage and haematopoietic 
progenitors. iMOST1-Myc activation in blood 
and endothelium didn’t show any contribu-
tion to cardiomyocytes in the E14.5 embr-
???????????? ?????????????????? ??????????? ?????
Myc overexpression in the Tie2-Cre lineage 
is unable to induce transdifferentiation to car-
diomyocytes. 
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Ex-vivo epicardial assays do not show 
a differentiation of the epicardium to car-
diomyocytes
We then decided to address if Myc overex-
pression was able drive the epicardial cells 
towards the cardiomyocyte lineage in an epi-
cardial explant culture system.
 We performed explant assays from iMOSWT 
and iMOST1-Myc mosaics at E10.5. After 6 days 
of culture, iMOSWT  and iMOST1-Myc explants 
showed an epicardial layer of cells typically 
cobble-stone shaped with some differentia-
tion to mesenchymal cells mostly at the ed-
????????????????????????????????????
However, we were unable to detect car-
diomyocytes by c-TnT staining or beating af-
ter scoring around 30.000 cells from different 
explants. Moreover, in the previously mentio-
ned co-explant assays, invading epicardial 
cells from iMOST1-Myc didn’t show myocardial 
????????????????????????????????
It has been reported that proepicardial ex-
plants (Garriock et al., 2014)  spontaneously 
give rise to cardiomyocytes, so we decided 
to assess if Myc overexpression could pro-
mote cardiomyocyte  differentiation from 
proepicardium. 
We performed proepicardial explants from 
E9.0 hearts of iMOSWT and iMOST1-Myc and af-
ter 24 hours beating cells could be scored. 
We detected contribution to beating cells 
from Wt1-Cre lineage in iMOSWT explants but 
we couldn’t detect any increase in the contri-
bution to cardiomyocytes upon Myc overex-
pression. 
These results show that   assays do not su-
pport a role of  Myc in driving the cardiomyo-
cyte fate from epicardial cells. 
??????????????????????????????????????? ????? ??? ??????????????? ????????????????????????? ????????????????-­‐
????????????????????? ?????????????
A-­‐B’	
    ?????????????????????????????????????????????????????????????????????	
    iMOSWT???????????????iMOST1-­‐Myc	
    ??????
?????????????????????????????? ??????????????????????????????????????????????????????????????????????????????
??????? ??????????????????????C-­‐D???????????????????????????????????????????????iMOSWT???????C???????MOST1-­‐Myc	
    
???????D???????????????????????????????????????????????????????????????????????????????????????????????????????
???	
    D’	
    ??????? ??????????????????C	
    ????D? ?????????????????????????????????????????????????
RESU
LTS
88
Contribution of Wt1 lineage to cardiom-
yocytes upon Myc overexpression takes 
place before establishment of the epicar-
dial layer
To pin down the origin of cardiomyocytes 
from Wt1-Cre lineage, we decided to ex-
plore the origin of Wt1-Cre lineage derived 
cardiomyocytes in earlier developmental sta-
ges. 
We analysed the contribution to cardiom-
yocytes in stages ranging from E9 to E9.5. 
Surprisingly, we found a small contribution to 
cardiomyocytes in both iMOSWT and iMOST1-
Myc at a similar proportion (around 75% of the 
????????????? ???????? ????????????? ????????-
?????????????????????????????????????????????-
gure 34 A-D).
 These observations suggest that the con-
tribution of the Wt1-Cre lineage to cardiom-
early labeled cardiomyocytes that would then 
expand by cardiomyocyte cell competition. 
We then decided to directly test the con-
tribution of the epicardial layer to the car-
diomyocyte population at later stages, which 
would avoid the confounding effect of the 
early contribution of the Wt1-Cre lineage. For 
this, we used again a Wt1 driver but this time 
controlling a  tamoxifen-inducible Cre. 
We induced recombination injecting bet-
ween E9-E9.5 and we found that even 
with the highest tolerable tamoxifen dose, 
although we detected recombination in the 
epicardium at E14.5, we were unable to de-
????? ???? ??????????? ?????????????? ???????
34 E-F). 
Taken together, these results indicate that 
in most likelihood, Myc overexpression in the 
epicardial layer does not drive epicardium or 
EPDC  differentiation towards the cardiomyo-
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Most likely, it is the contribution of the Wt1-
Cre lineage to the early cardiomyocyte line-
age what explains the presence  cardiomyo-
cytes in these experiments.
These cardiomyocytes would then expand 
by cell competition colonizing large portions 
of the ventricles.  Whether this early con-
tribution of the Wt1-Cre? ???????? ???????? ???
early expression of endogenous Wt1 in the 
cardiomyocyte lineage or a failure of the Cre 
line to recapitulate Wt1 expression at early 
developmental stages remains to be deter-
mined.
???????????????????????????????????????? ?????????????????????????????????????????????????????
A-­‐B’.??????????? ??????????????????????????????????????????????iMOSWT???????A??????iMOST1-­‐Myc	
    ???????B??????????
???????????A’?????B’?????? ?????????????????????????????A?????B??C.	
    ????????????????????????????????????????
????????Wt1? ???????? ???????????? ??? ??????????????? ??? iMOSWT? ????? ???? iMOST1-­‐Myc? ??? ?????? ??????D.? ??????
???????????????????????????Wt1???????????????????????????????????????????????iMOSWT????????????MOST1-­‐Myc???????
??? ????????????E,F.?????????? ? ????????????????????? ???????? ?????????????????? iMOSWT? ????? ?E?????? iMOST1-­‐Myc	
    
???????F?? ????????????
????????????????????????????????????E????	
    F????????????????????????????????????????????????????????????????????
????
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DISCUSSION
Something	
    good	
    will	
    come	
    of	
    all	
    things	
    yet
??????????????
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In this thesis we have demonstrated the ability of Myc mild overexpression in 
a mosaic fashion to trigger a response in 
the heart that eliminates cells with relative 
lower Myc levels, preserving organ size and 
function. 
Previous studies have pointed to Myc as 
an inducer of pathological responses in the 
heart, both during development, when it tri-
ggers cardiomyocyte overproliferation and 
??????????????????????????????????????????????
in an adult context, where Myc overexpres-
sion induces cell hypertrophy which eventua-
lly leads to cardiac failure and death (Xiao et 
al., 2001). 
These studies, however, rely on strong car-
diac promoters to drive Myc homogeneous 
overexpression and thus, cannot be used as 
????????????????????????????????????????????
such as the one used in this thesis. 
Myc overexpression through the iMOS sys-
tem in the heart is mild and has not rendered 
any pathological effects neither during deve-
????????????? ???????????????????????????????
functional level. This goes in agreement to 
what has been previously described for Myc 
levels through the Rosa 26?????????????????
do not induce cardiac hypertrophy even with 
two extra Myc alleles. 
Upon Myc overexpression in adult hearts 
we have detected, through differential ex-
pression analysis, a pattern that resembles 
cardiac overload response. The activated 
pathways (Nppa, HGF), are a consequence 
of reactivation of fetal programs.  This reac-
tivation has been described upon higher de-
mands in cardiac function and is cardiopro-
tective and benign (Kishimoto et al., 2001, 
Kuhn et al., 2002, Madonna et al., 2012). 
HGF in particular has been descri-
bed not only to play a protective role 
but also to be implicated in heart rege-
neration (Madonna et al., 2012). Mo-
???????? ?? ???????? ????????????????????????
pathway (EGF), usually present in maladap-
tative hypertrophic responses (Lee et al., 
2011) was downregulted in our experimen-
tal context. At the light of the transcriptomic 
analysis and the lack of pathological effect, 
neither anatomical nor functional, it is clear 
that Myc levels used to study cell competition 
in the heart are within homeostatic values, 
and do not induce any functional impairment 
or defect in the developing or adult heart. 
Myc overexpression in the developing heart 
is able to induce cell competition, eliminating 
those cardiomyocytes with relative lower Myc 
levels, and it promotes these changes in cell 
composition without exerting alterations in 
the function or size of the heart.
  The fact that cardiomyocytes are elimi-
nated during heart development goes in 
agreement with previous studies which have 
highlighted its enormous plasticity, (Drenckh-
ahn et al., 2008) being able to compensate 
for defective cell loss during morphogenesis 
whilst preserving organ size and function and 
give rise to a phenotypically normal heart. Our 
results indicate that even WT cells can be eli-
minated by cell competition when confronted 
with more active cells.  This suggests that the 
replacement ability observed by Drenckhahn 
et al. could be boosted by cell competition, 
although this aspect was not explored in this 
model.
Moreover, we have shown that this plastici-
ty is different if we induce cell competition in 
???????????????????????????????????????????????
suggesting that inducing cell competition at 
different differentiation stages (in this case, 
prior to the addition of precursors to the heart 
tube) (Cai et al., 2003) could have an effect 
??? ???? ???????????? ?????? ????????????????
although it could also be the case that second 
???????????????????????????????????????????????
heterogeneity in Myc levels per se and thus 
93
the competitive response is exacerbated. In 
the light of these data, and because we had 
detected Myc endogenous expression also in 
??????? ?????? ????? ???????????? ???????????
cell competition could also be taking place in 
this particular population. 
However, rescuing this cell population from 
death  by mosaic p35 overexpression did 
not result in a cell population with lower Myc 
levels, suggesting that programmed endo-
genous cell competition does not take place 
during cardiac development. 
The results obtained with the induced cell 
competition however show that cardiom-
???????? ??????? ?????????? ??? ??????? ??????-
geneity and do activate cell competition in 
response to it.  These observations suggest 
cell competition could be used contingently 
to eliminate accidentally defective cardiom-
yocytes. 
Whereas the mechanisms underlying cell 
competition remain elusive (not only in ma-
mmals but also in Drosophila), a common 
feature is the elimination of “loser” cells by 
apoptosis (Claveria et al., 2013). This also 
holds true in heart development induced cell 
competition, where it has also been shown to 
??????????????????????????????????????????????
a similar fashion to what has been described 
both in mammals (Claveria et al., 2013) and 
in Drosophila (Moreno and Basler, 2004, Mo-
reno et al., 2002). 
We have not detected, however, a compen-
satory overproliferation of winner cells or an 
increase in their size as a compensatory me-
chanism to ensure organ size, as it had been 
reported in Drosophila in postmitotic tissues 
(Tamori and Deng, 2013). 
Moreover, these results agree with pre-
viously reported effect of Myc overexpres-
sion through Rosa 26 promoter in the heart 
(Murphy et al., 2008) and the described 
cell competition in the mammalian epiblast 
(Claveria et al., 2013). Maintenance of cell
numbers and organ size could be due to 
the fact that cell competition is a rather lo 
???????????????? ???????????????? ??? ???????
during heart development (Poelmann et al., 
2000) and probably because a subtle increa-
se in the proliferation rate of both populations 
???????????? ???? ???? ?????????????????????????
thus preserving organ size and cell number 
but not being detected through our experi-
mental approach. 
Further attempts to gain insight in cell com-
????????? ??????????? ????? ????? ??????????
Flower  elimination did not show any altera-
tion of the Myc-induced competition in the 
heart, suggesting alternative mechanisms 
??????????????????????????????? ????????????-
diomyocytes must be present. 
We have tested competition by confron-
ting cell populations with different doses of 
overexpressed Myc and endogenous Mycn. 
Mycn has been previously shown to functio-
nally replace Myc (Malynn et al., 2000) and 
by depleting Mycn we have shown that com-
petition and its intensity depend on the com-
parison of relative Myc functional doses bet-
ween neighbouring cardiomyocytes, rather 
the absolute Myc levels. 
Moreover, we have shown that Myc-expres-
sing cardiomyocytes are able to promote a 
very strong elimination of Mycn KO cardiom-
yocytes from the developing heart, rescuing 
the otherwise embryonic lethal phenotype of 
Mycn mutants (Harmelink et al., 2013). 
Elimination of Mycn KO cardiomyocytes, 
however, is not due to a cell autonomous de-
leterious effect of the mutation since it has 
been shown that Mycn? ?????????? ? ????????
increase apoptotic rates in cardiomyocytes 
during development (Harmelink et al., 2013).
 Therefore, the strong depletion in Mycn KO 
cells is attributable to an active elimination by 
cell competition. These results indicate that 
cell competition underlies the plastic capacity 
??? ???? ??????????? ?????? ??? ??? ?????? ?????
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cells and restore myocardial function. 
Interestingly, this ability is maintained in 
adult life, albeit at a lower rate. Despite car-
diomyocytes being mostly a postmitotic cell 
population, cell competition appears to be 
able to displace the WT population without 
altering cardiac function. In contrast, in an 
example of postmitotic cell competition in 
Drosophila, lost cells are replaced by hyper-
trophy of the winners (Tyler et al., 2007). 
In adult heart competition there are, howe-
ver, notable differences with that observed 
in the developmental context. Wild-type 
cardiomyocytes are eliminated by a mecha-
nism prevented by p35 expression, and even 
though apoptosis wasn’t directly detected, 
a role for autophagy-driven cell death was 
found. 
Autophagy is a catabolic process by lyso-
somal degradation of cytoplasmic content. 
Homeostatic autophagy is usually protective 
and needed to maintain healthy cardiomyo-
cytes, but exacerbated  autophagy levels can 
be deleterious and lead to cell death. In seve-
ral studies it is autophagy and not apoptosis 
what leads to cell death in cardiomyocytes 
(Zhu et al., 2007, Knaapen et al., 2001).
 Apoptosis and autophagy pathways have 
been shown to be tightly linked and their 
crosstalk has been largely reported (Re-
viewed in Rubinstein and Kimchi, 2012) and 
(Jain et al., 2013). Moreover, a master re-
gulator of deleterious autophagy, Beclin1, is 
inhibited by Bcl2-family of antiapoptotic pro-
teins (Pattingre et al., 2005). 
The activation of autophagy in loser cells 
upon cell competition in the adult heart is most 
?????????????????????????????????????????????????
adult cardiomyocytes. Since their size is se-
veral times bigger than that of macrophages, 
in order for corpses to be cleared, presuma-
bly they need to be downsized, which would 
be achieved by increasing their autophagy 
levels. It has been described that autopha
gy can facilitate events leading to cell death 
(Qu et al., 2007) and the classic elimination of 
giant cells of the salivary gland in Drosophila 
involves caspase-dependent autophagic cell 
death (Martin and Baehrecke, 2004).
Interestingly, the observed replacement of 
cardiomyocytes in the adult context is rele-
vant to a long-debated question as to whe-
ther the heart is able to turn-over its cardiom-
yocyte population and the putative source 
of new cardiomyocytes. Since there’s an in-
crease in the relative EYFP-Myc cell popula-
tion and due to experimental design it seems 
likely that the new cardiomyocytes generate 
from pre-existing ones. Some authors argue 
that Myh6 is expressed in certain postnatal 
cardiac stem cells (Kwon et al., 2007, Bailey 
et al., 2009), which could be a confounding 
factor as of the source of the newly formed
 +Myc WT WT
Normal
Normal
Autophagy
Apoptosis
Development
Postnatal
???????????????????? ?????????????????????????-­‐
????????????????????????????????????????????????-­‐
???????????????????????
??????? ????????????? ???? ??????????????? ????
????????????????????????????????????? ??? ?????
???? ??? ??????? ??? ??????????? ??? ???? ?????? ???????
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cardiomyocytes. Other studies, however, 
???????????????????????????????????????????????
though this remains a controversial issue, it 
is highly likely that newly formed EYFP Myc 
?????????????????????????????????????????????
which would also be in agreement with pre-
vious reports on cardiomyocyte turnover (Ali 
et al., 2014, Senyo et al., 2013, Bergmann et 
al., 2009, Bersell et al., 2009). 
Moreover, there is an increase in the BrDU 
incorporation in EYFP Myc cardiomyocytes 
that would support this hypothesis, accoun-
ting for the relative increase in this popula-
tion. (Assuming of course that DNA synthe-
sis results in cytokinesis). In fact, the ratio 
between mono and multinucleated cardiom-
yocytes was maintained, suggesting that in-
creased bi-nucleation events were balanced 
with proliferation of mononucleated cardiom-
yocytes (Bersell et al., 2009). 
This proliferation cannot be attributed to a 
cell-autonomous effect, since homogeneous 
overexpression of up to two copies of Ro-
sa26-MycER do not lead to cardiomyocyte 
overproliferation (Murphy et al., 2008), and 
thus, most likely, corresponds to a mecha-
nism that compensates for the loss  of WT 
cells. 
The compensatory nature of this prolife-
ration is supported by the observation that 
in iMOST1-Myc/T2-p35 mosaics, heart size and 
shape is maintained. Therefore, our results 
suggest that local cell competition and com-
pensatory proliferation balance each other 
preserving heart size. 
Results from differential expression analy-
sis showed activation of fetal programs that 
are typical hallmarks of cardiac overload and 
hypertrophy.  This activation did not lead to 
phenotypic or functional cardiac alterations, 
suggesting they are directly activated by Myc 
in the absence of any cardiac stress.
 Disruption of these pathways has been 
shown to lead to cardiac pathologies and 
death (Oliver et al., 1997, Kuhn et al., 2002) 
and they have been shown to be protective 
in induced hypertrophy models (Kishimoto et 
al., 2001). 
Overall, these changes can be attributable 
to an autonomous effect of Myc overexpres-
sion and further transcriptomic and proteomic 
assays must be performed in detail in both 
winner and loser populations to shed light in 
mechanisms regulating cell competition. 
However, it is still to be explored whether 
Myc mild activation in cardiomyocytes trig-
gers by itself a protective response in hyper-
trophic or ischemic models.
 Epicardium
Given the limited regenerative capacity of 
the mammalian adult heart, the search for 
cells that can stimulate cardiac repair is in-
tense, and the epicardium has arisen as a 
potential source of cardiac progenitors (Wes-
sels and Perez-Pomares, 2004). 
The understanding of the full potential of 
epicardial cells to constitute a source of pro-
genitors with regenerative ability is of key im-
portance. Therefore, the quest to understand 
the full potential of this population during de-
velopment has been a focal point in cardiac 
developmental and regenerative studies. 
In this thesis we obtained results apparently 
pointing to Myc’s ability to induce differentia-
tion of epicardial or epicardial-derived cells 
to the cardiomyocyte lineage. Initial results 
showed a very strong contribution to the car-
diomyocyte lineage, which would be in agre-
ement with previous reports on the potential 
of epicardial cells to contribute to the deve-
loping myocardium (Zhou et al., 2008, Cai et 
al., 2008). 
However, studies of epicardial fate 
are confusing because of unreliabili-
ty of the tools used in the fate-mapping 
experiments (Rudat and Kispert, 2012, 
Zhou et al., 2008, Zhou  and Pu, 2012). 
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Genetic fate mapping studies strongly rely 
on Cre expression in the precursor tissue wi-
thout any leakiness in the target tissue. Re-
garding Tbx18-Cre, for example, contribution 
of EPDCs to myocardium has been debated 
(Christoffels et al., 2009) and direct Tbx18 
expression in cardiomyocytes has been re-
ported (Zeng et al., 2011). It has been shown 
that Wt1-Cre lines are not completely reliable 
recapitulating  Wt1 expression and sugges-
ted not to be useful to assign an epicardial 
origin of the traced cells (Rudat and Kispert, 
2012). 
Moreover, use of the inducible Wt1-
CreERT2????????????????????????????????????-
bination and studies on its contribution to 
the cardiomyocyte pool are also contradic-
tory (Zhou and Pu, 2012, Rudat and Kispert, 
2012, Zhou et al., 2008). Despite all of these 
??????????????????????????????????????????????????
?????????????????????????????????????????????
not been reported to label cardiomyocytes 
(Wessels et al., 2012, Wilm et al., 2005) besi-
des those found sparsely in the IVS. The rea-
son for a putative sporadic Cre activation in 
cardiomyocytes in this line (Wt1-CreEGFP) 
(Wessels et al., 2012) remains unknown but 
has also been reported elsewhere (Zhou and 
Pu, 2012). 
Some studies discard the expression of 
Wt1 in cardiomyocytes during development 
???????????????????????????????????????????-
velopmental stages from E10.5 onwards. 
However, expression of Wt1 in cardiomyo-
cytes has been detected at stage E9.5, albeit 
weak (Rudat and Kispert, 2012), and could 
underlie our observation. 
All of these studies highlight that results ob-
tained using these tools need to be carefully 
assessed. 
In our experiments, despite the initial appea-
rance, we could not relate the contribution of 
the Wt1-Cre lineage to cardiomyocytes to an 
epicardial origin. Our fate-mapping perfor-
med at E14.5 showed a strong contribution 
to cardiomyocytes upon Myc overexpres-
sion, but we have been unable to induce that 
differentiation in vitro and this observation 
has not been reproduced inducing temporal 
conditional epicardial lineage tracing.
Moreover, we have detected the presence 
of cardiomyocytes from a Wt1-Cre lineage 
prior to the appearance of the epicardium. 
This contribution was poorly reproducible 
and not dependent on Myc activation since it 
was observed equally in iMOSWT and iMOST1-
Myc mosaics. 
The fact that Myc overexpression provokes 
????? ????????? ???? ????? ???????????? ??? ??????
heart precursors and cardiomyocytes and 
the undetectable differences between Myc 
and control mosaics as we have detected in 
Islet1 progenitors, suggests that this contri-
bution of the Wt1-Cre lineage to cardiomyo-
cytes is produced from de novo activation in 
cardiomyocytes shortly before the time of ob-
servation (E9-9.5) and does not result from 
an early recombination in earlier cardiac pre-
cursors. 
The question on the origin and nature of 
the cardiomyocytes present at E14.5 and P0 
upon Myc overexpression is therefore still 
unanswered, although it seems that early ex-
pression in cardiomyocytes at E9.5 and fur-
ther expansion of these cardiomyocytes by 
cell competition is the most likely scenario. 
The inability to detect this cardiomyocyte 
population in the free walls of the ventricles at 
late stages in the WT mosaics is intriguing.
 One possibility is that this early Wt1-Cre-
labeled cardiomyoytes represents a subset 
of cardiomyocytes with limited ability to con-
????????????????????????? ????????????????????
the IVS, and upon Myc overexpression are 
rescued and promoted to contribute to the 
ventricular free wall through cell competition. 
Further studies need to be performed to 
address this hypothesis and if this is the 
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case, on the implications of rescuing this 
subset of cardiomyocytes for development 
and homeostasis.
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CONCLUSIONS
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Conclusions
 1.- Myc mild overexpression in a mosaic fashion induces cell competition in the de-
veloping heart, eliminating cells with lower Myc levels.
 2.- Elimination of WT cardiomyocytes is a phenotypically silent proces and heart 
morphology and function are preserved.
 3.- Elimination of WT cardiomyocytes relies on short range interactions.
? ?????????????????????????????????????????????????????????????????????????????
 5.- Adult cardiomyocytes compete, eliminating those with relative lower Myc levels 
in homeostasis.
 6.- Cell competition in the adult heart relies on proliferation of “winner cardiomyo-
cytes” at the expense of those with relative lower Myc levels, which activate autophagic 
pathways prior to their elimination.
 7.- Myc mosaic overexpression at moderate levels in the adult heart induces activa- 
tion of fetal programs typical of a protective response to cardiac overload.
 8.- Myc mosaic overexpression in Wt1 lineage induces cell competition in epicar-
dium and epicardial derived lineages.
 9.- Wt1-Myc overexpression promotes the contribution of Wt1 lineage to cardiomyo-
cytes in the ventricular free walls, although epicardial contribution to this lineage is discar-
ded.
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Conclusiones
 1.- La sobreexpresión moderada de Myc en mosaico induce competición celular en 
el corazón durante la gestación, eliminando aquéllas células con menor nivel relativo de 
Myc.
 2.- La eliminación de los cardiomiocitos salvajes es un proceso fenotípicamente 
silencioso y la morfologíaa y función del corazón están inalteradas.
 3.- La eliminación de los cardiomiocitos salvajes depende de interacciones a corta 
distacia.
 4.- Los progenitores del campo cardiaco secundario tienen una respuesta más acu-
sada a la competición celular.
 5.- Los cardiomiocitos adultos también son sensibles a la competición celular indu-
cida, eliminandose aquéllos con menos nivel de Myc.
 6.- La competición celular en el corazón adulto depende de la proliferación de los 
cardiomiocitos “ganadores” a expensas de aquellos con menor nivel relativo de Myc, que 
activan vías de señalización de autofagia previamente a ser eliminados.
 7.- La sobreexpresion moderada de Myc en el corazon adulto induce la  activacion 
de programas de expresión fetales característicos de una respuesta cardioprotectora en 
respuesta a la sobrecarga cardiaca.
 8.- La sobreexpresión de Myc en mosaico en progenitores Wt1 positivos induce 
competición en el epicardio y linajes derivados.
 9.- La sobreexpresión de Myc en mosaico en progenitores Wt1 positivos promueve 
su contribución a cardiomiocitos de la pared libre del ventrículo, aunque se descarta la 
contribución directa del epicardio.
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SUMMARY
Heterogeneous anabolic capacity in cell populations
can trigger a phenomenon known as cell competi-
tion, through which less active cells are eliminated.
Cell competition has been induced experimentally
in stem/precursor cell populations in insects and
mammals and takes place endogenously in early
mouse embryonic cells. Here, we show that cell
competition can be efficiently induced in mouse car-
diomyocytes by mosaic overexpression of Myc dur-
ing both gestation and adult life. The expansion of
the Myc-overexpressing cardiomyocyte population
is driven by the elimination of wild-type cardiomyo-
cytes. Importantly, this cardiomyocyte replacement
is phenotypically silent and does not affect heart
anatomy or function. These results show that the
capacity for cell competition in mammals is not
restricted to stem cell populations and suggest that
stimulated cell competition has potential as a cardio-
myocyte-replacement strategy.
INTRODUCTION
Cell competition is a mechanism that eliminates suboptimal cells
from tissues when ‘‘fitter’’ cells are present (reviewed in Baker,
2011; de Beco et al., 2012; Levayer and Moreno, 2013; Vincent
et al., 2013). Cell-to-cell heterogeneity in anabolic capacity led
to the first description of cell competition, during Drosophila
development (Morata and Ripoll, 1975), and is currently the
most frequent feature found associated with this phenomenon.
The fluctuations in anabolic capacity that trigger cell competition
are within a physiological range, and ‘‘loser’’ cells are viable and
capable, in the absence of fitter cells, of sustaining tissue growth
and performance. Cell competition can thus be envisioned as an
optimization mechanism enabling tissues to achieve their best
possible cellular composition by favoring the fitter cell population
at the expense of less-fit cells. Cell competition can be experi-
mentally induced by generating loser cells through the mosaic
reduction of cell anabolism (Morata and Ripoll, 1975) or by
generating ‘‘winner’’ cells through the mosaic increase of cell
anabolism (supercompetition) (de la Cova et al., 2004; Moreno
and Basler, 2004). The conserved cell anabolism regulator Myc
is involved in cell growth and proliferation (reviewed in Dang,
2013; Gallant, 2013; Levens, 2013) and plays essential roles in
mammalian development (Davis et al., 1993; reviewed in Hurlin,
2013). Moderate increase in Myc levels in a mosaic fashion in
Drosophila imaginal discs (de la Cova et al., 2004; Moreno and
Basler, 2004) and pregastrulation mammalian embryos (Claverı´a
et al., 2013) induces supercompetition, leading to the phenotyp-
ically silent replacement of wild-type cells by Myc-overexpress-
ing cells without overt phenotypic consequences. In addition,
natural Myc fluctuations trigger cell competition in the mouse
epiblast (Claverı´a et al., 2013), indicating an endogenous role
for cell competition in optimization of the pool of precursor cells
that generate the embryo. Mosaic Myc overexpression also in-
duces cell supercompetition in embryonic stem cell cultures
(Claverı´a et al., 2013; Sancho et al., 2013), and hematopoietic
stem cells have been shown to undergo p53-dependent cell
competition (Bondar and Medzhitov, 2010; Marusyk et al.,
2010). These observations suggest that the capacity for cell
competitionmight be associatedwith stemness, but this hypoth-
esis has not been tested. Here, we explored this issue by asking
whether cell competition could be induced in one of the first lin-
eages to differentiate in the mammalian embryo, the cardiac
lineage.
Cardiac precursors originate early in gastrulation within the
anteriormost embryonic mesoderm (reviewed in Vincent and
Buckingham, 2010). During mouse gastrulation, cardiac precur-
sors migrate anteriorly and form a cardiac crescent, which by
embryonic day 8.0 (E8.0) has folded into a primary tube contain-
ing still-proliferative but differentiated and functionally active
cardiomyocytes (reviewed in Evans et al., 2010; Rana et al.,
2013). A subset of cardiac precursors remain undifferentiated
in the second heart field (Kelly et al., 2001) and are progressively
added to the heart tube until cardiac chambers and outflow and
inflow tracts are definitively laid down around E10. After birth,
most cardiomyocytes stop dividing and undergo hypertrophy
to establish the mature definitive myocardium (Soonpaa et al.,
1996). Here, we show that mosaic Myc overexpression in cardi-
omyocytes at levels that do not alter heart anatomy or function
promote the phenotypically silent replacement of wild-type
(WT) cardiomyocytes in the mouse fetal and adult myocardium
through cell competition. Our results show thewidespread ability
of mammalian cells to undergo Myc-driven cell competition and
identify cell competition as an efficient mechanism for phenotyp-
ically silent substitution of cell populations while preserving
organ function.
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RESULTS
Mosaic Myc Overexpression Induces Cardiomyocyte
Population Expansion in the Developing Heart
To test the consequences of overexpressing Myc in the devel-
oping heart, we used the recently established iMOS system
(Claverı´a et al., 2013), which allows the Cre-mediated condi-
tional induction of random genetic mosaics. We first generated
control random genetic mosaics in cardiac lineages using
Nkx2.5-Cre (Stanley et al., 2002) to induce the iMOSWT trans-
gene, which produces a random mosaic of enhanced yellow
fluorescent protein (EYFP) and enhanced cyan fluorescent pro-
tein (ECFP) WT cells. Quantitative confocal analysis of iMOSWT
recombination at E10.5 in iMOSWT; Nkx2.5-Cre hearts con-
firmed the mosaic expression pattern of the two reporter
proteins in embryonic cardiomyocytes at a reproducible cell
population ratio, as previously described (EYFP:ECFP = 3:1)
(Figures 1A–1C, 1G, and 1H). Again as described (Stanley
et al., 2002), the fluorescent protein distribution pattern indi-
cated iMOS activation throughout the embryonic heart (Figures
1A–1C0). We then generated Nkx2.5-Cre-induced iMOST1-Myc
mosaics, in which the EYFP cell population moderately overex-
presses Myc (Claverı´a et al., 2013) (Figures 1D–1F0). Confocal
analysis of EYFP simultaneously with MYC protein immunode-
tection showed the expected increase in MYC levels in the
EYFP cell population of iMOST1-Myc mosaics, but not iMOSWT
mosaics (Figures 1I and 1J). We then quantified the contribution
of the mosaic cell populations by confocal analysis at different
stages of heart development. In the iMOST1-Myc mosaics we
found a progressive reduction in the relative abundance of the
ECFP-WT cell population—and a concomitantly increased rela-
tive abundance of the EYFP-Myc population— that was not
observed in the iMOSWT mosaics (Figures 2A–2G). The propor-
tion of ECFP cardiomyocytes at E9.5 in iMOST1-Mycmosaicswas
lower (but not significantly) than that observed in iMOSWT mo-
saics. From then on, the relative abundance of the ECFP-WT
population in iMOST1-Mycmosaics showed a progressive decline
to 60% of the iMOSWT value at E10.5, 40% at E11.5, and 25% at
postnatal day 0 (P0) (Figure 2G). The shift in cell populations thus
takes place mostly in a narrow time window between E9.5 and
E11.5.
Previous studies showed that Myc overexpression in cardio-
myocytes during fetal life can lead to pathological cardiac hyper-
plasia (Jackson et al., 1990). However, in these studies, Myc
expression was 20-fold above normal. To determine whether
the overexpression levels used here could lead to cardiac hyper-
plasia we characterized adult heart anatomy and cardiomyocyte
size. P0 hearts from Nkx2.5-Cre-recombined iMOST1-Myc and
iMOSWT mice were of normal size and anatomy (Figures S1A
and S1B and data not shown), and cardiomyocytes from the
iMOST1-Myc hearts were of a similar size to those from iMOSWT
hearts (Figure S1C).
The shift in the cell population proportion observed in iMOSWT
mosaics thus results from expansion of the EYFP Myc-overex-
pressing cardiomyocyte population and a concomitant reduc-
tion of the ECFP WT population relative contribution, without
disruption of heart cell composition or anatomy. These results
also indicate that the levels of Myc overexpression from the
iMOST1-Myc allele are within the limits that allow normal cardio-
myocyte development and do not provoke hyperplasia.
Figure 1. Mosaic Myc Overexpression
Driven by Nkx2.5Cre in the Developing
Heart
(A–C) Confocal sections showing EYFP+ car-
diomyocyte distribution and Myc expression by
immunofluorescence in the right ventricle of a
whole-mount Nkx2.5Cre-recombined iMOSWT
E10.5 heart (WT), as depicted in (G). (A0)–(C0) show
magnified details of the boxed areas in (A)–(C).
(D–F0) Similar data for the Nkx2.5Cre-recombined
iMOST1-Myc E10.5 heart (MYC). Scale bar, 50 mm.
Dashed lines in (B0) and (E0) outline the frontiers
between EYFP+ and EYFP! cells. ECFP fluores-
cence is lost upon Myc immunodetection; how-
ever, all EYFP! cells are ECFP+ (see Figure 2).
(G) Schematic representation of an E10.5 heart
identifying the area shown in A-F0. OFT, outflow
tract; RA, right atrium; LA, left atrium; RV, right
ventricle; LV, left ventricle.
(H) Graph showing the proportions observed of
EYFP and ECFP cardiomyocytes in Nkx2.5Cre-
recombined iMOSWT E10.5 whole hearts (n = 7).
Data are means ± SEM.
(I and J) Distribution of Myc protein levels in the
EYFP and ECFP cell populations of iMOSWT (I) and
iMOST1-Myc (J) mosaic whole hearts at E10.5; Myc
protein levels were quantified from the immuno-
fluorescence images similar to those in (A)–(F0). n =
425 cells in (I) and 449 in (J). Dashed vertical lines
indicate the mean for each distribution.
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Islet-1 Progenitors Are Highly Sensitive toMyc-Induced
Cell Competition
We next explored the impact of inducing Myc mosaicism in
Islet1+ cardiac progenitors. For this, we generated iMOST1-Myc
mosaics in second heart field (SHF) progenitors using Islet1-
Cre (Yang et al., 2006). This Cre driver provides partial inter-
spersed recombination of the SHF cell population, resulting in
about 7% EYFP recombined cardiomyocytes in the right
ventricle (RV) of iMOSWT mosaics (Figures 3A, 3D, 3E, and
3E0). In contrast, the RV of iMOS T1-Myc; Islet1-Cre hearts on
average contained 40% EYFP cardiomyocytes at P0, represent-
ing a 5.7-fold expansion during gestation of the original EYFP
cardiomyocyte population (Figures 3B, 3D, 3F, and 3F0). In addi-
tion, the ECFP cardiomyocyte population in the Islet-Cre-
induced iMOST1-Myc mosaic hearts was almost completely
eliminated by P0 (Figures 3E0, 3F0, and 3H). These results indi-
cate a more active elimination of the mosaic ECFP-WT cell pop-
ulation and a continued expansion of the Myc-overexpressing
cardiomyocyte population during fetal life, in a context in which
it is continuously confronted with WT cardiomyocytes. We then
Figure 2. The Myc-Overexpressing Cardio-
myocyte Population Expands in the Devel-
oping Heart
(A–F) Confocal sections showing EYFP+ and
ECFP+ cardiomyocyte distributions in the left
ventricle of whole-mount E10.5 hearts from
Nkx2.5Cre-recombined iMOSWT (WT) (A–C) and
iMOST1-Myc (MYC) (D–F) embryos. Scale bar,
50 mm.
(G) Percentage ECFP+ area at different embryonic
stages in whole hearts of the iMOST1-Myc (MYC)
mosaics relative to that observed in the iMOSWT
(WT) mosaics, which was normalized to 100%.
Numbers on the x axis indicate the day of em-
bryonic development; P0 indicates postnatal day
0 (nR 5 embryos).
(H–J) Confocal detection of EYFP+ and ECFP+
cardiomyocyte distributions in histological sections
of the left ventricle of P0 hearts from Nkx2.5Cre-
recombined iMOSWT (WT) (H), iMOST1-Myc (MYC)
(I), and iMOST1-Myc/T2-p35 (MYC/p35) mice. Scale
bar, 50 mm.
(K–M) show masks of the EYFP detection in (H)
and (I).
(N) Percentage of ECFP+ cells observed at P0 in
whole hearts of the iMOST1-Myc (MYC) and iM-
OSWT (WT) mosaics relative to that observed in the
iMOSWT (WT) mosaics, which was normalized to
100%.
For ease of comparison, data for ECFP proportion
in MYC mosaics at P0 is repeated in (G) and (N).
nR 4). Data in (G) and (N) are means ± SEM; *p <
0.05; **p < 0.01; ***p < 0.001.
characterized the temporal progression
of ECFP cardiomyocyte depletion in
iMOST1-Myc mosaics, finding that this
population was already reduced to 40%
of its original contribution by E9.5, with
further progressive reduction until the
final residual presence at birth (Figures 3I–3L). The enhanced
early elimination of WT progenitors in the Islet-Cre-induced mo-
saics indicates that undifferentiated Islet1+ cardiac progenitors
are highly sensitive to Myc mosaicism.
The Myc-Overexpressing Cardiomyocyte Population
Expands by Apoptosis-Driven Cell Competition
To study the mechanisms underlying the expansion of the Myc-
overexpressing cardiomyocyte population during development,
we first determined the abundance of PHH3+ cells and bromo-
deoxyuridine (BrdU) incorporation in iMOS mosaics at E10.5,
when the shift in the cell population proportion is taking place.
Overall, PHH3+ and BrdU+ cell frequencies did not differ signifi-
cantly between iMOST1-Myc and iMOSWT cardiomyocytes (Fig-
ure S2). Moreover, the PHH3+ and BrdU+ cell frequencies in
the EYFP cell population of iMOST1-Myc mosaics was not
different from that in the ECFP population (Figures S2D and
S2E). These results fit with previous studies showing that the
Myc dosage induced by a single Rosa26 allele does not increase
proliferation rates in most tissues (Claverı´a et al., 2013; Murphy
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et al., 2008) and suggest that the shift in cardiomyocyte popula-
tions is not produced by overt differences in cell proliferation be-
tween the two cell populations.
To evaluate the role of cell death in the depletion of WT cardi-
omyocytes, we generated mosaics of the iMOST1-Myc/T2p35
strain, which produces a random mosaic of EYFP-Myc and
ECFP-p35 cells. p35 is a baculoviral caspase inhibitor able to
prevent apoptosis in insects and mammals (Claverı´a et al.,
1998; Hay et al., 1994). Quantitative confocal analysis of P0
hearts from iMOST1-Myc/T2p35 mosaics induced with either
Nkx2.5-Cre or Islet1-Cre showed that the p35-expressing
ECFP population was substantially, although not completely,
protected against elimination (Figures 2H–2N, 3C, and 3G–3H).
This result indicates that cell death is a predominant mechanism
in the population shift observed in iMOST1-Myc mosaics. How-
ever, expansion of the EYFP-Myc cell population did not differ
significantly between Islet1-Cre-induced iMOST1-Myc/T2p35 and
iMOS T1-Myc mosaics (Figure 3D), indicating that expansion of
Myc-enriched cardiomyocytes can progress through elimination
of nonrecombined WT cardiomyocytes even when small
numbers of apoptosis-resistant ECFP-p35 cardiomyocytes are
present.
We next scored apoptosis by TUNEL at E10.5 in the Nkx2.5-
Cre-induced mosaics, concentrating on the outflow tract (OFT)
because this region had higher rates of apoptosis in the iMOSWT
mosaics. The iMOST1-Myc mosaics had a 5-fold higher overall
apoptosis rate than iMOSWT mosaics (Figures 4A–4C). Further-
more, the apoptosis rate in ECFP-WT cells of the iMOST1-Myc
mosaic was markedly higher than observed in the EYFP-Myc
cells (Figures 4D–4F). Interestingly, the apoptosis rate varied
between heart regions: whereas the ECFP/EYFP TUNEL ratio
was 4- to 5-fold above baseline in the ventricles, in the OFT it
was over 10-fold higher, indicating that ECFP-WT cardiomyo-
cytes in this region are especially sensitive to mosaic Myc
overexpression.
To study the range limit of the cellular interaction leading to
ECFP-WT cardiomyocyte apoptosis in iMOST1-Myc mosaics,
we took advantage of the Islet-Cre strain. The low-rate, inter-
spersed recombination induced by this line allowed us to score
apoptosis separately for WT cardiomyocytes in direct contact
Figure 3. Enhanced Expansion of Myc-
Overexpressing Cardiomyocytes upon
Mosaic Induction in Islet-1+ Progenitors
(A–G0 ) Confocal detection of EYFP+ (A–C), anti-
GFP immunofluorescence (detecting both EYFP
and ECFP) (E–G) and colocalization of both signals
(E0–G0) in histological sections from Islet1Cre-re-
combined iMOSWT (WT) (A, E, and E0), iMOST1-Myc
(MYC) (B, F, and F0), and iMOST1-Myc/T2-p35 (MYC/
p35) newborn mice. In (E0)–(G0), EYFP+ cells are
yellow because they are positive for both EYFP
and anti-GFP, and ECFP+ cells are detected in red,
as they are only positive for anti-GFP. Scale bar,
100 mm for (A)–(C) and 50 mm for (E0 ). RA, right
atrium; LA, left atrium; RV, right ventricle; LV, left
ventricle. (D) Percentage of the RV area positive
for anti-GFP immunofluorescence in Islet1Cre-
recombined iMOSWT (WT), iMOST1-Myc (MYC),
and iMOST1-Myc/T2-p35 (MYC/p35) newborn mice
(nR 4).
(H) Percentage of ECFP+ recombined area
with respect to the total EYFP+ECFP-recombined
area observed at P0 in the iMOST1-Myc (MYC) and
iMOST1-Myc/T2-p35 (MYC/p35) mosaics relative to
that observed in the iMOSWT (WT) mosaics, which
was normalized to 100% (nR 4).
(I–K) Confocal sections of the E9.5 (I) and E10.5 (J)
OFT and the E15.5 RV (K) from Islet1Cre-re-
combined iMOST1-Myc hearts, showing overlays of
EYFP and anti-GFP signals. Scale bar, 50 mm for I
and J and 100 mm for (K).
(L) Percentage of ECFP+ area with respect to the
total EYFP+ECFP-recombined area observed at
different stages in the iMOST1-Myc (MYC) mosaics
relative to that observed in the iMOSWT (WT) mo-
saics, which was normalized to 100%. Numbers
on the x axis indicate the day of embryonic
development; P0 indicates postnatal day 0 (nR 4).
For ease of comparison, data for ECFP proportion
in MYC mosaics at P0 are repeated in (H) and (L).
Data in (D), (H), and (L) are means ± SEM. *p <
0.05; **p < 0.01; ***p > 0.001.
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with EYFP cells and those not in contact (Figures 4G–4H0).
Apoptosis was 17-fold more frequent in WT cardiomyocytes in
direct contact with Myc-overexpressing EYFP cardiomyocytes
than in those not contacting EYFP cardiomyocytes (Figure 4I;
Movie S1).
These results indicate that the expansion ofMyc-overexpress-
ing cardiomyocytes requires the elimination of neighboring
WT cardiomyocytes through apoptosis triggered by direct cell-
cell contact or short-range signaling. Our characterization thus
establishes that the replacement of the WT cardiomyocyte
population by the Myc-overexpressing population is due to
apoptosis-driven cell competition.
MycOverexpression Induces Cardiomyocyte Population
Expansion in the Adult Heart
To determine whether increased Myc levels impact cardiomyo-
cyte population homeostasis during adult life, we inducedmosa-
icism in the adult cardiomyocyte population by using the tamox-
ifen-inducible aMHC-merCremer strain (Sohal et al., 2001)
(Figure 5A). Mosaics were induced by feeding animals tamoxifen
during the first month after weaning, and hearts were analyzed
immediately after tamoxifen cessation and at subsequent inter-
vals up to 1 year (Figure 5A). This protocol produced an initial
EYFP recombination slightly above 50% (Figure 6D). Previous
studies have shown that strong Myc overexpression in cardio-
myocytes of adult mice induces cardiomyocyte hypertrophy
(Xiao et al., 2001). We thus first analyzed whether hypertrophy
also resulted from long-term moderate Myc overexpression.
Tamoxifen-induced adult iMOST1-Myc and iMOSWTmice showed
no spontaneous cardiac malfunction and their hearts were of
normal size and anatomy even after 2 months of an intense exer-
cise protocol (Figures 5B–5E). Measurement of average cardio-
myocyte 2D size, both in histological sections and in cultures of
disaggregated cardiac cells (Figures 5F–5I), showed that cardio-
myocytes in iMOST1-Myc hearts were not only not bigger than
those in iMOSWT hearts but also in fact slightly smaller (Figure 5J).
Due to binucleation, adult cardiomyocytes could contain more
that one EYFP-Myc copy, and the levels of EYFP are expected
to correlate with theMyc dose in the iMOST1-Myc mosaics. Anal-
ysis of per-cell cardiomyocyte size and EYFP level showed no
Figure 4. Myc-Overexpressing Cardiomyo-
cytes Expand by Inducing Apoptosis of
Neighboring WT Cardiomyocytes
(A and B) Maximal projections of confocal stacks
(30 mm deep) from the OFT region of Nkx2.5Cre-
recombined iMOSWT (WT) (A) and iMOST1-Myc
(MYC) (B) whole-mount TUNEL-stained E10.5
hearts. Scale bar, 50 mm.
(C) TUNEL staining frequency in cardiomyocytes
from the mosaics shown in (A) and (B) (n = 4 WT
and 7 MYC mosaics).
(D and E) Confocal sections from the left ventricle
(LV) of Nkx2.5Cre-recombined iMOSWT (WT) (D)
and iMOST1-Myc (MYC) (E) whole-mount TUNEL-
stained E10.5 hearts, showing overlaid EYFP,
ECFP, and TUNEL signals. Filled arrowheads
point to EYFP+ TUNEL+ cells and empty arrow-
heads to ECFP+ TUNEL+ cells. Scale bar, 50 mm.
(F) ECFP/EYFP TUNEL frequency ratios in
different regions of Nkx2.5Cre-recombined iM-
OSWT (WT) and iMOST1-Myc (MYC) whole-mount
E10.5 hearts (n = 4 WT and 7 MYC mosaics). LV,
left ventricle; RV, right ventricle; OFT, outflow
tract. Arrowhead marks the unbiased ECFP/EYFP
TUNEL frequency ratio = 1.
(G) Maximal projection of the OFT from an Islet1-
MerCreMer-recombined iMOST1-Myc E10.5 heart
(MYC), showing overlaid EYFP, DAPI and TUNEL
signals. Scale bar, 70 mm.
(H) Computer 3D reconstruction of the stack
shown in (G).
(H0 ) Magnification of the boxed region in (H),
showing TUNEL+ WT cells contacting (red) and
not contacting (light blue, arrowhead) MYC-over-
expressing cells. Scale bar, 20 mm.
(I) TUNEL frequency inWT cells contacting and not
contacting EYFP cells in Islet1MerCreMer-re-
combined iMOST1-Myc E10.5 hearts (MYC) (N = 3
andR 2,815 cells).
Data in (C), (F), and (I) are means ± SEM. *p < 0.05;
**p < 0.01; ***p < 0.001.
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correlation between these two parameters in either iMOSWT or
iMOST1-Myc mosaic hearts (Figures 5K and 5L). These results
show that sustained Myc overexpression from the iMOST1-Myc
allele during adult life does not provoke cardiomyocyte hypertro-
phy. Heart size and heart/body weight ratios were moreover
similar in both mosaics, indicating that overall cardiac cellular
and organ anatomy are preserved.
We next determined the proportions of cardiomyocyte popu-
lations at different times after mosaic induction. While in iMOSWT
hearts the proportion of EYFP cardiomyocytes was 53% at
1 year of age (Figures 6A and 6D), in the iMOST1-Myc mosaics,
the proportion increased progressively from a frequency similar
to that found in iMOSWT hearts to 66% at 1 year of age (Figures
Figure 5. Mosaic MYC Overexpression in
Adult Cardiomyocytes Is Phenotypically
Silent
(A) aMHCmerCremer-recombined iMOST1-Myc
mosaics and control littermates were treated as
schematized for experiments in (B)–(L) and in
Figure 6.
(B) Long axis M-mode echocardiography image
from an iMOST1-Myc (MYC) mosaic WT littermate
at t2.
(C) Graphs show ejection fraction (EF) and left
ventricle (LV) mass from the echocardiographic
study in the iMOST1-Mycmosaics (MYC) and in WT
littermates (WT) at t3 (nR 3).
(D) EF and LVmass at t2 after a protocol of intense
exercise from t0 to t2 (see Experimental Pro-
cedures).
(E) Heart/body weight ratios in the iMOST1-Myc
mosaics (MYC) and in WT littermates (WT) at t3
(nR 3).
(F and G) Confocal sections showing wheat germ
agglutinin (WGA) staining to highlight cell perime-
ters in iMOSWT (WT) (F) and iMOST1-Myc (MYC) (G)
mosaics at t3. Scale bar, 50 mm.
(H and I) Bright-field confocal section of car-
diomyocytes isolated from iMOSWT (WT) (H) and
iMOST1-Myc (MYC) (I) mosaic hearts at t3. Scale
bar, 50 mm.
(J) Size (2D area) of cardiomyocytes shown in (H)
and (I). n R 4 hearts and 236 cells.*p < 0.1; **p <
0.05; ***p < 0.001. Horizontal bars represent mean
values.
(K and L) EYFP fluorescence intensity plotted
against cell size for cardiomyocytes isolated from
iMOSWT (WT) (K) and iMOST1-Myc (MYC) (L) mo-
saics. Lines in (K) and (L) represent the regression
line (R2 = 2.040 3 10!5 and 0.007204, respec-
tively).
Data in (C)–(E) are means ± SEM.
6B and 6D). Interestingly, half of this
enrichment took place during the first
month of observation. Since there were
no major changes in heart mass or cardi-
omyocyte size (Figures 5E and 5J), these
observations suggest that Myc-overex-
pressing cardiomyocytes expand at the
expense of WT cardiomyocytes during
adult life. To directly test this, we determined the relative fre-
quency of ECFP cardiomyocytes with respect to all fluorescent
(ECFP+EYFP) cardiomyocytes in 1-year-old iMOST1-Myc and
iMOSWT mosaics (Figures 6E–6H). The ECFP cell frequency
was "60% lower in the iMOST1-Myc mosaics, confirming that
the expansion of the Myc-overexpressing cardiomyocyte popu-
lation is concomitant with a reduction in theWT population. Most
adult cardiomyocytes in the mouse are tetraploid and contain
two nuclei (Soonpaa et al., 1996); this, together with the partial
recombination achieved by tamoxifen treatment, generates het-
erogeneous levels of EYFP-Myc content in cardiomyocytes, with
a predicted predominance of cardiomyocytes with one or two
active EYFP-Myc copies. We therefore refined our study to
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determine whether cardiomyocyte population expansion corre-
lated with EYFP-Myc levels. Fluorescence was measured in iso-
lated cardiomyocytes and the frequency of cells according to
fluorescence intensity was determined (Figure 6I). This analysis
showed that the enrichment in EYFP+ cardiomyocytes in
iMOST1-Myc mosaics mostly affects the populations with higher
EYFP levels at the expense of EYFP-negative cardiomyocytes,
whose frequency decreased (Figure 6I). These observations indi-
cate a correlation between Myc dose levels and cardiomyocyte
population prevalence in the adult myocardium.
Analysis of the Pathways Involved in Adult
Cardiomyocyte Competition
To identify the pathways altered in the iMOST1-Myc adult mosaic
heart, we performed a transcriptomic analysis by RNA se-
quencing (RNA-seq), comparing 8-week old iMOST1-Myc and
control hearts (Figure S3). Among the genes more significantly
up- or downregulated in iMOST1-Myc hearts, there is a strong rep-
resentation of genes involved in the response to cardiac over-
load, in cell growth/division, in energy metabolism, and in
apoptosis (Figure S3A). Gene set enrichment analysis on all
genes present in the RNA-seq experiment again detected the
protective response to cardiac overload in iMOST1-Myc hearts,
including the activation of the atrial natriuretic peptide and fetal
cardiomyocyte programs (Kishimoto et al., 2001; Kuhn et al.,
2002) and the hepatocyte growth factor (HGF)/Rho/tissue
remodeling pathways (Madonna et al., 2012). In contrast, the
epidermal growth factor (EGF) pathway, involved in the develop-
ment of pathological hypertrophy (Shah and Catt, 2003), was
found repressed in iMOST1-Myc hearts. Regarding metabolic
processes, activation of the ribosome biosynthesis, a typical
response to Myc overexpression, was also detected. In parallel,
activation of the lysosomal pathway was as well present, indi-
cating that metabolic activity was globally increased including
both anabolic and catabolic processes. With regard to the meta-
bolic processes, iMOST1-Myc hearts showed a reduction in lipid
catabolism and in assembly of the peroxisome, the main organ-
elle for lipid catabolism, suggesting a modification in the fuel
usage by Myc-overexpressing cardiomyocytes. A remarkable
alteration was found in various regulators of the circadian
rhythm; Dbp and Per1, 2, and 3 were upregulated and Arntl
(Bmal1) was downregulated. Circadian rhythm transcription fac-
tors are essential regulators of cardiac metabolism and regulate
the balance between lipid and glucose usage in the heart and
display a feedback regulation with the oxidative phosphorylation
pathway in the heart (Durgan and Young, 2010). A major regu-
lator of cardiac metabolism, AMP-activated protein kinase, has
also been described to undergo circadian regulation (Tsai
et al., 2010), its regulatory subunit is overexpressed in the
iMOST1-Myc hearts, and it can be activated by Myc overexpres-
sion (Nieminen et al., 2013). The results observed are therefore
compatible with a modified metabolic status of the iMOST1-Myc
Figure 6. Myc Overexpression Induces
Replacement of Adult Cardiomyocytes
(A–C) Confocal images of plated cardiomyo-
cytes isolated at t3 (12 months after tamoxifen
administration; see scheme in Figure 5) from
aMHCmerCremer-recombined iMOSWT (WT) (A),
iMOST1-Myc (MYC) (B), and iMOST1-Myc/T2-p35
(MYC/P35) (C) mosaics, showing native EYFP
expression and background autofluorescence.
(D) Percentage of EYFP+ cardiomyocytes in
cultures obtained from aMHCmerCremer-re-
combined iMOSWT (WT) hearts at t1 and t3 and
from iMOST1-Myc (MYC) hearts at t1-t3 (nR 3 and
300 cells). Data are means ± SEM.
(E–G) Confocal images of plated cardiomyocytes
obtained as in (A) –(C), showing anti-GFP immu-
nofluorescence, which identifies EYFP+ and
ECFP+ cardiomyocytes. Scale bar, 50 mm.
(H) Quantification of data represented in (A)–(G)
at t3. The graph on the left shows the absolute
frequencies of EYFP-Myc and ECFP-WT car-
diomyocytes in iMOSWT (WT), iMOST1-Myc
(MYC) and iMOST1-Myc/T2-p35 (MYC/P35) mo-
saics. In the graph on the right, the same data
were expressed as relative ECFP+/EYFP+ car-
diomyocyte proportions relative to that observed
in iMOSWT (WT) mosaics, which was normalized
to 100%.
(I) Graph represents the frequency of car-
diomyocytes according to EYFP intensity in
tamoxifen-induced aMHCmerCremer-recom-
bined iMOSWT (WT) and iMOST1-Myc (MYC) mo-
saics, measured in cardiomyocytes isolated at t3,
as in (A) –(C). The vertical dotted line marks the limit between background-fluorescent and EYFP-positive cardiomyocytes. Arrows indicate regions in which the
frequencies overtly differ between the two mosaics studied. Data in bar graphs are means ± SEM. *p < 0.05 **p < 0.01 ***p < 0.001.
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with either a direct or indirect impact of Myc overexpression on
the circadian metabolic regulation. In agreement with this view,
the Ingenuity Pathway analysis on the selected up- and downre-
gulated genes (Figure S3B) indicates a modification of the lipid
metabolism and a reduction of the oxidative phosphorylation
activity in iMOST1-Myc hearts. The top networks identified by
this analysis for the upregulated, downregulated, and joint
gene sets are again the networks activated in response to car-
diac overload (Figures 3B and 3C). In agreement with these
results, we found that the expression of the atrial natriuretic pep-
tide was clearly activated in a patchy pattern in the ventricles of
the iMOST1-Myc mosaic hearts (Figure S3D).
Given the known functions of Myc in cardiomyocytes, the
pathways detected likely result from cell-autonomous Myc func-
tions and may relate to the ability of Myc-overexpressing cardi-
omyocytes to replace theWT cardiomyocyte population. In addi-
tion, the gene set enrichment study identified the activation of the
apoptosis regulation and inflammation pathways in iMOST1-Myc
hearts, which could be related to the death and removal of WT
cardiomyocytes. We therefore used the iMOST1-Myc/T2p35 mo-
saics to undertake a functional study of the involvement of cell
death. This analysis showed that p35 expression largely rescues
the ECFP cell population (Figures 6C, 6G, and 6H). These results
indicate that adult cardiomyocytes undergo Myc-induced cell
competition, which progresses by elimination of WT cardiomyo-
cytes and their replacement by cardiomyocytes with high Myc
levels. We then analyzed whether increased proliferation of the
Myc-overexpressing population is contributing to this phenome-
non. We found that BrdU incorporation was 4-fold more frequent
in the EYFP-Myc cardiomyocytes than in theWT cardiomyocytes
of iMOST1-Myc mosaic hearts (Figure 7B). This increase did not
alter the proportion of mononucleated cardiomyocytes (Fig-
ure 7C), suggesting that the balance between mononucleated
cardiomyocyte division and binucleation is preserved.
To directly assess the involvement of apoptosis in the cardio-
myocyte population shift, we analyzed the TUNEL pattern in
adult iMOST1-Mycmosaics; however, we found no significant dif-
ferences in TUNEL frequency between the EYFP-Myc and
ECFP-WT cell populations. These results suggested that, unlike
the situation during development, apoptosis might not be
involved in the elimination of WT cardiomyocytes in adults,
despite the activation of apoptotic pathways detected by RNA-
seq. We then explored whether alternative cell-death pathways
could be operating in postnatal cardiomyocytes. Given that
p35, in addition to inhibiting apoptotic cell death, can also inhibit
autophagic cell death (Martin and Baehrecke, 2004) and that
many apoptosis regulators are also involved in autophagic
cell death, we tested whether this pathway could be involved
in postnatal cardiomyocyte cell competition. Analysis of the au-
tophagic death-specific marker Beclin (Liang et al., 1999)
showed rare positive cells in iMOSWT hearts (Figures 7D–7D0 0);
however, the frequency of Beclin-positive cells increased by 5-
fold in iMOST1-Myc mosaic hearts (Figure 7E–7E0 0 and 7F). More-
over, the frequency of Beclin-positive cells within the iMOST1-Myc
mosaics was 9-fold higher in ECFP-WT cells than in EYFP-Myc
cells (Figure 7G). These results indicate that autophagic cell
death instead of apoptotic cell death is a major contributor to
postnatal cardiomyocyte cell competition.
DISCUSSION
In this study, we demonstrate the ability of moderate Myc over-
expression to induce cell competition in the developing and
adult mouse heart. Previous studies showed that strong Myc
Figure 7. Analysis of Autophagy and BrdU Incorporation in Post-
natal Hearts
(A) Confocal image of cardiomyocytes isolated from an iMOST1-Myc adult heart
showing GFP and BrdU staining. Arrowheads show BrdU+/GFP+ mono-
nucleated (empty arrowheads) and binucleated (filled arrowheads) car-
diomyocytes. Scale bar, 50 mm.
(B) Graph showing the frequency of BrdU+ cardiomyocytes in the ECFP-WT
(WT) and EYFP-Myc (MYC) populations of the iMOST1-Myc adult hearts. Bi,
binucleated; Mo, mononucleated.
(C) Graph showing the proportion of mononucleated cardiomyocytes within
the ECFP-WT (WT) and EYFP-Myc (MYC) populations of the iMOST1-Myc adult
hearts. n = 4 hearts and >300 cells/heart.
(D and E) Confocal sections showing postnatal hearts from iMOSWT (WT) (D)
and iMOST1-Myc (MYC) mosaics (E) showing Beclin-1 antibody staining
together with iMOS cell populations mapping. Scale bar, 50 mm. (D0 and E0)
Higher magnification of boxed areas in (D) and (E). Arrowheads point to Beclin+
cells. (D0 0 and E0 0) Beclin signal from (D0) and (E0) in isolation. Scale bar, 20 mm.
(F) Total Beclin+ cell frequency in iMOSWT (WT) and iMOST1-Myc (MYC)mosaics
(n = 3 WT and 5 MYC).
(G) Beclin+ cell frequency within the ECFP-WT (ECFP) and EYFP-Myc cell
populations (MYC) of the iMOST1-Myc mosaics.
Graphs in (C), (F), and (G) showmeans ± SEM. *p < 0.1; **p < 0.05; ***p < 0.001.
Statistical analysis in (B) was done using the c2 test. ns, not significant.
1748 Cell Reports 8, 1741–1751, September 25, 2014 ª2014 The Authors
overexpression during fetal life leads to cardiac hyperplasia due
to cardiomyocyte hyperproliferation, while overexpression in
adults leads to cardiac hypertrophy due to cardiomyocyte over-
growth (Jackson et al., 1990; Xiao et al., 2001). In contrast, we
found that the Myc overexpression levels provided by the
endogenous promoter of theRosa26 locus do not lead to cardiac
hypertrophy or hyperplasia. These results agree with previous
evidence of ubiquitous MycERT2 expression from the Rosa26 lo-
cus, which did not induce cardiac hypertrophy evenwhen two al-
leles were present (Murphy et al., 2008). A molecular signature
typical of the response to cardiac overload however was acti-
vated. The activated pathways (Nppa, HGF) are cardioprotective
and stimulate benign adaptation to increased cardiac function
demands (Kishimoto et al., 2001; Kuhn et al., 2002; Madonna
et al., 2012). In particular, the HGF pathway is not only involved
in the cardiac overload response but also stimulates cardiac
regeneration (Madonna et al., 2012). The activation of these
pathways in the absence of cardiac overload, or in the presence
of increased cardiac demand due to intense exercise, did not
result in functional impairment. In fact, the EGF pathway,
involved in pathological cardiac hypertrophy (Lee et al., 2011),
was found inhibited in the Myc mosaic hearts. The Myc levels
used here therefore can be considered ‘‘homeostatic’’ in the
heart, since hearts exposed to these levels stay within normal
anatomical and functional parameters. Interestingly, these
expression levels provided in a mosaic fashion are enough to
trigger cell competition, thereby enabling Myc-high cardiomyo-
cytes to eliminate neighboring WT cardiomyocytes and expand
to replace them. These results identify a window in which Myc
level fluctuations can affect cardiomyocyte behavior to promote
homeostatic changes in myocardial cell composition without
affecting organ development and function.
These observations highlight the remarkable ability of fetal
cardiomyocyte populations to undergo changes in composition
without disrupting cardiac function. Previous studies showed
that in mosaic hearts composed of wild-type cardiomyocytes
and others carrying a deleterious mutation, the wild-type cardio-
myocytes overproliferate during development to compensate for
the loss of mutant cardiomyocytes (Drenckhahn et al., 2008).
These studies indicate that the fetal heart bears sensing mecha-
nisms that detect the loss of functional cardiomyocytes and pro-
mote their replacement. Our present results show that this
replacement ability can also be stimulated by cell competition,
whereby even undamaged wild-type cardiomyocytes can be
eliminated and replaced by more competitive cells, without
compromising cardiac homeostasis. Interestingly, this ability is
retained during adult life, albeit at a notably slower pace with
respect to that observed during development. In Drosophila,
damaged postmitotic cells in the ovary can be eliminated and
compensated for by hypertrophy of the remaining healthy cells
(Tamori and Deng, 2013), while in the eye, postmitotic cells
become refractory to cell competition (Tyler et al., 2007). Here,
we found that, despite the predominant postmitotic nature of
adult cardiomyocytes, the loss of the outcompeted population
is not compensated by hypertrophy of winner cells but through
overproliferation.
The mechanisms by which neighboring cells compare their
fitness during cell competition in the mammalian embryo remain
unknown, but a common theme of cell competition in the
epiblast and the developing heart is the elimination of loser cells
by apoptosis. In fact, in the fetal heart, we did not observe overt
differences in proliferation between the two mosaic populations.
This result is in apparent conflict with the fact that overexpansion
of Islet-Cre-recombined cardiomyocyte population requires
overproliferation and with the fact that the relative reduction of
the WT cardiomyocyte population in the Nkx2.5-Cre-recom-
bined mosaics requires compensatory proliferation to preserve
normal heart size. The 5.73 expansion of the IsletCre-recom-
bined population, however, involves only 2.5 extra cell cycles
per cell in the 11 days between the activation of the driver at
E7.5 and birth. This yields a total of 0.22 extra divisions per cell
and day. In the case of the studies with the Nkx2.5Cre driver, be-
tween E8.5 and E11.5, a 60% reduction in the original 25% WT
cardiomyocyte population was observed, which represents a
15% of the total cardiomyocyte population. To replace the
15% missing cardiomyocytes, only 0.15 extra cell divisions/car-
diomyocyte would be required during the 3-day observation
period. The degree of overproliferation required to explain the
changes observed is therefore small and might not be experi-
mentally detectable, especially since PHH3 and BrdU alone
might not be enough for a full characterization of the cell prolifer-
ation rate cell proliferation.
In adult cardiomyocytes, however, we found a clear increase
in the proliferative ability of winner cardiomyocytes, which likely
contributes to the replacement of the loser population. While this
increased proliferation capacity might be essential for the
competitive ability, it is clearly not sufficient, and elimination of
the loser population is still a requirement for cell competition in
the adult heart. In fact, this overproliferation is most likely only
compensatory for the loss of WT cardiomyocytes, since the ho-
mogeneous overexpression of two ROSA26-MycER copies
does not lead to overproliferation in the adult heart (Murphy
et al., 2008). The compensatory nature of this overproliferation
would also explain the absence of cardiac overgrowth upon
Myc mosaic overexpression.
These results suggest that fitness comparison between neigh-
bors and death of the less-fit cells is a common theme in cell
competition in very different scenarios. The fact that autophagic
instead of apoptotic cell death is observed in adult cardiomyo-
cytes could be more related to the specific features of adult car-
diomyocytes than to the cell-competition phenomenon. Dying
cells are normally eliminated by macrophages, but the size of
an adult cardiomyocyte is about 100 times that of amacrophage,
so a phase of self-destructive autophagy might be necessary
before they can be eliminated by macrophages in a controlled
manner. In fact, the typical example of autophagic death in
Drosophila involves as well the elimination of giant cells of the
salivary gland (Martin and Baehrecke, 2004). These consider-
ations are in agreement with the predominance of TUNEL-nega-
tive autophagic cardiomyocyte death reported in heart failure
patients (Knaapen et al., 2001).
The fact that cardiomyocytes undergo Myc-induced cell
competition suggests that cell competition operates during
normal heart development for the elimination of impaired cardi-
omyocytes unable to meet the anabolic rates demanded in the
myocardium. Anabolism-induced cell competition thus appears
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as a widespread phenomenon in mammalian tissues and not
restricted to stem cell pools like the epiblast. There is an impor-
tant difference, however, between endogenous cell competition
in the epiblast and how it might operate during cardiogenesis:
whereas epiblast development is characterized by a strong
pattern of cell competition-associated apoptosis, during cardio-
genesis, cardiomyocyte death is very infrequent (Poelmann
et al., 2000). This suggests that while cell competition would
work as a cell quality-control mechanism in both scenarios, in
the epiblast it functions as a constitutive program, whereas
during cardiogenesis it is used contingently, only if impaired car-
diomyocytes appear. Since cardiomyocyte competition ability
extends into adult life, it will be very interesting in the future to
study whether cell competition is involved in maintaining tissue
fitness during aging and whether it can contribute to natural or
induced repair of cardiac insults in which cardiomyocytes are
lost or impaired.
EXPERIMENTAL PROCEDURES
Mouse Strains
The iMOSWT, iMOST1-Myc, and iMOST1-Myc/T2-p35 mouse lines have been
described (Claverı´a et al., 2013). Here, they were used in combination with
different Cre-expressing lines to induce genetic mosaics in the developing
and adult mouse heart. Experimental embryos or born mice were generated
from crosses of homozygous iMOS females with males carrying the different
Cre drivers: Nkx2.5Cre (Stanley et al., 2002), Islet1Cre (Yang et al., 2006),
and aMHCmerCremer (Sohal et al., 2001). Mice were genotyped by PCR
(Claverı´a et al., 2013). To induce recombination in iMOS;aMHCmerCremer
mice, they were fed for 1 month with pellets containing tamoxifen at 40 g/kg
(Teklad ref. TD.07262).
Confocal Microscopy
Whole embryonic hearts or histological sections were imaged with a Nikon
A1R confocal microscope using 405, 458, 488, 568, and 633 nm wavelengths
and 203/0.75 dry and 403/1.30 oil objectives. Areas occupied by EYFP and
ECFP cells were quantified using the threshold detection and particle analysis
tools in ImageJ (NIH; http://rsb.info.nih.gov/ij). To calculate the relative fre-
quency of ECFP cells, the percentage of ECFP area observed was divided
by the average percentage in iMOSWT mosaics. All percentages were normal-
ized to a 100% value in theWTmosaic. ECFPwas scored either by direct iden-
tification of native ECFP fluorescence or by subtracting the area of native EYFP
from the anti-GFP staining, which detects both EYFP and ECFP.
Immunofluorescence and TUNEL Assay
Embryos were obtained at different days of gestation and fixed overnight at
4!C in 2% paraformaldehyde in PBS. Hearts were either dissected for
whole-mount staining or gelatin embedded and cryosectioned. Adult cardio-
myocytes were isolated by Langerdorff perfusion with liberase (Roche Applied
Science) and plated for confocal imaging as described previously (Garcı´a-
Prieto et al., 2014). Primary antibodies used were anti-phosphohistone H3
(Ser 10), anti-Myc polyclonal antibody (Millipore), Living colors Rabbit poly-
clonal anti-GFP antibody (Clontech), Beclin1 (Cell Signaling), and Nppa (Milli-
pore). Immunofluorescence was performed following standard procedures.
TUNEL was performed on whole-mount embryonic hearts or sections using
terminal deoxynucleotidyl transferase (TdT) and biotin-16-20-deoxy-uridine-
50-triphosphate (Biotin-16-dUTP) (both from Roche), and developed with
various streptavidin fluorescent conjugates (Jackson ImmunoResearch).
Statistical Analysis
To compare average percentages of ECFP cells/area between more than two
groups, the Kruskal-Wallis test was used (assuming nonnormal distributions).
For comparisons of two groups, a Mann-Whitney test was used. To test the
correlation between cell size and EYFP expression, a linear regression model
was used. All comparisons were made using Prism statistical analysis soft-
ware. The significance of BrdU+ frequency andmononucleated cardiomyocyte
frequency comparisons from adult hearts was analyzed using a proportions
test as implemented in R.
ACCESSION NUMBERS
The NCBI Gene Expression Omnibus database accession number for the
RNA-seq data reported in this paper is GSE58858.
SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures,
three figures, and one movie and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.08.005.
ACKNOWLEDGMENTS
We thank J.L. de la Pompa for comments on the manuscript, V. Garcı´a for
mouse work, E. Arza and A.M. Santos for help with microscopy and 3D recon-
struction, J. Garcı´a-Prieto for help with cardiomyocyte isolation, A.V. Alonso
for the echocardiography assays, F. Sa´nchez-Cabo for statistics, and S. Bar-
tlett for text editing. The CNIC Genomics unit performed the RNA sequencing
procedures. This work was supported by grants BFU2012-31086 and RD12/
0019/0005 (ISCIII) from the Spanish Ministry of Economy and Competition
(MINECO) and grant P2010/BMD-2315 from the Madrid Regional Govern-
ment. C.V. is supported by a FPI grant from the MINECO. The CNIC is sup-
ported by the MINECO and the Pro-CNIC Foundation.
Received: February 5, 2014
Revised: April 21, 2014
Accepted: August 1, 2014
Published: September 4, 2014
REFERENCES
Baker, N.E. (2011). Cell competition. Curr. Biol. 21, R11–R15.
Bondar, T., and Medzhitov, R. (2010). p53-mediated hematopoietic stem and
progenitor cell competition. Cell Stem Cell 6, 309–322.
Claverı´a, C., Albar, J.P., Serrano, A., Buesa, J.M., Barbero, J.L., Martı´nez-A,
C., and Torres, M. (1998). Drosophila grim induces apoptosis in mammalian
cells. EMBO J. 17, 7199–7208.
Claverı´a, C., Giovinazzo, G., Sierra, R., and Torres, M. (2013). Myc-driven
endogenous cell competition in the early mammalian embryo. Nature 500,
39–44.
Dang, C.V. (2013). MYC, metabolism, cell growth, and tumorigenesis. Cold
Spring Harb Perspect Med 3.
Davis, A.C., Wims, M., Spotts, G.D., Hann, S.R., and Bradley, A. (1993). A null
c-myc mutation causes lethality before 10.5 days of gestation in homozygotes
and reduced fertility in heterozygous female mice. Genes Dev. 7, 671–682.
de Beco, S., Ziosi, M., and Johnston, L.A. (2012). New frontiers in cell compe-
tition. Dev. Dyn. 241, 831–841.
de la Cova, C., Abril, M., Bellosta, P., Gallant, P., and Johnston, L.A. (2004).
Drosophila myc regulates organ size by inducing cell competition. Cell 117,
107–116.
Drenckhahn, J.D., Schwarz, Q.P., Gray, S., Laskowski, A., Kiriazis, H., Ming,
Z., Harvey, R.P., Du, X.J., Thorburn, D.R., and Cox, T.C. (2008). Compensatory
growth of healthy cardiac cells in the presence of diseased cells restores tissue
homeostasis during heart development. Dev. Cell 15, 521–533.
Durgan, D.J., and Young, M.E. (2010). The cardiomyocyte circadian clock:
emerging roles in health and disease. Circ. Res. 106, 647–658.
Evans, S.M., Yelon, D., Conlon, F.L., and Kirby, M.L. (2010). Myocardial line-
age development. Circ. Res. 107, 1428–1444.
1750 Cell Reports 8, 1741–1751, September 25, 2014 ª2014 The Authors
Gallant, P. (2013). Myc function in Drosophila. Cold Spring Harb Perspect Med
3, a014324.
Garcı´a-Prieto, J., Garcı´a-Ruiz, J.M., Sanz-Rosa, D., Pun, A., Garcı´a-Alvarez,
A., Davidson, S.M., Ferna´ndez-Friera, L., Nuno-Ayala, M., Ferna´ndez-Jime´-
nez, R., Bernal, J.A., et al. (2014). b3 adrenergic receptor selective stimulation
during ischemia/reperfusion improves cardiac function in translational models
through inhibition of mPTP opening in cardiomyocytes. Basic Res. Cardiol.
109, 422.
Hay, B.A., Wolff, T., and Rubin, G.M. (1994). Expression of baculovirus P35
prevents cell death in Drosophila. Development 120, 2121–2129.
Hurlin, P.J. (2013). Control of vertebrate development by MYC. Cold Spring
Harb Perspect Med 3, a014332.
Jackson, T., Allard, M.F., Sreenan, C.M., Doss, L.K., Bishop, S.P., and Swain,
J.L. (1990). The c-myc proto-oncogene regulates cardiac development in
transgenic mice. Mol. Cell. Biol. 10, 3709–3716.
Kelly, R.G., Brown, N.A., and Buckingham, M.E. (2001). The arterial pole of the
mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev.
Cell 1, 435–440.
Kishimoto, I., Rossi, K., and Garbers, D.L. (2001). A genetic model provides
evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) in-
hibits cardiac ventricular myocyte hypertrophy. Proc. Natl. Acad. Sci. USA 98,
2703–2706.
Knaapen, M.W., Davies, M.J., De Bie, M., Haven, A.J., Martinet, W., and
Kockx, M.M. (2001). Apoptotic versus autophagic cell death in heart failure.
Cardiovasc. Res. 51, 304–312.
Kuhn, M., Holtwick, R., Baba, H.A., Perriard, J.C., Schmitz, W., and Ehler, E.
(2002). Progressive cardiac hypertrophy and dysfunction in atrial natriuretic
peptide receptor (GC-A) deficient mice. Heart 87, 368–374.
Lee, K.S., Park, J.H., Lim, H.J., and Park, H.Y. (2011). HB-EGF induces cardi-
omyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway. Cell.
Signal. 23, 1100–1109.
Levayer, R., and Moreno, E. (2013). Mechanisms of cell competition: themes
and variations. J. Cell Biol. 200, 689–698.
Levens, D. (2013). Cellular MYCro economics: Balancing MYC function with
MYC expression. Cold Spring Harb Perspect Med 3.
Liang, X.H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H.,
and Levine, B. (1999). Induction of autophagy and inhibition of tumorigenesis
by beclin 1. Nature 402, 672–676.
Madonna, R., Cevik, C., Nasser, M., and De Caterina, R. (2012). Hepatocyte
growth factor: molecular biomarker and player in cardioprotection and cardio-
vascular regeneration. Thromb. Haemost. 107, 656–661.
Martin, D.N., and Baehrecke, E.H. (2004). Caspases function in autophagic
programmed cell death in Drosophila. Development 131, 275–284.
Marusyk, A., Porter, C.C., Zaberezhnyy, V., and DeGregori, J. (2010). Irradia-
tion selects for p53-deficient hematopoietic progenitors. PLoS Biol. 8,
e1000324.
Morata, G., and Ripoll, P. (1975). Minutes: mutants of Drosophila autono-
mously affecting cell division rate. Dev. Biol. 42, 211–221.
Moreno, E., and Basler, K. (2004). dMyc transforms cells into super-competi-
tors. Cell 117, 117–129.
Murphy, D.J., Junttila, M.R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D.A.,
Brown-Swigart, L., Johnson, L., and Evan, G.I. (2008). Distinct thresholds
govern Myc’s biological output in vivo. Cancer Cell 14, 447–457.
Nieminen, A.I., Eskelinen, V.M., Haikala, H.M., Tervonen, T.A., Yan, Y., Parta-
nen, J.I., and Klefstro¨m, J. (2013). Myc-induced AMPK-phospho p53 pathway
activates Bak to sensitize mitochondrial apoptosis. Proc. Natl. Acad. Sci. USA
110, E1839–E1848.
Poelmann, R.E., Molin, D.,Wisse, L.J., andGittenberger-de Groot, A.C. (2000).
Apoptosis in cardiac development. Cell Tissue Res. 301, 43–52.
Rana, M.S., Christoffels, V.M., and Moorman, A.F. (2013). A molecular and ge-
netic outline of cardiac morphogenesis. Acta Physiol. (Oxf.) 207, 588–615.
Sancho, M., Di-Gregorio, A., George, N., Pozzi, S., Sa´nchez, J.M., Pernaute,
B., and Rodrı´guez, T.A. (2013). Competitive interactions eliminate unfit embry-
onic stem cells at the onset of differentiation. Dev. Cell 26, 19–30.
Shah, B.H., and Catt, K.J. (2003). A central role of EGF receptor transactivation
in angiotensin II -induced cardiac hypertrophy. Trends Pharmacol. Sci. 24,
239–244.
Sohal, D.S., Nghiem, M., Crackower, M.A., Witt, S.A., Kimball, T.R., Tymitz,
K.M., Penninger, J.M., and Molkentin, J.D. (2001). Temporally regulated and
tissue-specific gene manipulations in the adult and embryonic heart using a
tamoxifen-inducible Cre protein. Circ. Res. 89, 20–25.
Soonpaa, M.H., Kim, K.K., Pajak, L., Franklin, M., and Field, L.J. (1996). Cardi-
omyocyte DNA synthesis and binucleation during murine development. Am. J.
Physiol. 271, H2183–H2189.
Stanley, E.G., Biben, C., Elefanty, A., Barnett, L., Koentgen, F., Robb, L., and
Harvey, R.P. (2002). Efficient Cre-mediated deletion in cardiac progenitor cells
conferred by a 3’UTR-ires-Cre allele of the homeobox gene Nkx2-5. Int. J. Dev.
Biol. 46, 431–439.
Tamori, Y., and Deng, W.M. (2013). Tissue repair through cell competition
and compensatory cellular hypertrophy in postmitotic epithelia. Dev. Cell 25,
350–363.
Tsai, J.Y., Kienesberger, P.C., Pulinilkunnil, T., Sailors, M.H., Durgan, D.J., Vil-
legas-Montoya, C., Jahoor, A., Gonzalez, R., Garvey, M.E., Boland, B., et al.
(2010). Direct regulation of myocardial triglyceride metabolism by the cardio-
myocyte circadian clock. J. Biol. Chem. 285, 2918–2929.
Tyler, D.M., Li, W., Zhuo, N., Pellock, B., and Baker, N.E. (2007). Genes
affecting cell competition in Drosophila. Genetics 175, 643–657.
Vincent, S.D., and Buckingham, M.E. (2010). How to make a heart: the origin
and regulation of cardiac progenitor cells. Curr. Top. Dev. Biol. 90, 1–41.
Vincent, J.P., Fletcher, A.G., and Baena-Lopez, L.A. (2013). Mechanisms
and mechanics of cell competition in epithelia. Nat. Rev. Mol. Cell Biol. 14,
581–591.
Xiao, G., Mao, S., Baumgarten, G., Serrano, J., Jordan, M.C., Roos, K.P., Fish-
bein, M.C., and MacLellan, W.R. (2001). Inducible activation of c-Myc in adult
myocardium in vivo provokes cardiacmyocyte hypertrophy and reactivation of
DNA synthesis. Circ. Res. 89, 1122–1129.
Yang, L., Cai, C.L., Lin, L., Qyang, Y., Chung, C., Monteiro, R.M., Mummery,
C.L., Fishman, G.I., Cogen, A., and Evans, S. (2006). Isl1Cre reveals a common
Bmp pathway in heart and limb development. Development 133, 1575–1585.
Cell Reports 8, 1741–1751, September 25, 2014 ª2014 The Authors 1751
125
Wu	
    wei
